The EEG in acute ischaemic cerebrovascular disease by Bentes, Carla Cristina Paulo Gabriel
  
 
UNIVERSIDADE DE LISBOA 
Faculdade de Medicina  
 
 
 
The EEG in Acute Ischaemic Cerebrovascular Disease 
 
 
Carla Cristina Paulo Gabriel Bentes 
 
 
 
Orientadores: Prof. Doutor José Manuel Morão Cabral Ferro 
 Prof.ª Doutora Maria Teresa de Aguiar dos Santos Paiva 
 
 
 
Tese especialmente elaborada para obtenção do grau de Doutor em 
Medicina, ramo de Neurologia 
 
 
 
2018 

  
UNIVERSIDADE DE LISBOA 
Faculdade de Medicina  
 
The EEG in Acute Ischaemic Cerebrovascular Disease 
 
Carla Cristina Paulo Gabriel Bentes 
 
Orientadores: Prof. Doutor José Manuel Morão Cabral Ferro 
 Prof.ª Doutora Maria Teresa de Aguiar dos Santos Paiva 
 
Tese especialmente elaborada para obtenção do grau de Doutor em Medicina, ramo de 
Neurologia 
 
Júri 
Presidente: Doutor José Luís Bliebernicht Ducla Soares, Professor Catedrático em regime 
de tenure da Faculdade de Medicina da Universidade de Lisboa 
Vogais:  
- Doutor António Freire Gonçalves, Professor Associado com Agregação da Faculdade de 
Medicina da Universidade de Coimbra 
- Doutor António Martins da Silva, Professor Catedrático Convidado Jubilado do 
Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto 
- Doutor António José Gonçalves Ferreira, Professor Catedrático da Faculdade de 
Medicina da Universidade de Lisboa 
- Doutor José Manuel Morão Cabral Ferro, Professor Catedrático da Faculdade de 
Medicina da Universidade de Lisboa  
- Doutor Mamede Alves de Carvalho, Professor Catedrático da Faculdade de Medicina 
da Universidade de Lisboa 
 
2018 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As opiniões expressas nesta publicação são da exclusiva responsabilidade do seu autor  
 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aos meus Pais 
À Catarina, ao Francisco, ao Afonso e ao Duarte 
Ao Filipe 
 

The EEG in Acute Ischaemic Cerebrovascular Disease 
 
I 
 
PREAMBLE 
 
 
 
“It is important to learn; but it is much more important to learn how to learn,  
and to desire to go on learning all through life” 
Pedro Arrupe 
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O meu gosto pela Neurologia começou em 1988 na Faculdade de Medicina da Universidade 
de Lisboa, à qual me proponho agora para obtenção do grau de Doutor. O início aconteceu 
durante a cadeira de Anatomia II com o Professor Doutor António Gonçalves Ferreira, 
cresceu e amadureceu significativamente na cadeira de Neurologia pela mão do meu 
assistente, o Dr. Francisco Pinto e fortificou-se no 6.º ano na cadeira de Neurocirurgia por 
influência marcante do Professor Doutor João Lobo Antunes.   
Desde então, não mais parei de me entusiasmar pelas infindáveis potencialidades e mistérios 
do Sistema Nervoso. Esta paixão alimenta-se dia-a-dia com o apoio de Neurologistas 
extraordinários com os quais tenho tido o privilégio de percorrer este caminho. Logo nos 
primeiros anos do internato, no Serviço de Neurologia do Hospital de Santa Maria, a 
Professora Doutora Maria de Lurdes Salles Luís e o Professor Doutor Mamede de Carvalho 
deram-me a conhecer a Neurofisiologia e mudaram por completo a minha forma de estar e 
pensar em Neurologia. O entusiasmo foi tão forte e evidente que a minha diferenciação nesta 
área foi perfeitamente natural, como se nunca pudesse ter escolhido outro campo de 
diferenciação na Neurologia. Houve ainda uma influência fundamental do Grupo de Estudos 
da Epilepsia do Serviço e do Grupo da Cirurgia da Epilepsia, na altura ainda no seu inicio 
(com o Professor Doutor António Gonçalves Ferreira, Professor Doutor Carlos Garcia, Dr. 
Francisco Pinto e Professora Doutora Maria Sande Lemos). Alguém muito especial no meu 
percurso foi, sem dúvida, a Professora Doutora Teresa Paiva, responsável pelo Laboratório 
de EEG/Sono onde fiz o meu estágio de Neurofisiologia, primeiro obrigatório e depois 
opcional, e onde continuei a trabalhar desde então. Foi desta forma que durante o internato 
conheci o mundo aliciante, os factos e os enigmas de duas áreas neurológicas em franco 
desenvolvimento, a Epilepsia e o Sono, aliados inseparáveis da Neurofisiologia Clinica, e 
que dei o primeiro passo de uma viagem que me trouxe até aqui. Realço ainda o Professor 
Doutor Colin Binnie e a Dr. Nandini Mullati com os quais tive oportunidade de trabalhar no 
King´s College Hospital em Londres, meus mentores no gosto e diferenciação em 
Neurofisiologia Clínica e estudos neurofisiológicos no doente com epilepsia.  
 
O meu percurso académico esteve lado a lado com a minha formação e vida hospitalar e 
muitas vezes foi exatamente o mesmo. Durante o curso de Medicina, dei tímidos passos na 
investigação laboratorial com a Professora Doutora Leonor Parreira e Professora Doutora 
Carmo Fonseca no Laboratório de Biologia Celular, nessa altura da responsabilidade do 
Professor Doutor David Ferreira. Posteriormente, tive o privilégio de me formar e depois 
adquirir um vínculo de trabalho num Serviço onde a investigação, o ensino e clínica viviam 
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e vivem em harmonia, complementando-se numa relação de simbiose autossustentável e 
gratificante. Foi então essencial, uma vez mais, a influência do Professor Doutor Mamede 
de Carvalho com quem dei os primeiros passos na comunicação e publicação em Ciência. 
Com uma mente brilhante e uma motivação inesgotável, o Professor Doutor Mamede de 
Carvalho será sempre uma referência na minha vida profissional. Agradeço-lhe todos os 
minutos em que me ensinou Neurofisiologia e Ciência. Sem eles, a minha vida profissional 
teria seguido, certamente, um rumo diferente. Mais tarde, o Professor Doutor José Pimentel 
e a Professora Doutora Teresa Paiva incentivaram o meu interesse pela investigação em 
epilepsia e medicina do sono, respectivamente. Por outro lado, o meu gosto em ensinar 
(provavelmente genético) e pela formação médica sempre esteve presente. Desde cedo a 
minha colaboração voluntária nas aulas práticas de neurologia foi um estímulo para o meu 
próprio crescimento e aprendizagem. Sempre, a Professora Doutora Teresa Paiva e o 
Professor Doutor José Pimentel incentivaram este meu gosto e proporcionaram-me 
diferentes experiências curriculares na formação pré e pós-graduada, médica e não médica, 
dentro e fora da Faculdade de Medicina da Universidade de Lisboa, que enriqueceram a 
minha própria formação.  
 
Desde o final do internato que tinha a intensão de prosseguir para o doutoramento. Outros 
projetos e imponderáveis foram protelando a decisão de o iniciar. Achei que precisava de 
me tornar formalmente neurofisiologista pelo que fiz o Ciclo de Estudos Especiais em 
Neurofisiologia Clínica, ganhando progressivamente prática na interpretação dos exames 
neurofisiológicos. Estive 4 anos num hospital distrital, numa “vaga de carenciados”, onde 
aprendi outra realidade sobre a medicina e em particular sobre a Neurologia em Portugal. 
No Ribatejo, fiz ainda alguns amigos. Constituí a minha própria família, numerosa por 
opção. Assumi precocemente a responsabilidade de um Laboratório de EEG/Sono e de uma 
consulta externa num Departamento de Neurociências de um Hospital Universitário e, por 
este motivo, decidi fazer uma pós-graduação em liderança e gestão de unidades de saúde. 
Não foi tempo perdido, foi tempo ganho a adquirir outras capacidades, competências, 
atitudes e a construir um curriculum, principalmente “escondido”, que muito me tem ajudado 
a fazer a minha viagem profissional, clinica e académica, e a construir a pessoa que sou hoje. 
 
A decisão de juntar o EEG, a Epilepsia e as Doenças Vasculares Cerebrais numa tese de 
doutoramento tem naturalmente a influência e a liderança perspicaz do Professor Doutor 
José Manuel Ferro, Diretor do Departamento de Neurociências onde trabalho. O tema não 
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era algo totalmente novo no meu percurso clinico e académico, tendo já trabalho publicado 
desde 2001 não só sobre crises e epilepsia pós-AVC 1,2, sob a orientação do Professor Doutor 
José Manuel Ferro, mas também sobre recomendações na utilização do EEG em epilepsia  3, 
com a orientação do Professor Doutor António Martins da Silva.  Agora, a vertente 
neurofisiológica, já mais amadurecida, foi adicionada ao tema. Tive como principal objetivo 
sair um pouco da minha zona de conforto para conseguir aprender mais sobre investigação 
clínica e método científico. Queria aprender mais para conseguir um dia ensinar melhor. 
Começar do início, de uma hipótese, projetar, escrever e desenvolver um projeto original, 
implementá-lo na prática clínica multi e interdisciplicarmente, utilizar diferentes técnicas e 
métodos de análise em investigação clinica e neurofisiológica, recolher dados e analisá-los 
corretamente,  escrever, escrever e reescrever, tantas vezes quanto o meu sentido crítico 
exigisse, aprender a lidar com a revisão por pares ao ponto de se tornar um desafio viciante 
e gratificante e, no final, conseguir resumir vários anos de trabalho num texto de 1200 
palavras ou em 20 minutos de apresentação. Estas foram as minhas prioridades na escolha 
do tema da tese e do meu orientador.  Estava consciente de que para adquirir um novo Saber 
era preciso “desaprender” primeiro, relativizar algumas coisas que sabia ou pensava que 
sabia, começar de novo com alguém que me questionasse por tudo, que fosse mais exigente 
do que eu própria e que me permitisse abandonar alguns hábitos, mas principalmente criar 
outros. Sendo uma referência Nacional e Internacional, Clínica e Académica, na área da 
Neurologia e Doenças Vasculares Cerebrais, com um gosto secreto pela Epilepsia (gosto de 
acreditar que sim...), quem melhor do que o Professor Doutor José Manuel Ferro para me 
fazer sair da minha zona de conforto?  Agradeço-lhe ter-me acolhido nesta área e a confiança 
que em mim depositou ao aceitar o desafio de ser meu orientador. Peço-lhe desculpa por 
todos os e-mails ao fim-de-semana e por todos os textos e pedidos de assinaturas para 
submissão de artigos, que lhe enviei quando estava de férias. A orientação conjunta da 
Professora Doutora Teresa Paiva surgiu naturalmente. Não teria sentido de outra forma. 
Muito do que aprendi e continuo a aprender sobre Neurofisiologia, Sono e sobre a Vida em 
geral devo à Professora Doutora Teresa Paiva. Tenho imenso orgulho em fazer parte da 
Escola que formou, e continua a formar, e de merecer a sua amizade.  
A escolha do tema da tese teve ainda dois outros motivos subjacentes, mutuamente 
relacionados. Sendo uma tese de doutoramento em Neurologia, fazia-me sentido que 
englobasse e integrasse diferentes áreas do conhecimento neurológico de uma forma 
concertada. Por outro lado, tem sido meu objetivo abrir as portas do Laboratório de 
EEG/Sono onde trabalho a outras áreas da Neurologia, convicta que a Neurofisiologia e a 
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Medicina do Sono são áreas transversais e essenciais às Neurociências (e não ilhas isoladas), 
e que todas ganham com o contributo multi e interdisciplinar. A colaboração com grupo de 
Doenças Vasculares Cerebrais do Serviço de Neurologia, ao qual agradeço a oportunidade 
que me foi dada, foi um exemplo bem sucedido disso mesmo. Este projeto de doutoramento 
foi pensado e planeado para que pudesse ocorrer no dia-a-dia de um Serviço de Neurologia, 
tanto na sua vertente ambulatória como de internamento, com os recursos humanos, técnicos, 
logísticos e de espaço previamente existentes (na verdade foi feito em plena troika...). A 
organização do Laboratório com esse objetivo foi um exercício muito interessante de gestão 
e liderança e permitiu que o laboratório se tornasse mais eficiente, antecipando o crescente 
número de exames eletroencefalográficos que foram requisitados que nos anos seguintes, 
principalmente a doentes internados.  
 
Será certamente não o fim, mas um novo princípio. Quero levar o que aprendi a outras áreas 
a que me dedico na Neurologia e Neurofisiologia, principalmente no âmbito da Epilepsia e 
da Medicina do Sono. Quero poder ensinar o que aprendi e, sobretudo, quero continuar a 
aprender. 
 
 
CB 
Setembro de 2017 
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The EEG in Acute Ischaemic Cerebrovascular Disease  
 
The electroencephalogram (EEG) is a neurophysiological technique with high temporal 
resolution and sensibility in the evaluation of brain function in real time. Besides this, EEG 
is the gold standard for the identification of epileptogenesis and ictogenesis biomarkers.  
 
Epileptic seizures and Cerebrovascular disease are two of the most frequent neurological 
disorders imposing important mutual challenges. Furthermore, in recent years, stroke care 
has evolved remarkably and, facing a new paradigm of acute standard of care (centred on 
multidisciplinary Stroke Units), epileptic seizures (as stroke complications) deserve to be 
rethought.  The EEG is an essential neurophysiological exam in the evaluation of patients 
with epileptic seizures, status epilepticus and/or epilepsy, both for diagnosis and 
classification, as well as for the establishment of a correct treatment or outcome prediction. 
Furthermore, EEG has been previously used in cerebrovascular disease with different 
purposes. However, its clinical usefulness in the differential diagnosis of transient 
neurological symptoms, specifically in the differentiation between a transient ischaemic 
attack and some epileptic seizures, and also in the diagnosis or prediction of post-stroke 
seizures or in post-stroke prognosis prediction, remains uncertain.  
 
In this work, we aim to use the clinical model of acute ischaemic cerebrovascular disease to 
study the value of EEG in the differential diagnosis of transient neurological symptoms, in 
the diagnosis and prediction of post-stroke seizures and epilepsy, as well as to analyse if 
electroencephalographic abnormalities and/or epileptic seizures are independent predictors 
of an anterior circulation ischaemic stroke outcome. Furthermore, since the gold standard of 
acute stroke care (namely intravenous alteplase treatment) is associated with a reduction of 
mortality and incapacity of treated patients with possible consequences in post-stroke seizure 
frequency, but a pro-convulsive and an epileptogenic effect of alteplase has also been 
described, we aim to test the hypothesis that ischaemic stroke patients treated with 
intravenous alteplase have a different frequency of epileptic (clinic and/or 
electroencephalographic) manifestations compared to non-treated patients.   
 
Different research methodologies were used in this thesis. A systematic review and meta-
analysis of observational studies was performed to evaluate both the frequency of post-stroke 
(ictal and interictal) epileptiform activity in the EEG, and the quality of studies about this 
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subject. Furthermore, different types of observational studies (including clinical case report, 
case series and cohort studies) were completed to answer relevant clinical questions. 
We performed a prospective longitudinal study of possible transient ischaemic attacks (TIA) 
patients evaluated at a tertiary centre during 36 months, with 1-3 months follow-up and also 
of acute anterior circulation ischaemic stroke patients, consecutively admitted to a Stroke 
Unit over 24 months and followed-up for one year. In both studies, patients underwent 
standardized clinical, diagnostic and neurophysiological assessment. 
A short duration (≤60 minutes) video-EEG protocol with an extended montage including 64 
EEG, two electrooculogram, one electrocardiogram and at least one electromyogram 
channel was established. Different electroencephalographic investigation technics including 
visual, back-average and quantitative analysis were used in the clinical workup of patients 
with possible and definite, transient and established, cerebrovascular disease as tools for the 
differential diagnosis and for brain functional assessment, concerning not only epileptic 
manifestations detection and prediction but also to search for predictors of ischaemic stroke 
functional outcome and vital prognosis.  
 
Although epileptic seizures were the most frequent defined final diagnosis (n=13; 16.3%) in 
our series of 80 patients with difficult-to-diagnose transient neurological symptoms, visual 
inspection of EEG supported this diagnosis only in 7.5% (n=6) of patients with possible TIA. 
Moreover, the majority (n=6; 53.8%) of patients with the final diagnosis of epileptic seizures 
did not have interictal epileptiform activity in an early EEG. Furthermore, early focal slow 
wave activity, the most frequent EEG abnormality in this patient’s series, did not 
distinguished between TIA and seizure patients. 
Our systematic review and random-effects meta-analysis showed that the pooled frequency 
of post-stroke ictal and interictal epileptiform activity was 7% (95%CI: 3%-12%) and 8% 
(95%CI: 4%-13%) respectively. Only 2 out of 17 included studies (11.7%) attained the 
maximum quality score. Moreover, no study exclusively enrolled ischaemic stroke patients, 
highlighting the need for higher quality studies in the evaluation of epileptiform activity 
frequency in this type of cerebrovascular disease. Furthermore, due to detection bias, it was 
not possible to correlate clinical and electrographic seizures.  
In our prospective cohort of 151 anterior circulation acute stroke patients, we identified 
different post-stroke, clinical and electroencephalographic, epileptic manifestations 
including 22.7% (5/22) of acute symptomatic seizures that were exclusively electrographic 
and therefore could not otherwise be recognised. Furthermore, only EEG back-average 
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analysis allowed the diagnosis of cortical myoclonus during intravenous alteplase perfusion 
in one clinical vignette included in this work and the recognition of epilepsia partialis 
continua as a chronic complication of this stroke type in 1.7% of patients. This original work 
also showed that studied clinical and EEG epileptic manifestations were not significantly 
different between intravenous alteplase treated and non-treated patients.  
This thesis work established which abnormalities of an early EEG after acute stroke 
(background activity asymmetry and the presence of interictal epileptiform activity) are 
independent predictors of epilepsy in the year after (even when adjusted for clinical and 
imaging stroke severity). Besides this, early (within the first 72h) post-stroke EEG features, 
extracted from visual (background activity diffuse slowing and asymmetry) and quantitative 
(such as delta-theta to alpha-beta ratio and alfa relative power) analysis were recognized as 
independent predictors of death or functional dependency, at hospital discharge and at 12 
months after stroke. Furthermore, outcome models that incorporate delta-theta to alpha-beta 
ratio or alpha relative power were better than models based exclusively on clinical and 
imaging-related ischaemic stroke severity at hospital admission. Additionally, post-stroke 
acute symptomatic seizures and epilepsy were independently associated to death and to an 
unfavourable outcome 1 year after an acute anterior circulation ischaemic stroke, 
respectively.   
 
Globally, these research projects have shown the value of EEG in the current paradigm of 
stroke patient’s care. Furthermore, they expand the knowledge both about the EEG role as a 
complementary neurophysiological tool in general Neurology and about different aspects of 
the diagnosis and outcome of two of the most prevalent neurological disorders, 
Cerebrovascular Diseases and Epilepsy, in particular.  
Beyond the value of specific results, with this work several other research questions about 
EEG and seizures in ischaemic cerebrovascular disease emerge. Therefore, new possibilities 
of future research, ideally multicentric, clinical or translational arise. 
 
 
Key-words: EEG, cerebrovascular disease, transient ischaemic attacks, ischaemic stroke, 
alteplase, intravenous thrombolysis, acute symptomatic seizures, unprovoked seizures, 
epilepsy, diagnosis, prediction, outcome. 
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O EEG na Doença Vascular Cerebral Isquémica Aguda  
 
O eletroencefalograma (EEG) é uma técnica neurofisiológica com uma elevada resolução 
temporal e sensibilidade na avaliação da função cerebral em tempo real. Para além disso, o 
EEG é o gold standard para a identificação de biomarcadores da epileptogénese e 
ictogénese.  
 
As crises epilépticas e a doença vascular cerebral são duas das doenças neurológicas mais 
frequentes e que impõem mutuamente desafios importantes. Além disso, nos últimos anos, 
os cuidados ao doente com AVC evoluíram de uma forma notável e num novo paradigma 
de cuidados agudos (centrados em equipas multidisciplinares), as crises epilépticas (como 
complicações pós-AVC) merecem ser re-estudadas. O EEG é um exame neurofisiológico 
essencial na avaliação de doentes com crises epilépticas, estado de mal epilético e/ou 
epilepsia, tanto para o diagnóstico e classificação, como para o estabelecimento de um 
tratamento adequado e predição prognóstica. Para além disso, o EEG foi usado previamente 
na doença vascular cerebral com diferentes objectivos. Contudo, é ainda incerta a sua 
utilidade clínica no diagnóstico diferencial dos sintomas neurológicos transitórios, 
nomeadamente na diferenciação entre um acidente isquémico transitório e alguns tipos de 
crises epilépticas, e também no diagnóstico ou predição de crises epilépticas após um 
acidente vascular cerebral (AVC) ou na predição do prognóstico pós-AVC.  
 
Neste trabalho, tivemos como objectivo usar o modelo clínico da doença vascular cerebral 
para estudar o valor do EEG no diagnóstico diferencial dos sintomas neurológicos 
transitórios, no diagnóstico e predição das crises pós-AVC, assim como para analisar se as 
alterações eletroencefalográficas e/ou as crises epilépticas são preditoras independentes do 
prognóstico num doente com um acidente vascular cerebral isquémico da circulação 
anterior.  Ademais, porque o tratamento atual padrão dos doentes com acidente vascular 
cerebral isquémico agudo (alteplase endovenosa) está associado a redução da mortalidade e 
da incapacidade, com possíveis consequências na frequência de crises pós-AVC, mas um 
efeito pró-convulsivo e epileptogénico da alteplase também foi descrito, quisemos estudar a 
hipótese dos doentes tratados com alteplase endovenosa terem uma frequência diferente de 
manifestações epilépticas (clínicas e/ou eletroencefalográficas) comparativamente com os 
doentes não tratados.  
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Diferentes metodologias de investigação foram usadas neste trabalho. Foi efetuada uma 
revisão sistemática e meta-análise de estudos observacionais para avaliar a frequência de 
atividade epileptiforme (crítica e intercrítica) e a qualidade dos estudos existentes sobre este 
assunto. Adicionalmente, foram completados diferentes estudos observacionais (incluindo 
descrição de caso clínico, série de casos e estudos de coorte) respondendo a perguntas 
clínicas relevantes.  
Efetuámos um estudo longitudinal prospectivo de doentes com acidentes isquémicos 
transitórios possíveis, avaliados num centro terciário durante 36 meses e com 1-3 meses de 
seguimento. Estudámos ainda doentes com um AVC isquémico agudo da circulação anterior, 
admitidos consecutivamente numa Unidade de AVC durante 24 meses e seguidos durante 1 
ano. Em ambos os estudos os doentes foram submetidos a uma avaliação clínica, diagnóstica 
e neurofisiológica estandardizada.  
Foi estabelecido um protocolo de vídeo-EEG de curta duração (≤60 minutos) com uma 
montagem que incluía pelo menos 64 canais de EEG, dois de eletrooculograma, um de 
eletrocardiograma e pelo menos um de eletromiograma. Diferentes técnicas 
eletroencefalográficas foram usadas na avaliação de doentes com doença vascular cerebral 
possível ou definitiva, transitória ou estabelecida. Estas ferramentas foram utilizadas para o 
diagnóstico diferencial e para a avaliação da função cerebral, não só no que diz respeito à 
detecção e previsão de manifestações epilépticas, mas também à identificação de preditores 
do prognóstico funcional e vital de doentes com um acidente vascular cerebral isquémico.  
 
Embora as crises epilépticas tenham sido o diagnóstico final definido mais frequente 
(n=13/16.3%) na nossa série de 80 doentes com sintomas neurológicos transitórios de difícil 
diagnóstico, a análise visual do EEG suportou este diagnóstico somente em 7.5% (n=6) dos 
doentes com AIT possível. Aliás, a maioria dos doentes (n=6; 53,8%) com o diagnóstico 
final de crises epilépticas não tinha atividade epileptiforme no EEG precoce. Por outro lado, 
a atividade lenta focal precoce, alteração mais frequente no EEG nesta série de doentes, não 
permitiu o diagnóstico diferencial entre um AIT e uma crise epiléptica. 
A revisão sistemática e a meta-análise de efeitos aleatórios efetuadas mostrou uma 
frequência estimada de atividade epileptiforme crítica e intercrítica de 7% (95%CI: 3%-
12%) e 8% (95%CI: 4%-13%), respectivamente. Somente 2 dos 17 estudos incluídos 
(11,7%) obtiveram uma pontuação máxima na escala de avaliação de qualidade utilizada. 
Para além disso, nenhum estudo envolveu doentes exclusivamente com AVC isquémico, 
mostrando a necessidade de trabalhos de melhor qualidade na avaliação da frequência da 
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atividade epileptiforme neste tipo de doença vascular cerebral. Além disso, devido a um viés 
de detecção, não foi possível correlacionar as crises clínicas e eletrográficas.  
No estudo prospectivo de 151 doentes com AVC isquémicos da circulação anterior, 
identificámos diferentes manifestações epilépticas pós-AVC, clínicas e 
eletroencefalográficas, incluindo 22.7% (5/22) de crises sintomáticas agudas que foram 
exclusivamente eletrográficas e que, portanto, não poderiam ter sido reconhecidas de outra 
maneira. Da mesma forma, somente a análise de “back-average” permitiu o diagnóstico de 
mioclonias corticais durante a perfusão endovenosa de alteplase numa vinheta clínica 
incluída neste trabalho e o reconhecimento de epilepsia partialis continua como uma 
complicação crónica deste tipo de AVC em 1.7% dos doentes. Este trabalho original também 
mostrou que as manifestações epilépticas estudadas, clínicas e eletroencefalográficas, não 
foram significativamente diferentes entre doentes tratados e não tratados com alteplase 
endovenosa, após ajustamento para a idade e gravidade clínica e imagiológica do enfarte.  
Esta tese identificou ainda alterações eletroencefalográficas precoces após um acidente 
vascular cerebral agudo do território anterior (assimetria da eletrogénese de base e atividade 
epileptiforme intercrítica no EEG) como preditores independentes de epilepsia pós-AVC no 
ano seguinte (mesmo após ajuste para a gravidade clínica e imagiológica do enfarte). Além 
disso, características eletroencefalográficas precoces (das primeiras 72h) pós-AVC, 
extraídas não só da análise visual (lentificação e assimetria da eletrogénese de base) mas 
também quantitativa do EEG (como o rácio delta-teta / alfa-beta e a potência relativa do alfa) 
foram reconhecidas como preditores independentes de morte ou dependência funcional, não 
só na alta como 12 meses depois de um AVC isquémico da circulação anterior. Para além 
disso, os modelos de prognóstico que incorporaram o rácio delta-theta / alfa-beta ou a 
potência realtiva do alfa tiveram uma melhor capacidade discriminativa do que o modelo 
baseado exclusivamente na gravidade clínica e imagiológica do enfarte aquando da admissão 
hospitalar do doente com um AVC agudo do território anterior. Adicionalmente, as crises 
sintomáticas agudas e a epilepsia pós-AVC associaram-se a morte e a um prognóstico 
desfavorável, respetivamente, no ano seguinte a um AVC agudo da circulação anterior.  
 
Na sua globalidade, os projetos de investigação incluídos nesta tese mostraram o valor do 
EEG no paradigma atual dos cuidados médicos ao doente com AVC isquémico. Ademais, 
ampliam o conhecimento sobre o valor do EEG como uma técnica neurofisiológica 
complementar em Neurologia e sobre o diagnóstico e prognóstico de duas das mais 
prevalentes doenças neurológicas, as Doenças Vasculares Cerebrais e a Epilepsia.  
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Para além do valor dos resultados específicos, surgem com este trabalho várias outras 
perguntas de investigação sobre o EEG e as crises epilépticas pós AVC.  Emergem assim 
novas possibilidades de investigação futura, idealmente multicêntrica, clínica e 
translacional. 
 
 
Palavras-Chave: EEG, doença vascular cerebral, acidente isquémico transitório, AVC 
isquémico, alteplase, trombólise endovenosa, crises sintomáticas agudas, crises não 
provocadas, epilepsia, diagnóstico, predição, prognóstico. 
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I. INTRODUCTION 
 
 
 
“Start by doing what's necessary;  
then do what's possible;  
and suddenly you are doing the impossible” 
S. Francisco de Assis 
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1. RESEARCH TOPIC IMPORTANCE AND KNOWLEDGE GAPS SYNOPSIS 
 
The electroencephalogram (EEG) is a neurophysiological technique with high temporal 
resolution and sensibility in the evaluation of brain function in real time. Besides, EEG is 
the gold standard for identifying different epileptogenesis and ictogenesis biomarkers4,5. 
Moreover, EEG does not have relevant contraindications, and is a painless exam that can be 
done at the patient's bedside, repeatedly or continuously, according to the clinical evolution 
without increased risks. It is also a low-cost exam, available in most hospitals. First used in 
humans in 1929 by Hans Berger6, EEG survived rapid technological advances of brain 
imaging technics arising mainly in the 70s7, and evolved including different technical 
modalities of recording and analysis of bioelectrical cerebral activity. Therefore, it 
progressively increased its importance in the diagnosis, treatment programing and evaluation 
and also in functional prognostication of specific neurological disorders. Currently, it is 
frequently used in Neurology clinical practice as a complementary technique to the essential 
clinical assessment of brain function, either alone or in a multimodal perspective7.  In fact, 
EEG is an essential neurophysiological exam in the evaluation of patients with epileptic 
seizures, status epilepticus and/or epilepsy, both for diagnosis and classification, as well as 
for the establishment of a correct treatment3,8. Furthermore, EEG has been used in 
cerebrovascular disease with different clinical and research purposes (described in detail in 
introduction point 2). However, the clinical usefulness of this neurophysiological technique 
in the differential diagnosis of transient neurological symptoms (namely in the 
differentiation between a transient ischaemic attack and some types of epileptic seizures) 
and also in the diagnosis or prediction of post-stroke seizures or even in stroke 
prognostication remains uncertain. 
 
Cerebrovascular disease and epileptic seizures are two of the most frequent neurological 
disorders9 being associated to different mutual challenges and relationships in clinical 
practice (expanded topic of introduction point 3).  
The first clinical challenge is the differential diagnosis10–16. Although expert clinical 
assessment and cerebral imaging are undoubtedly useful, there is still a need for 
complementary diagnosis tools in helping this distinction17.  However, there are few 
studies18 about the EEG’s value in the discrimination of these neurological entities.  
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Secondly, cerebrovascular disease is a frequent risk factor for epileptic seizures19,  
accounting for more than half of all cases of epilepsy in elderly patients20. However, reported 
frequency of post-stroke seizures after an ischaemic stroke is variable (2-67%)21–26 possibly 
due to different study methodologies including the lack of an electroencephalographic 
record27. Furthermore, in recent years, stroke care has evolved remarkably and facing a new 
paradigm of acute standard care (centred on multidisciplinary Stroke Units), epileptic 
seizures (as stroke complications) deserve to be rethought.  As a matter of fact, intravenous 
alteplase (rtPA), the gold standard treatment for acute ischaemic stroke, has been associated 
with clinical seizures and the occurrence of epileptiform activity in the EEG28,29. It has even 
been documented that seizures during rtPA perfusion can occur even in the absence of a 
cerebral lesion, as described in 2 patients submitted to thrombolysis for acute myocardial 
infarction30. In fact, neurotoxic and epileptogenic properties31 of rtPA are known. Other 
postulated mechanisms for seizures during thrombolysis for ischaemic stroke include 
secondary cortical infarct from distal embolization or reperfusion/hyperperfusion 
syndrome32. A different imaging pattern of the infarct in patients treated with rtPA might 
also predispose to seizure occurrence. Despite the clinical relevance of these observations, 
rtPA related seizures30,32,33 and the frequency of seizures in patients treated with rtPA34,35 
has been mostly described in a few retrospective and non-controlled case series. 
Furthermore, it is known that clinical stroke severity and infarct dimension are risk factors 
for post-stroke epileptic seizures and vascular epilepsy27 and that EEG is a sensitive 
neurophysiological technique in the detection of acute cerebral ischaemia36 and a robust one 
in the functional assessment of the brain37. However, it is unclear whether 
electroencephalographic markers of acute vascular injury severity are independently 
associated with an increased risk of post-stroke seizures or useful for their prediction.  
The third interaction between cerebrovascular disease and epileptic seizures is a possible 
outcome influence. Stroke is a leading cause of disability and mortality worldwide and 
global stroke burden is expected to rise in the future38. Despite the existence of demographic, 
clinical and imaging27,39–42 predictors of stroke functional outcome, there is large 
interindividual variability in short and long-term outcome of ischaemic stroke43 and still the 
need to identify reliable, inexpensive biomarkers that can add prognostic information in 
these patients. Post-stroke seizures44,45 (and also electrographic seizures and interictal 
epileptiform discharges in critically ill patients46–48) have been associated to an unfavourable 
functional outcome of stroke patients. However, it is not known if this association is 
independent from stroke severity. Furthermore, due to accumulating evidence regarding 
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neuro-vascular uncoupling in acute ischaemic stroke, neurophysiological biomarkers seem 
increasingly relevant for predicting outcome49. 
 
We thought this project could expand the knowledge both about the EEG’s value as a 
complementary neurophysiological tool and regarding two of the most prevalent 
neurological disorders, specifically regarding their differential diagnosis, the frequency and 
prediction of post-stroke epileptic seizures and epilepsy, and the influence of seizures and 
EEG abnormalities in stroke outcome.  
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2. THE EEG IN ISCHAEMIC CEREBROVASCULAR DISEASE  
 
The recording and monitoring of EEG in patients with acute ischaemic cerebrovascular 
disease has been done in different contexts and is based on various types of evidence, which 
are described in the following paragraphs.  
 
2.1. The EEG in the differential diagnosis of a Transient Ischaemic Attack (TIA)  
 
The use of EEG in clinical models of TIA has been poorly explored. However, De Reuck & 
Van Maele50 showed the importance of the EEG in the differential diagnosis of a TIA versus 
an inhibitory epileptic seizure. Comparing clinical and EEG features of patients with TIA 
and patients with inhibitory epileptic seizures, they found differences in age, sex and 
cerebrovascular risk factors between the two groups. In addition, most patients with seizures 
had EEG abnormalities (specific and nonspecific), while 90% of patients with TIA had a 
normal EEG. Furthermore, in a subgroup analysis (TIA with symptoms lasting less than 24 
hours versus less than 1 hour) the clinical differences previously found were not significant, 
but (regardless of TIA definition) EEG findings remain different between TIA and epileptic 
seizures patients. The authors conclude that an urgent EEG is essential in the investigation 
of a transient episode of neurological dysfunction. In fact, EEG differences appeared to be 
larger than those found when comparing patients with and without unprovoked seizures after 
stroke51. This evidence increased the number of EEG requests for patients admitted to the 
TIA Clinic of our Neurology Department, especially in patients with difficult-to-diagnose 
transient neurological symptoms or possible TIA. However, the type and frequency of EEG 
abnormalities in possible TIA and their value in the distinction between an epileptic seizure 
and a TIA is not exactly known.  
 
2.2. The EEG in the detection of acute cerebral ischaemia  
 
EEG abnormalities are early markers of cerebral ischaemia and reflects the disturbance of 
oxygen metabolism52 and the reduction of cerebral blood flow53,54.  The first EEG changes 
occur when cerebral blood flow reaches 25-30 ml/100g/minute. At this level, therapeutic 
interventions may prevent brain damage which is established for flows lower than 18 
ml/100g/minute55–57 and reversible until a flow of 12ml/100g/minute36. Mild hypoxia 
(cerebral blood flow of 25-30 ml/100g/min) determines a subtle reduction of the amplitude 
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of rapid activity (>13 Hz) in the EEG. The worsening of ischaemia results in the appearance 
of polymorphic delta activity and more marked attenuation of rapid activities, including 
alpha and sleep spindles58,59. The use of quantitative EEG (qEEG) also showed a relationship 
between focal ischaemia and some indices such as the absolute and relative power of 
different spectral bands58,60,61 and brain symmetry index62.  
Given the availability and characteristics of current cerebral imaging techniques, EEG is not 
currently used for the diagnosis or for the topographical location of an ischaemic stroke. 
However, some EEG patterns such as regional attenuation without delta (RAWOD)63 have 
been suggested as possible support for patient selection in the emergency department for 
thrombolysis or treatment of cerebral oedema64.  In fact, some authors agree that EEG can 
be used in an acute stroke setting as a continuous monitor of cerebral perfusion to detect 
progressive or recurrent ischaemia59. 
 
2.3. The EEG in the detection of revascularization and ischaemic stroke treatments 
effects 
 
The EEG is sensitive to cerebral reperfusion and can demonstrate recovery earlier than the 
clinical examination65. This observation makes it a potentially very useful tool for 
continuously monitoring cerebral perfusion and stroke revascularization therapy. In fact, 
EEG monitoring was classically performed during endarterectomy36,66. This technique 
demonstrated that cerebral reperfusion is associated with neurophysiological abnormalities 
including changes in the EEG background activity frequency and amplitude and even 
epileptiform activity. EEG changes are not exclusive to endarterectomy. In fact, several other 
studies showed EEG changes associated with different ischaemic stroke treatments:  
- Focal EEG slowing normalized when regional cerebral blood flow was elevated above the 
ischaemic threshold after hypervolaemic and hypertensive therapy67.   
- There was a correlation between the percentage of theta and delta activity in relation to 
total activity (qEEG) and cerebral blood flow measured by single photon emission computed 
tomography (SPECT), before and after isovolaemic haemodilution in patients with middle 
cerebral artery stroke68  
- There was a good correlation between topographic maps based on qEEG parameters and 
control of blood pressure in atherosclerotic acute stroke patients69. 
- An improvement in acute delta change index (ADCI) and National Institutes of Health 
Stroke Scale70 (NIHSS) score was observed in the only patient of the Finnigan et al.71 study 
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treated with intravenous thrombolysis. According to the authors, this favourable clinical 
evolution would not be suspected based on acute MRI. 
- A relationship was demonstrated between NIHSS score and brain symmetry index (BSI)62, 
in 16 patients undergoing intravenous thrombolysis. Van Putten and collaborators suggested 
that abnormalities of this qEEG index could alert the clinician to re-examine the patient, 
detecting early clinical abnormalities. 
Despite these evidences, and the fact that intravenous thrombolysis72 (sometimes followed 
by mechanical thrombectomy) is now the gold standard treatment for acute ischaemic stroke, 
there is no large prospective study, using EEG monitoring during or after thrombolysis. 
Claassen & Hirsch73 further suggested that monitoring may also be used in hospitalized 
patients at high risk of stroke after TIA74 for early detection of ischaemia and maximize the 
benefit of thrombolysis. 
 
2.4. The EEG in the detection of epileptiform activity after ischaemic stroke  
 
Seizures and status epilepticus often occur after acute brain injury. In an intensive care 
environment, seizures are mainly electrographic and therefore cannot be detected merely by 
clinical observation. Claassen and colleagues75, in a series of neurological patients admitted 
to an Intensive Care Unit (ICU) and submitted to continuous EEG monitoring showed that 
19% had seizures, mostly (92%) without obvious clinical manifestations. EEG monitoring 
is also essential in the diagnosis and treatment of status epilepticus in a neurological ICU46. 
One type of acute brain injury is ischaemic stroke and it is known that among these patients, 
those with clinical indication for continuous EEG monitoring, 11% will have seizures36,76, 
9% exclusively non-convulsive seizures and 7% criteria for the diagnosis of non-convulsive 
status epilepticus75. Furthermore, a prospective study 29 using EEG monitoring showed that 
17%  of acute ischaemic and haemorrhagic stroke patients have epileptiform activity but the 
time interval between stroke and EEG and the record duration time (between 1 and 37 hours) 
were not predictors of that occurrence. Therefore, the optimal duration of an EEG record to 
detect epileptiform activity after stroke is still to be defined. Moreover, in the study of 
Carrera and collaborators29, factors that significantly increased the likelihood of EEG 
epileptiform activity were: NIHSS score on admission, cortical involvement and intravenous 
thrombolysis. However, in multivariate regression analysis, only the NIHSS score was an 
independent predictor. In fact, this study included 100 patients but only 11 were treated with 
intravenous thrombolysis (4 of whom had epileptiform activity in the EEG). Therefore, a 
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conclusion about the epileptogenic effect of rtPA could not be inferred. However, it is 
suggested that patients undergoing this treatment, particularly those with secondary clinical 
worsening, should have a tight EEG follow-up to exclude electrographic seizures. In animal 
models tissue plasminogen activator may facilitate seizures77 and has been implicated in 
epileptogenesis78. Nevertheless, the relationship between intravenous alteplase and clinical 
seizures is not established. There are studies suggesting an association of acute symptomatic 
seizures and intravenous thrombolysis28 but De Reuck and Van Maele32, comparing the 
occurrence of seizures in patients treated and or not treated, showed that early seizures were 
related to stroke severity and late seizures tended to be lower in the treated group. 
Furthermore, the influence of seizures in the outcome of ischaemic stroke patients submitted 
to intravenous thrombolysis is also a matter of discussion. Some studies suggest that seizures 
during thrombolysis represent reperfusion and neurological recovery32 whereas others 
indicate a potential negative influence of seizures on clinical outcome of thrombolysed 
stroke patients28.  
 
2.5. The EEG in the prediction of ischaemic stroke outcome 
 
Seizures, status epilepticus and EEG abnormalities have been associated with an 
unfavourable stroke outcome44,45,64,71,79–89. Nevertheless, it is questionable whether these 
features are markers of the extent of brain damage or even if they cause further brain injury.  
Regarding ischaemic stroke, several EEG features have been associated with an 
unfavourable outcome, including: EEG background slowing85,86 and contralateral slowing86; 
polymorphic delta/theta, slowing of alpha or depressed beta activity, or both87; different 
qEEG indexes89 including an increase in Acute Delta Change Index (ADCI)71 and regional 
attenuation without delta activity (RAWOD)64. Sometimes qEEG abnormalities were better 
than clinical (using Canadian Neurological Scale)89 or imaging investigation for the outcome 
prediction71.  However, it is unknown whether the association between EEG abnormalities 
and stroke functional outcome is independent from already known cerebral infarct outcome 
predictors, namely age and stroke (clinical and imaging) severity39–42.  
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In short, in ischaemic cerebrovascular disease, the EEG can potentially be used for the 
differential diagnosis of transient ischaemic events and, in acute stroke, as a cerebral 
perfusion monitor to detect progressive or recurrent ischaemia59, to detect the presence of 
epileptiform activity, to monitor its therapy or even to predict its outcome73.    
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3. INTERRELATIONS BETWEEN EPILEPTIC SEIZURES AND ISCHAEMIC 
CEREBROVASCULAR DISEASE 
 
Epileptic seizures and cerebrovascular disease are two of the most frequent neurological 
disorders9. In addition to their high prevalence, these disorders share different biunivocal 
and bidirectional associations and relationships with some consequences for their own 
diagnosis, outcome and therapy. The following paragraphs describe these interrelations 
including differential diagnosis challenges, the causal relationship, mutual treatment 
interference, and outcome effects. 
 
3.1. Differential diagnosis between an epileptic seizure and a TIA 
 
One of multiple biunivocal relationships between epileptic seizures and cerebrovascular 
disease is the difficulty that can exist in their differential diagnosis. In both disorders 
transient focal neurological symptoms that can appear to be clinically similar are 
physiopathologically distinct.  
 
3.1.1. Possible TIA and possible epilepsy 
About a quarter of transient ischaemic attacks patients have "probable" or "possible" 
TIA90,91, defined as a clinical syndrome lasting less than 24 hours that do not fulfil accepted 
criteria for TIA nor for another diagnosis, although a vascular origin cannot be excluded91,92.  
The main reasons for classification difficulties of possible TIA include odd accompanying 
symptoms (such as prickles/itching sensations, rigid postures or movement of the limbs), 
march of symptoms, consciousness disturbance or amnesia with focal symptoms, multiple 
stereotyped episodes, positive visual phenomena, isolated speech disturbance/confusion and 
focal symptoms plus panic or anxiety and paucity of details in the symptoms description91. 
Similarly, in the absence of a seizure documented by video-EEG recording and typical for 
the patient´s usual seizures, there will be situations where a diagnosis of epilepsy remains 
uncertain93. One approach to this difficulty is to consider uncertain cases as “probable” or 
“possible epilepsy”. The ILAE task force, aimed to formulate an operational definition of 
epilepsy for clinical diagnosis purposes93, has indeed left that possibility open for the future.  
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3.1.2. Akinetic seizures and Todd´s phenomena as TIA mimics 
It is true that epileptic seizure semiology is most frequently associated with positive 
symptoms. Nevertheless, negative ones (when occurring) may bring difficulties to the 
differential diagnosis with cerebrovascular events. In fact, electrical stimulation of the 
human cortex typically elicits positive sensorimotor effects although several cortical 
stimulation studies, since Penfield and Jasper94 (1954), have also reported cortical areas in 
which stimulation produces inhibition or arrest of on-going movement95. These cortical 
regions are located laterally in the inferior frontal gyrus and premotor cortex and medially 
in the supplementary motor area (SMA) and pre-SMA95,96. In the dominant hemisphere, the 
dorsal negative motor area coincides with Broca´s area. Lüders and collaborators97 named 
these cortical zones as “negative motor areas", and speculate their involvement in motor 
planning. Typical negative motor responses by electrical stimulation of these areas include 
speech arrest and arrest of movements of the hand, leg and foot without loss of awareness. 
Ikeda et al.96 suggested that negative motor areas are indeed responsible for negative motor 
seizures, a rare epileptic condition that consists of motor arrest, inability to conduct voluntary 
movements or praxis, due to epileptic interference in a similar way to how it occurs in higher 
cortical areas (such as the language areas) where epileptic activation always produces 
inability of the functions (such as aphasia, but never creates spontaneous words or speech). 
Negative motor seizures should be distinguished from focal ictal paresis (or ictal atonia), 
linked to primary sensorimotor cortex inactivation96. Nevertheless this distinction is not 
always evident in literature 10,98–101 and is often difficult in clinical practice. It seems puzzling 
that the same cortical area (primary motor cortex) can produce positive and negative 
symptoms, that is, is capable of generating clonic and also atonic seizures. This phenomenon 
may be explained by the amount of cortex involved in the epileptic discharge102, a 
phenomena that was named vertical restriction of focal seizure activity. Engel and 
Speckmann103 showed that superficial epileptic foci and foci involving all layers of the 
cortex produce indistinguishable epileptiform discharge. However, only the focus involving 
all cortical layers was able to produce a spinal discharge and only spikes localized in the 
superficial layer produced sustained inhibitory activity in the deep layer. This may explain 
negative motor events when an epileptiform potential is recorded over the motor cortex.  
Despite having different cortical generator mechanisms, clinically negative motor seizures 
and focal ictal paresis are rarely distinguished, since simultaneous EMG recording is often 
not performed. The diagnosis relies on either clinical testing for a movement task or detailed 
history after the event to determine whether the patient intended to perform movements. To 
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avoid nomenclature misunderstanding, some authors prefer to call these two seizure types 
(negative motor seizures and focal ictal paresis) as akinetic seizures referring to seizures 
with both lack of initiation of movement or paucity of movement secondary to muscle 
atonia102.  
In the De Reuck et al. study18, speech disturbance was the most common presentation of 
inhibitory seizures occurring in more than 60% of elderly patients. Moreover, speech 
disturbances are one of the reasons for classification difficulties of possible TIA91. Different 
forms of speech disturbance can be observed in epileptic seizures including ictal speech 
arrest due to negative motor seizures and ictal aphasia arising in and involving language 
areas such as Broca’s area104, Wernicke’s area105 and basal temporal language area106. 
Post ictal paresis (Todd`s paralysis) lasting hours to days or other symptoms of Todd post-
ictal phenomena including gaze palsy, hypoesthesia and aphasia107 or even neglect and other 
neurocognitive focal deficits108, can also trigger differential diagnosis problems with 
cerebrovascular disease, specifically with transient ischaemic attacks. This is so because an 
outside observer may not testify transient ictal positive symptoms preceding post-ictal 
deficits or the patient, due to aphasia, anosognosia, memory or consciousness impairment, 
might also not describe them. Various hypotheses about the mechanism of this post-ictal 
symptom have been proposed including exhaustive neuronal firing, desensitization and 
active suppression.   
 
3.1.3. Limb-shaking TIA and other epileptic seizures mimics  
Diagnostic challenges between a TIA and an epileptic seizure include not only non-
convulsive, atonic and inhibitory or negative seizures10–13,109,110 but also TIA with positive 
symptoms such as "limb-shaking” TIA, first reported by Miller Fisher14 in 1962. In this 
entity, jerky involuntary movements involving an arm or leg can be recognized by their short 
duration and are often accompanied by paresis and precipitated by standing up or exercise111. 
Limb-shaking TIA is indicative of an impaired haemodynamic state of the brain and a 
manifestation of an intracranial and extracranial carotid occlusion or severe stenosis. 
Recently, Muraga15 and collaborators described a patient with a “limb-shaking TIA” 
associated with intracranial carotid stenosis having jerk-locked back-average proven cortical 
myoclonus and suggested that ischaemia-induced neuronal hyperexcitability of the cerebral 
cortex was associated with contralateral shaking movements. 
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Further hampering the distinction between a TIA and an epileptic seizure is the possibility 
that epileptic seizures can be caused by a TIA13,112,113 and the existence of other mimics with 
a non-vascular and non-epileptic origin16.  
 
3.1.4. The particular case of amyloid spells 
Sporadic cerebral amyloid angiopathy is a common age related cerebral small vessel disease. 
It is characterised by progressive deposition of amyloid-β in the wall of small to medium 
sized blood vessels of the brain and leptomeninges114. Although usually asymptomatic, it is 
an important cause of primary intracerebral haemorrhage in the elderly. In addition to the 
typical lobar (cortical or cortical-subcortical) haemorrhage, various types of abnormal 
imaging features might also be found in this pathological condition, such as, lobar 
microbleeds, convexity subarachnoid haemorrhage, cortical superficial siderosis, 
microinfarction and leukoaraiosis115,116.  
The clinical spectrum of sporadic cerebral amyloid angiopathy include not only focal 
neurological deficits due to lobar (especially occipital and temporal) intracerebral 
haemorrhage in older individuals (generally over 55 years) but also cognitive impairment, 
dementia, and transient focal neurological symptoms117–119, frequently called “amyloid 
spells”.  
Amyloid spells have been described as recurrent, stereotyped and transient episodes of 
‘positive’ spreading sensory symptoms (paraesthesias) into contiguous body areas118. 
However, positive ("aura-like") and negative symptoms ("TIA-like", such as focal weakness 
and dysphasia) appear to be equally common (52% vs. 48%, respectively)116. Therefore, 
clinically, amyloid spells might resemble TIA, migraine aura or even seizures120 and should 
be included in the differential diagnosis of those conditions, especially in adults over 55 
years.  
Amyloid spells are probably more often related to bleeding into the brain (especially 
superficial cortical siderosis, convexity subarachnoid haemorrhage and lobar cerebral 
microbleeds) rather than ischaemia116,120. For that reason, blood-sensitive magnetic 
resonance imaging sequences, including T2*-weighted gradient-recalled echo (T2*-GRE) 
and susceptibility-weighted imaging (SWI) should be included in the investigation of such 
episodes. In fact, in Andreas Charidimou et al. multicentre cohort116 transient focal 
neurological episodes were strongly associated with cortical superficial siderosis likely 
resulting from repeated bleeding into the subarachnoid space and subsequent deposition of 
hemosiderin in the superficial (subpial) cortical layers. Physiopathologically, it remains 
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unclear whether amyloid spells are related to cortical spread depression, to an epileptic 
process, to both (together or sequentially), or if these two mechanisms operate differently in 
different amyloid related cerebral lesions. In line with this concept, both antiepileptic drugs 
and migraine prophylaxis121 have been suggested for symptomatic treatment of these 
transient neurological symptoms. 
The diagnosis of amyloid spells is important due to the fact that they seem to predict a high 
early risk of symptomatic intracerebral haemorrhage (about 50% at two to three-months)116. 
Furthermore, their misinterpretation with TIA associated with the prescription of antiplatelet 
agents122 or anticoagulation123,124 is likely to increase the risk of haemorrhage. 
 
3.1.5. Ancillary investigation and differential diagnosis between an epileptic seizure and a 
TIA 
An acute ischaemic lesion in diffusion-weighted brain Magnetic Resonance Imaging (DWI) 
can be used in clinical practice in this differential diagnosis. However, this exam 
demonstrates an acute ischaemic lesion in only 30% to 50% of TIA patients, depending on 
the additional performance of a perfusion-weighted study125. In addition, the proposed 
paradigm shift in the TIA definition126,127 might increase the differential diagnosis difficulty 
between a TIA and an epileptic seizure. If the TIA definition based on the duration of the 
clinical event ("time-based") is changed to the absence of an ischaemic lesion ("tissue-
based"), both conditions (a TIA and an epileptic seizure) are characterized by the absence of 
an acute ischaemic lesion. Therefore, this shift enhances the need for other complementary 
strategies for this important neurological differential diagnosis. On the other hand, epileptic 
seizures128,129 and status epilepticus130–132 have also been associated with evanescent 
diffusion-weighted imaging abnormalities mimicking those of a transient ischaemic attack.  
In fact, Lansberge130 et al. described cortical hyperintensity on DWI and T2-weighted 
sequences and a corresponding area of low apparent diffusion coefficient in complex partial 
status epilepticus patients. However, these findings were readily differentiated from typical 
ischaemic stroke in their nonvascular distributions, an increased signal of the ipsilateral 
middle cerebral artery on magnetic resonance angiography, and leptomeningeal 
enhancement on post contrast magnetic resonance imaging.  
 
Perfusion CT scan has also been described as a possible differential diagnosis tool between 
cerebrovascular disease and stroke mimics including inhibitory seizures, ictal or post-ictal 
paresis (Todd`s paralysis)133–135. Seizures have been demonstrated to cause an increase in 
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cerebral blood flow and cerebral blood volume in the acute phase, likely due to a vasodilatory 
response to the increased metabolic demands of ictal activity.  However, the results of this 
exam depend on the time from the beginning of ictal symptoms (transient by nature) as an 
hypoperfusion pattern on perfusion CT has also been described136,137.  
 
The EEG and its related techniques are the gold standard for the identification of 
epileptogenesis and ictogenesis biomarkers4,5. Therefore, it is plausible that it can be useful 
in the differential diagnosis between epileptic seizure and TIA. However, clinical evidence 
about the application of this neurophysiological test is quite limited and is restricted to the 
results of a single workgroup50.  
 
3.2. Seizures as a consequence of cerebrovascular disease  
 
3.2.1. Post-stroke seizures/epilepsy frequency  
The most obvious connection between epileptic seizures and cerebrovascular disease is 
perhaps the possibility of the former being a consequence of the latter. Epilepsy patient 
cohorts reveal a high frequency of vascular epilepsy. A systematic review of epilepsy 
epidemiology in Europe138 showed that the most common aetiology for epilepsy was 
cerebrovascular disease (ranging from 14-21%), especially ischaemic stroke (16-18%). In 
fact, cerebrovascular disease is the most common cause of acquired epilepsy19 corresponding 
to 22% of epilepsy in adults and 55% of de novo seizures in the elderly139. Thus, with the 
expected average longevity increase, the prevalence of post-stroke seizures and vascular 
epilepsy may increase. 
The frequency of post-stroke seizures and epilepsy is quite different in cerebrovascular 
disease patient studies, varying between 2 and 67%21–26, possibly due to different study 
methodologies, such as the prevalence of different types of stroke and stroke lesions in a 
given study population. In fact, different post-stroke seizures and epilepsy risk factors have 
been identified27,140,141. Haemorrhagic stroke, haemorrhagic transformation of an infarct, 
cortical involvement and stroke severity are among the most important risk factors for post-
stroke seizures and epilepsy140,141. Furthermore, different post-stroke seizures and epilepsy 
definitions have been used in different studies, certainly affecting frequency analysis. To 
overcome this problem in future studies, the International League Against Epilepsy (ILAE) 
has published recommendations for seizure type definition142 in relation to acute and remote 
cerebral lesions. Furthermore, the definition of epilepsy has been recently adjusted93, 
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theoretically modifying the incidence and prevalence of epilepsy, especially in studies with 
a short follow-up time.  
Another factor that has been reported as contributive to the discrepancy in post-stroke 
seizures frequency analysis is the absence of EEG in most studies27. In patients with acute 
neurological injury the majority of seizures are electrographic75. Therefore, in the absence 
of a neurophysiological study the frequency of seizures may be underestimated, even in 
patients who do not require hospitalization in intensive care units.  
Other caveats to the interpretation of clinical data related to post-stroke seizures frequency 
include accuracy of stroke diagnosis, follow-up duration, sample size and heterogeneity of 
study designs, use of univariate versus multivariate statistics for data analysis, availability 
and analysis of CT and MRI scans for diagnosis and follow-up, accuracy regarding the 
localization and type of primary lesion, and the use of drugs and other medications acutely 
or during follow-up27.  
 
3.2.2. Post-stroke seizures/epilepsy definitions, physiopathology and clinical implications 
Epileptic seizures can occur with different temporal associations with stroke and distinctive 
physiopathological mechanisms have been proposed for their occurrence21,143. Seizures 
occurring in the first 7 days after stroke142 are considered acute symptomatic seizures and 
are thought to result from cellular biochemical dysfunction and local metabolic disturbances 
(and not necessarily altered neuronal networks) leading to electrically irritable tissue. 
Possible physiopathological mechanisms parallel those of acute ischaemic lesion and include 
glutamate excitotoxicity, accumulation of intracellular calcium and sodium with 
depolarization of the transmembrane potential and other calcium-mediated effects lowering 
seizure threshold144. In contrast, occurrence of post-stroke unprovoked seizures145 or 
seizures  after that time point44,142,145 have been associated with different physiopathological 
mechanisms including inflammation and remodelling of synaptic networks leading to 
gliosis, development of a meningocerebral cicatrix and brain acquisition of an enduring 
predisposition to generate epileptic seizures, conceptually defining epilepsy146. This insult-
induced process where a cascade of changes transforms the nonepileptic brain into one that 
generates spontaneous recurrent seizures is called epileptogenesis. Traditionally, a latent 
period between stroke and the development of symptomatic acquired epilepsy has been 
described. However, a different concept has also been proposed147 with epileptogenesis and 
often subclinical epilepsy starting immediately after brain injury without any appreciable 
latent period147, based on recent data from both animal models and clinical studies. The risk 
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of epileptogenesis after stroke is most likely influenced by injury severity, location and type 
of pathological changes, genetic factors and also pre-injury and post-injury exposure to non-
genetic factors (i.e., the exposome)27. In fact, hyperglycaemia, diabetes, dyslipidaemia, 
hypertension, cardiovascular morbidities, peripheral infections, early seizures, haemorrhagic 
transformation, depression, use of antidepressants, use of statins, and pre-existing dementia 
might modulate post-stroke epileptogenesis27.  
Although the 7 days cut-off time-point for differentiation between acute symptomatic 
seizures and unprovoked seizures has been considered arbitrary27 (and, therefore, not 
consensual), it is biologically plausible as it is associated with a different seizure recurrence 
risk. In fact, the risk of subsequent unprovoked seizure after 10 years of follow up is 33.0% 
(95% CI = 20.7-49.9%) for those who experience a first acute symptomatic seizure within 7 
days of the stroke onset and 71.5% (95% CI 59.7-81.9%) for first unprovoked seizure after 
stroke44. For this reason, this 7 days cut-off time-point is clinically very important as it 
implies that a patient with one unprovoked seizure after stroke has epilepsy93 and therefore 
antiepileptic drug therapy should be considered148. This is a new concept in epileptology93. 
Epilepsy was defined conceptually in 2005146, as a disorder of the brain characterized by an 
enduring predisposition to generate epileptic seizures. This definition was usually practically 
applied as having two unprovoked seizures more than 24 h apart. However, the “two 
unprovoked seizure” definition of epilepsy was inadequate in some circumstances, such as 
in patients with brain insults, which have a comparable risk of a second or a third unprovoked 
seizure. Consequently, the ILAE commissioned a task force to formulate an operational 
definition of epilepsy for purposes of clinical diagnosis, published by Fisher et al. in 201493. 
This new definition includes “one unprovoked (or reflex) seizure and a probability of further 
seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, 
occurring over the next 10 years”. The 60% value was selected as it is the 95% confidence 
interval inferior value of the recurrence risk of the first acute symptomatic seizure after 
stroke44. 
 
3.3. Seizures, a biomarker of cerebrovascular disease  
 
After 60 years of age, 5-20% of incident cases of seizures or epilepsy can herald stroke149. 
The term heraldic seizures has been used for epileptic seizures caused by silent ischaemia 
and occurring before a clinical stroke150,151.  As a marker of subclinical vascular disease, 
seizures can in this context be considered biomarkers of cerebrovascular disease.  
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Cleary et al. study152 revealed that the onset of seizures at or after the age of 60 in patients 
without a history of cerebrovascular disease, other acquired brain injury, brain tumour, drug 
or alcohol misuse, or dementia is associated with relative hazard of stroke of 2.89 (95% CI 
2·45-3.41) compared to randomly selected matched controls with no history of seizures. 
These authors comment that this relative hazard can be compared with the relative risk of 
1.46 associated with low HDL-cholesterol concentrations153 and is the doubling of the risk 
associated with smoking154,155.  Furthermore, Maxwell and collaborators156 investigated the 
prevalence of radiological cerebrovascular disease in late onset epilepsy patients showing 
that small vessel disease (periventricular or subcortical white matter lesions, including 
leukoaraiosis) is more prevalent in patients than in controls matched for age, gender and type 
of brain imaging. Another interesting finding is that different ictal onset zones seem to be 
associated to different types of radiologic cerebrovascular disease. While in patients with 
post-stroke epilepsy and a well-defined vascular lesion, epileptogenic focus was coherent 
with it, in patients with leukoaraiosis temporal lobe epilepsy predominated. Although a 
casual relation or the occurrence of cortical microinfarcts could not be excluded, the authors 
discuss hypothetical leukoaraiosis-induced damage to temporal lobe networks. 
Also, a systematic review157 suggests that patients with seizures occurring for the very first 
time in late life and without clinically overt cerebrovascular disease should be considered as 
having an increased risk of stroke and be screened for the presence of vascular risk factors. 
 
3.4. Seizures and the current acute stroke standard of care  
 
Acute stroke care has change tremendously in recent years. Stroke patients who receive 
organised inpatient care in multidisciplinary teams that manage stroke patients in a dedicated 
ward are more likely to be alive, independent, and living at home one year after the 
stroke158,159. Currently, it is recommended that all stroke patients are treated in a Stroke Unit 
(Class I, Level A recommendation72). Furthermore, long-term survival160 and outcome161 
improved in patients receiving intravenous thrombolysis. However, it is unclear what the 
impact is of intravenous alteplase (rtPA) on the frequency of post-stroke seizures.  
Some lines of evidence, from basic science and clinical research28,29,31,32,77,78,162,163, suggest 
that alteplase may have a proconvulsive and even an epileptogenic effect. Also, the survival 
of islands of cortical viable tissue164 have been described in patients with post-stroke 
epileptic seizures165. Furthermore, the "stunned brain" syndrome166,167, theoretically, might 
also contribute to a higher risk of epileptic events. In fact, clinical response immediately 
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after revascularisation therapy differs among patients and almost 40% of non-responsive 
alteplase treated patients still achieved good outcomes at 3 months, suggesting the possibility 
of a "stunned brain" syndrome with delayed recovery166,167. This syndrome can be described 
as a state where the brain is temporarily and reversibly “stunned” by the ischaemic insult168 
paralleling the “stunned myocardium”169 or post ischaemic myocardial dysfunction 
characterized by a prolonged contractile depression after alleviation of severe ischaemia by 
reperfusion of coronary occlusion. At least in part, this contractile dysfunction can be viewed 
as a form of "reperfusion injury"170. Cardiac reperfusion arrhythmias have also been 
described as marker of flow restoration during intracoronary thrombolysis for acute 
myocardial infarction171 and several different mechanisms may potentially account for the 
"stunned myocardium" and also for reperfusion arrhythmias. The two major hypothesis are 
that it is caused by the generation of oxygen-derived free radicals (oxyradical hypothesis) 
and by a transient calcium overload (calcium hypothesis) on reperfusion170. Curiously, the 
cascade of events described in reperfusion heart dysfunction is similar to that suggested for 
reperfusion related cerebral injury and cerebral hyperperfusion syndrome. In fact, seizures 
as a manifestation of cerebral reperfusion injury after administration of intravenous 
alteplase30, have been described. 
On the other hand, the reduction of clinical severity and infarct size associated with 
intravenous alteplase may influence the occurrence of seizures exactly in the opposite 
direction. Intravenous alteplase related seizures30,32,33 and seizure frequency in patients 
treated with alteplase34,35 has been mostly described using retrospective and non-controlled 
case series. The hypothesis that treatment with alteplase may influence the prevalence of 
post-stroke seizures remains unanswered.  
Furthermore, seizures after stroke have been associated with an unfavourable outcome in a 
few clinical studies on rtPA effect in functional outcome in the subgroup of patients treated 
with intravenous alteplase. Vincent Alvarez et al.28 found that alteplase treated patients with 
post-stroke seizures have an unfavourable functional outcome at three months. In Gensicke 
and collaborators study172, seizures were also independent predictors of long term poor 
outcome in rtPA treated patients. However, it is not known if outcome is different in patients 
with seizures treated and not treated with alteplase.  
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3.5. Prediction of seizures in cerebrovascular disease 
 
Seizures and cerebrovascular disease are both known causes of neurological disability38. 
Furthermore, the occurrence of seizures seems to be associated to a lower quality of life in 
older patients with an ischaemic stroke173. Therefore, knowledge of post-stroke seizure 
predictors may have a high clinical impact. Already known predictors of seizures after 
ischaemic stroke include clinical and imaging stroke severity and its cortical 
involvement25,174,175. Although EEG is a sensitive neurophysiological technique in the 
detection of acute cerebral ischaemia36 and a robust one in the functional assessment of the 
brain37, it is unclear whether electroencephalographic markers of acute vascular injury 
severity are independently associated with an increased risk of post-stroke seizures or useful 
for its prediction. Furthermore, epileptogenic zone and cortical hypersynchronisation 
neurophysiological biomarkers, and its independence from already known risk factors for 
post-stroke seizures have not been explored, again, by the lack of prospective 
electroencephalographic records in most studies.  
The search for a reliable biomarker or, more likely, a profile of biomarkers176 of 
epileptogenesis and ictogenesis that could predict who has or will get epilepsy is of utmost 
clinical relevance, allowing a more personalized Medicine and Neurology care and 
increasing the feasibility of an eventual antiepileptic drug trial after stroke175, in the future. 
 
3.6. Seizures and the outcome of cerebrovascular disease  
 
The possibility emerged in the literature of an association between post-stroke seizures (and 
status epilepticus) and the functional outcome of stroke44,45,79–83. However, the question 
remains whether this association is independent from other known prognostic factors of 
cerebrovascular disease. Furthermore, although the EEG is essential for the detection of 
interictal and ictal epileptiform activity, it is unknown whether the presence of these 
electroencephalographic activities is also associated to post-stroke functional outcome.  
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3.7. Other interrelationships between seizures and cerebrovascular disease  
 
Different pharmacological therapies can affect both seizures and cerebrovascular disease. 
Statin therapy has been widely used in the prevention of stroke for many years and associated 
not only with a favourable outcome at stroke onset177, but with a reduced risk of early post-
stroke seizures178 and hospitalization for epilepsy179. Furthermore, some antiepileptic drugs 
can affect vascular risk factors180 including serum lipid profile181,182 and interact with 
different stroke treatments as anticoagulants and other cardiovascular medications183,184. 
Besides, since AED work by modulating neuronal signalling (suppressing neuronal 
excitability or enhancing inhibitory neurotransmission) they often lead to cognitive and 
behavioural deficits185 and also to psychiatric effects186, with the risk of inducing or 
worsening co-morbidity in cerebrovascular patients. As a matter of fact, for the management 
of stroke-related seizures, no single antiepileptic drug was found to be more effective over 
others, though newer AEDs were associated with fewer side effects187. Furthermore, some 
AED have been demonstrated to impair functional recovery after stroke in the animal model 
188 and in patients with intracranial haemorrhage189. 
Another challenge between cerebrovascular diseases and epilepsy is the task of prevention. 
Although the incidence of epilepsy in those younger than 65 years has not changed in the 
last 40 years, epilepsy in the elderly population has increased 5-fold190 meaning that 
prevention of epilepsy includes certainly the improvement of care to prevent and treat 
cerebrovascular disease.  
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II. AIM OF THE STUDY  
 
 
 
“Setting goals is the first step in turning the invisible into the visible” 
Tony Robbins 
 

Aim of the study 
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In this work, the aim was to use the clinical model of acute ischaemic cerebrovascular disease 
(transient and established) to study the value of EEG in the differential diagnosis of transient 
neurological symptoms namely possible TIA, in the diagnosis and prediction of post-stroke 
seizures (and EEG epileptiform activity), as well as to analyse if EEG abnormalities and 
epileptic seizures are independent predictors of anterior circulation ischaemic stroke 
outcome. 
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III. RESEARCH QUESTIONS and RESEARCH OUTLINE 
 
 
 
“This is a good question.  
I once learned that a good question is greater than the most brilliant answer”  
Louis Kahn

Research questions and research outline 
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The following research questions drove different research projects, as displayed in the 
research projects outline (Table 1): 
 
Question 1. What is the frequency of electroencephalographic abnormalities in patients with 
possible TIA and to which clinical/imaging characteristics are they associated? 
 
Question 2. What is the percentage of patients with possible TIA having a final diagnosis of 
epileptic seizure or definitive TIA and which electroencephalographic characteristics 
differentiate these diagnoses?   
 
Question 3. What is the frequency of post-stroke EEG epileptiform activity, both ictal and 
interictal in observational studies? 
 
Question 4. Is the frequency of electrographic and clinical seizures different in stroke 
patients admitted to a Stroke Unit? 
 
Question 5. What is the frequency of epilepsia partialis continua as a remote stroke 
complication?  
 
Question 6. Are involuntary movements observed during intravenous alteplase perfusion of 
cortical origin?  
 
Question 7. Is the frequency of seizures and electroencephalographic abnormalities different 
between stroke patients treated and non-treated with rtPA?  
 
Question 8. Are early electroencephalographic abnormalities independent predictors of 
post-stroke epilepsy? 
 
Question 9. Which are the predictors of EEG epileptiform activity in acute ischaemic 
stroke?  
 
Question 10. Are seizures and early electroencephalographic abnormalities independent 
predictors of stroke functional and vital outcome? 
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Question 11. Are qEEG abnormalities independent predictors of stroke functional outcome? 
 
Question 12. Is qEEG superior to visual analysis in the prediction of stroke functional 
outcome? 
 
 
Table 1. Research projects outline  
 Ischaemic Cerebrovascular Disease 
 
Type of event: 
 
Aim of the EEG: 
TIA 
 
Stroke 
(anterior circulation) 
Differential Diagnosis 
Question 1 and 2 
Project 1 
Question 6 
Project 5 
Post-Stroke Seizures (and EEG 
epileptiform activity) Diagnosis 
- 
Question 3, 4, 5 and 7 
Project 2, 3, 4, and 6 
Post-stroke Seizures (and EEG 
epileptiform activity) Prediction 
- 
Question 8 and 9 
Project 7 
Stroke Outcome Prediction - 
Question 10, 11 and 12 
Project 8 and 9 
 
 
The projects included in this thesis were planned to study not only different types of 
ischaemic cerebrovascular disease using EEG with distinctive purposes but also diverse 
types of EEG analysis and clinical study designs (Figure 1).   
 
All projects have been already submitted to international peer-review magazines and most 
of them published (Table 2). 
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IV. PROJECT 1 
 
 
 
“One of the commonest problems in medicine  
is the interpretation of transitory spells or attacks of central nervous system origin” 
Charles Miller Fisher (1913-2012)
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USEFULNESS OF EEG FOR THE DIFFERENTIAL DIAGNOSIS OF POSSIBLE 
TRANSIENT ISCHAEMIC ATTACK 
 
AUTHORS  
Carla Bentes, Patrícia Canhão, Ana Rita Peralta, Pedro Viana, Ana Catarina Fonseca, Ruth 
Geraldes, Teresa Pinho e Melo, Teresa Paiva, José Manuel Ferro 
 
ABSTRACT  
Objective: EEG value in possible transient ischaemic attacks (TIA) is unknown.  We aim to 
quantify focal slow wave activity (FSWA) and epileptiform activity (EA) frequency in 
possible TIA, and to analyse its contribution to the final diagnosis of seizures and/or 
definitive TIA.  
Methods: Prospective longitudinal study of possible TIA patients evaluated at a tertiary 
centre during 36 months and with 1-3 months follow-up.  EEG was performed as soon as 
possible (early EEG) and one month later (late EEG). A stroke neurologist established final 
diagnosis after reassessing all clinical and diagnostic tests.   
Results: 80 patients underwent an early EEG (45.8 hours after possible TIA): 52 had FSWA 
and 6 of them also EA. Early FSWA was associated with epileptic seizure or definitive TIA 
final diagnosis (p=0.041). Patients with these diagnoses had early FSWA (19/23; 82.6%) 
more frequently than EA (6/23; 26.1%). 6/13 (46.2%) patients with epileptic seizure final 
diagnosis had EA.  
In the late EEG, 43 (58.1%) patients demonstrated persistent FSWA and 3 of them also EA.  
Persistent FSWA in the late EEG was more frequent in seizures than in TIA patients (91.7% 
vs. 45.5%). FSWA disappearance was associated with acute vascular lesion on neuroimage.  
Conclusions:  FSWA was the commonest EEG abnormality found in the early EEG of 
patients with possible TIA, but did not distinguish between TIA and seizure patients. In 
patients with seizures, FSWA was more common than EA and its persistence in the late EEG 
was more likely in patients with epileptic seizures than with TIA.  
Significance: The majority of possible TIA patients with the final diagnosis of epileptic 
seizures do not have EA in the early or late EEG  
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KEY-WORDS 
transient neurological symptoms, transient ischaemic attack, seizure diagnosis, epilepsy, 
epileptiform activity, focal slow wave activity 
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1. INTRODUCTION  
 
Neurological syndromes lasting less than 24 hours include not only Transient Ischaemic 
Attacks (TIA) but also other clinical entities such as epileptic seizures. The differential 
diagnosis between a transient ischaemic attack (TIA), an epileptic seizure or other transient 
neurological disturbances can be challenging and depends on the clinician’s 
expertise90,91,192–195 and also on the available clinical information90,91,196–198.  
After extensive clinical investigation, approximately one-fourth of TIA patients are only 
labelled as "probable" or "possible TIA"90,91, defined as a clinical syndrome lasting less than 
24 hours that do not fulfil accepted criteria for TIA nor for another diagnosis, although a 
vascular origin cannot be excluded91,92. The main reasons for classification difficulties of 
possible TIA include odd accompanying symptoms (such as prickles/itching sensations, 
rigid postures or movement of the limbs), march of symptoms, consciousness disturbance or 
amnesia with focal symptoms, multiple stereotyped episodes, positive visual phenomena, 
isolated speech disturbance/confusion and focal symptoms plus panic or anxiety and paucity 
of details in the symptoms description91. 
Diagnostic challenges between a TIA and an epileptic seizure include non-convulsive and 
inhibitory or negative seizures10–13 and TIA with positive symptoms, such as  limb-shaking 
TIA14,15. Further hampering this distinction is the possibility of epileptic seizures caused by 
a TIA13,112,113 and the existence of other mimics with a non-vascular and non-
epileptic origin16.  
De Reuck and Van Maele50 analysed the role of EEG in the differential diagnosis of a TIA 
versus an inhibitory seizure and concluded that an early EEG is crucial in their 
investigation. However, the type and frequency of electroencephalographic abnormalities in 
possible TIA and its value in the distinction between epileptic seizures and TIA is not exactly 
known.  In this study we aim to respond to the following:   
 
1) What is the frequency of electroencephalographic abnormalities in patients with possible 
TIA and to which clinical/imaging characteristics are they associated? 
2) What is the percentage of patients with possible TIA with a final diagnosis of epileptic 
seizure or definitive TIA and which electroencephalographic characteristics differentiate 
these diagnoses?    
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2. METHODS  
 
Prospective longitudinal study of patients with a diagnosis of possible TIA evaluated at the 
TIA Clinic or admitted to the Stroke Unit of the Hospital de Santa Maria (HSM-CHLN), 
between November 2010 and October 2013. The Ethics Committee “Comissão de Ética para 
a Saúde” of the HSM-CHLN approved this study.  
 
As inclusion criteria, the patients had to meet the clinical criteria for an initial diagnosis of 
possible TIA (see definition below) and gave their informed consent. Symptoms suggestive 
of brainstem/cerebellum involvement were exclusion criteria. The study design is described 
in Figure 2. 
 
 
Figure 2. Study Design  
 
Legend to figure 2: TIA - Transient Ischaemic Attack 
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2.1. Standardized clinical and ancillary evaluation91,92 
Patients were referred to the TIA Clinic by the HSM-CHLN emergency department (ED) or 
their family doctor.  In the ED, patients underwent routine blood tests, ECG and brain non-
contrast CT scan (CT) and were prescribed with antiplatelet agents and statins. In the daily 
TIA Clinic, a stroke neurologist performed a structured clinical interview and physical and 
neurological examination. On the same day, patients underwent carotid and vertebral duplex 
scans, transcranial Doppler and blood tests. Transthoracic or transesophageal 
echocardiography or 24h Holter were ordered, whenever considered necessary. When 
possible, a MRI including diffusion-weighted imaging (DWI) was done. A neuroradiologist 
reported all imaging exams. The stroke neurologist, after review of all exams, decided about 
further treatment, the need for hospitalization and booked the patient for a follow-up 
appointment one to three months later.  
 
Patients with a possible TIA were admitted to the Stroke Unit, from the ED or TIA Clinic, 
whenever a definitive diagnosis of TIA was not established, symptoms had not cleared or 
the patient was judged to be at a high risk of recurrence. The evaluation of admitted patients 
and their follow-up was similar to those in the TIA Clinic. 
 
The following symptoms associated with possible TIA were systematically recorded: motor, 
sensory, speech disturbances, partial or total amnesia for the event, consciousness 
disturbance, and confusional period. Positive symptoms were defined as the occurrence of 
involuntary movements, sensory symptoms apart from numbness or anaesthesia (such as 
tingling, stinging, prickling, burning sensations or pain) and visual delusions (palinopsia, 
polyopia, micro, macro or metaphormopsia), simple (e.g.: lights, spots, oscillating lines with 
bright, sparkle or colour) or complex hallucinations. The presence of a Jacksonian march of 
symptoms was considered whenever there was sequential spread of motor (or sensory) 
symptoms beginning at a specific body region to involve other body parts, accordingly to an 
electrical disturbance spreading through the homunculus of the motor (or sensory) cortex199  
 
Patients were classified in 5 symptomatic groups, not mutually exclusive, taking into account 
symptom characteristics and their different specificity for the final diagnosis:  
1. Motor symptoms  
2. Positive phenomena and/or march of symptoms (more frequent in seizures than 
in TIA)  
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3. Sensory and/or visual symptoms (posterior brain symptoms) 
4. Speech disturbance 
5. Amnesia for the event and/or consciousness disturbance and/or confusional 
period (including consciousness, level or content, disturbance symptoms) 
 
2.2. Diagnostic criteria  
The diagnosis of each patient was defined according to the following criteria:  
- Initial diagnosis: established at the end of the first observation in TIA Clinic or Stroke Unit 
by a stroke neurologist (PC).  
- Final diagnosis: established after the end of the study by a stroke neurologist (PC), taking 
into account clinical reassessment 1 to 3 month after the clinical episode, and the result of 
all diagnostic tests (including early and late EEG).  Patients were reclassified in the 
following final diagnosis groups: TIA; possible TIA; epileptic seizures; other TIA mimic 
(including migraine; psychiatric disturbance; others). Another neurologist trained in 
epilepsy (CB), having had access to the same clinical and complementary information, 
independently reclassified the patients in the same final diagnosis groups.  
 
The following definitions were used for the diagnosis (initial and final): 
- Transient ischaemic attack (TIA): Clinical syndrome characterized by sudden focal 
neurological symptoms, presumed to be of vascular origin, that lasted less than 24 hours200, 
regardless of whether or not brain imaging showed a recent ischaemic lesion. This diagnosis 
group included patients with an acute onset of temporary (less than 24 h) neurological 
dysfunction consistent with focal brain ischaemia and with supportive or no contradictory 
complementary diagnostic tests including brain imaging demonstrating or not an acute 
vascular ischaemic lesion. The typical history for a TIA was a swift onset (no symptoms to 
maximal symptoms in less than five minutes) of a motor defect, sensory defect, aphasia, loss 
of vision in one eye or in part of one eye, homonymous hemianopia, or a combination of the 
above200. In these patients an epileptic seizure or another TIA mimic did not cause the 
clinical syndrome. 
- Possible transient ischaemic attack (possible TIA): Neurological syndrome lasting less than 
24 hours that do not fulfil international accepted criteria for TIA nor the criteria for a specific 
mimic diagnosis, although a vascular origin could not be excluded91,92. This diagnosis group 
included patients with odd accompanying symptoms (such as prickles/itching sensations, 
rigid postures or movement of the limbs), march of symptoms, consciousness disturbance or 
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amnesia with focal symptoms, multiple stereotyped episodes, positive visual phenomena, 
isolated speech disturbance/confusion and focal symptoms plus panic or anxiety and paucity 
of details in the symptoms description91, without imaging/laboratory evidence of ischaemic 
cerebral pathology201 nor of another TIA mimic. 
- Transient ischaemic attack mimic (TIA mimic): Focal neurological syndrome lasting less 
than 24h, for which a non-vascular cause was definitively established according to 
predefined criteria91 (e.g.: migraine with aura)202, metabolic syndrome, transient global 
amnesia203,204, panic attack205, somatoform disorder205. An epileptic seizure can also be a 
TIA mimic but was classified separately in this study. 
- Epileptic seizure (seizure): transient occurrence of signs and/or symptoms due to 
abnormally excessive or synchronous neuronal activity in the brain93.  This diagnosis group 
included patients with positive motor, sensitive, or sensorial symptoms (as previously 
described) and also with motionless, unresponsive or automatic behaviour according to 
stereotyped focal seizures and/or successful response to antiepileptic treatment, epileptiform 
activity on EEG206 or the occurrence of an unequivocal seizure in the follow-up. In these 
patients a TIA and a TIA mimic have been excluded. Accordingly, in patients with possible 
TIA, the final diagnosis of seizure was established (if other diagnoses were considered 
excluded after all diagnostic tests and clinical reassessment) in two different circumstances: 
1) in patients with possible seizure semiology and epileptiform activity in the EEG; 2) in 
patients with possible seizure semiology and no epileptiform activity in the EEG but with 
additional (or better described) clinical events clearly indicative of seizures during the 
follow-up.  
 
TIA and epileptic seizures were considered the two final diagnoses of interest for this study 
 
2.3. Neurophysiological assessment  
All patients underwent a 64-channel video-EEG using a digital Nihon-Kohden device and 
electrodes placed in accordance with the international 10/10 system and following national 
and international recommendations3,207–210 in two different  periods: 1) As soon as possible 
after the possible TIA (early EEG); 2) One month after (late EEG). We intend to repeat EEG, 
based on guidelines reporting that repeating EEG may be helpful when the diagnosis of 
epilepsy is unclear8. One month after the clinical event was the date chosen for EEG 
repetition to match the scheduled follow-up clinical visit.   
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The record had a maximum duration of 60 minutes, including an eye closed wake resting 
condition and eye open, hyperventilation and photic stimulation manoeuvres.  
 
Two clinical neurophysiologists (CB+RP), blinded for the final diagnosis, interpreted the 
records. Discrepancies were decided by consensus. All EEG records were evaluated for the 
presence of the following abnormalities: background activity slowing211; asymmetry212; 
suppression (focal, hemispheric or diffuse)212; focal slow wave activity (including focal and 
regional concept)211; epileptiform activity211, periodic discharges212 and others.  
 
The two EEG variables of interest for the present study were Focal Slow Wave 
Activity (FSWA) and Epileptiform Activity (EA) (Figure 3). The following operational 
definitions were used:  
- FSWA: continuous or intermittent slow activity i.e. theta and/or delta band activity211 
limited to an area of the brain or scalp region (includes the concept of focal and regional211).  
- EA211: transients clearly distinguishable from background activity, with a characteristic 
spiky morphology at a conventional time scale, duration of 70 to 200 ms (sharp wave) or 
from 20 to under 70 ms (spike) and a main component generally negative relative to other 
areas  
FSWA evolution between early and late EEG was also analysed and considered “persistent” 
if existing in both exams (even if intermittently), “transient” if present in the early but absent 
in the late and “absent” if non-existent in both EEG.  
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Figure 3.  Focal Slow Wave Activity and Epileptiform activity 
 
Legend to figure 2: Source derivation montage of a 15mm/sec EEG page. Left black 
square highlights Focal Slow Wave Activity and right black square identifies Epileptiform 
Activity (abrupt wave followed by a slow wave). 
 
2.4. Statistics  
Univariate descriptive statistics was used for categorical and continuous variables. Bivariate 
analysis was performed using χ2 test, Fisher´s exact test or t-student or Mann-Whitney test, 
as appropriate. The level of significance was established at α<0.05 (two-tailed).  
 
To define independent predictors of neurophysiological outcomes, significant variables at 
p<0.05 in the bivariate analysis were tested in multivariate analysis using a 
stepwise binomial logistic regression with backward elimination. A Hosmer and Lemeshow 
test assessed the calibration of the model and the Receiver Operator Characteristic (ROC) 
curve its discriminative capacity.  
 
As a measure of  interobserver agreement for the final diagnosis we used Cohen’s kappa 
statistic.  
 
Statistical analysis was performed using SPSS software version 21 for Mac. 
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3. RESULTS 
 
Eighty patients were included with the initial diagnosis of possible TIA. Table 3 describes 
the demographic, clinical, imaging and electroencephalographic characteristics of these 
patients. 
 
 
Table 3. Demographic, clinical, imaging and electroencephalographic characteristics 
of patients with the initial diagnosis of possible TIA 
 Demographic characteristics 
Male / Female  36 / 44 (45% / 55%) 
Age (years) Mean: 65.5 (SD 14.4); Median: 68.5  
Clinical characteristics  
Sudden onset (<1min) 54 (71.1%) 
Motor symptoms 20 (25%) 
Positive symptoms and/or march of symptoms 40 (50%) 
Sensory symptoms and/or visual symptoms  43 (53.8%) 
Speech disturbance 43 (53.8%) 
Amnesia and/or consciousness disturbance and/or 
confusional period  
36 (45%) 
Number of previous episodes  Mean: 2.1 (SD 1.3); Median: 2 
Mean duration of the last episode (hours) Mean: 2.4 (SD 4.8); Median: 0.5 
Time between symptoms and EEG (hours) Mean: 45.8 (SD 37.5); Median: 37.5 
Imaging characteristics  
MRI 
(n=43 / 53.8%) 
DWI+ 4 (9.3%) 
Another lesion 22 (51.2%) 
Electroencephalographic characteristics  
Early EEG 
(n=80) 
FSWA 52 (65%) 
EA 6 (7.5%) 
Late EEG  
(FSWA evolution; 
n=73 / 91.2%) 
Persistent FSWA 43 (58.9%) 
Absent or transient FSWA 30 (41.1%) 
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Legend to table 3: EA - Epileptiform Activity; FSWA - Focal Slow Wave Activity; DWI+ - 
acute vascular lesion on Diffusion-Weighted brain magnetic resonance Imaging; SD - 
Standard Deviation 
 
3.1. Frequency of EEG abnormalities  
In the early EEG, 52/80 patients (65%) had FSWA, 6 of them also EA (6/80 7.5%) and 7/80 
(11.7%) other abnormalities (increase of beta activity in 5 and diffuse slowing of background 
activity in 2). The EEG record was reported as normal in 21/80 patients (26.2%).  
 
After one month, 74 patients (92.5%) repeated the EEG, which was normal in 25 (33.8%). 
In this record, 44/74 (59.5%) patients had FSWA. FSWA evolution was demonstrated 
persistent in 43 (58.1%), transient in 6 (8.1%) and absent in 24 (32.4%) patients.  In one 
patient (1.4%), FSWA only emerged in the late EEG.  Only 3 of the 6 patients with EA in 
the early EEG retained this activity in the late EEG. No patient showed EA in this exam 
when not present in the early EEG.  
 
At the time of the early EEG (Appendix A), 11 patients (13.8%) were being treated with 
antiepileptic drugs (AED). During follow-up, 7 patients (3 with EA in early EEG) were 
prescribed AED (6 for epileptic seizures and 1 for migraine). At the time of the late EEG, 
18 patients (24.3%) were on AED.  
 
3.2. Clinical/Imaging characteristics associated with EEG abnormalities   
 3.2.1. Age 
Both patients with FSWA in the early EEG and patients with demonstrated persistent FSWA 
in the late EEG were respectively 12.3±3.4 (t(43.43)=3.63, p=0.001) and 11.3±3.1 years 
(t(46.52)=3.66, p=0.001) older than the remaining sample. 
There was no significant difference in the mean age of patients with or without EA in the 
EEG (t(78)=-1.17, p=0.902).  
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3.2.2. Neurological syndrome characteristics 
No significant associations were found between the variables of the two EEG and the number 
of previous episodes, duration or the time interval between the clinical event and the EEG. 
The electroencephalographic characteristics of the different symptomatic groups under 
study are depicted in Table 4. 
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In the early EEG, FSWA was associated with amnesia for the event and/or consciousness 
disturbance and/or a confusional period (Table 4). In this exam, 5 patients with EA (83%) 
had a clinical syndrome with speech disturbances and 4 (66.7%) at least one of the 
following: amnesia for the event, consciousness disturbance and/or confusional period. EA 
was significant associated with a neurological syndrome with consciousness disturbance 
(Fisher's exact test, p=0.040, OR=6.59, 95% CI: 1.11-39.15).  
 
In the late EEG, persistent FSWA was associated with the presence of speech 
disturbances (χ2=7.41, p=0.006, OR=3.77, 95% CI: 1.42-9.97) and transient FSWA with a 
confusional period (Fisher's exact test, p=0.047, OR=6.25, 95% CI: 1.04-37.37).  
 
In a binomial logistic regression model, FSWA was no longer predicted (p=0.499, OR=1.47, 
95% CI: 1.02-1.11) by "amnesia and/or consciousness disturbance and/or confusional 
period" when adjusted for age (χ2(2) = 14.00, p<0.0005; NagelkerkeR2=22.1%; Hosmer-
Lemeshow test, p=0.839; AUC=0.74, p<0.0005, 95% CI: 0.62-0.87).  
 
Persistent FSWA in the late EEG was independent predicted by both age (p=0.002, 
OR=1,08, 95% CI: 1.03-1.13) and "speech disturbances” (p=0.02, OR=3.54, 95% CI: 1.22-
10.28) in the logistic regression model (χ2(1) = 17.73, p<0.0005; NagelkerkeR2=31.4%; 
Hosmer-Lemeshow test, p=0.714; AUC 0.80; p<0.0005, 95% CI: 0.69-0.90).  
 
3.2.3. Imaging characteristics  
No differences in EEG variables were observed in patients with and without normal MRI. 
Among patients with an acute vascular lesion in the MRI (DWI+), three (75%) had FSWA 
in the early EEG and in two of them (66.7%) this activity disappeared in the late EEG 
(Fisher's exact test, p=0.011).  
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3.3. Final diagnosis of epileptic seizure or definitive TIA in patients with possible TIA 
After all diagnostic tests and clinical reassessment, patients with possible TIA were 
reclassified in a final diagnosis (Figure 4).  
 
 
Figure 4.  Reclassification of possible TIA 
 
Legend to figure 4: *one patient classified as TIA had the concomitant diagnosis of epileptic 
seizures (partial complex seizures) in the clinical follow-up  
 
Thirteen patients were diagnosed with epileptic seizures (16.3%) and 11 (13.8%) 
with definitive TIA by the stroke neurologist (PC).  One patient had a final dual diagnosis 
of definitive TIA and epileptic seizures.  This patient was discharged from the Stroke Unit 
with a TIA diagnosis. However, in the follow-up appointment the patient reported different 
clinical episodes that were then diagnosed as partial complex seizures.  
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3.3.1. Interobserver agreement   
The two neurologists agreed in the diagnosis of 59 patients (73.8%). The interobserver 
concordance in the final diagnosis was good (k=0.627, p<0.0005, 95% CI: 0.48-0.77). In the 
analysis of the diagnosis of seizure (vs. non-seizure), the two classifiers agreed in 73 patients 
(91.2%). The interobserver agreement was good (k=0.707, p<0.0005, 95% CI: 0.50-0.91). 
Also, for the diagnosis of definitive TIA (vs. non-definitive TIA) the interobserver 
agreement was good (k=0.789, p<0.0005, 95% CI: 0.59-0.99), with a concordant diagnosis 
in 76 patients (95%).  
 
3.3.2. Clinical/Imaging characteristics associated with the final diagnosis of interest 
No significantly mean age difference was found between patients with final diagnosis of 
epileptic seizures or TIA and other final diagnosis (t(65.85)=1.474, p=0.145).  
 
Clinical and EEG characteristics of patients with the final diagnosis of seizures and 
definitive TIA are displayed in Table 5.  
 
Of the evaluated symptoms, only the existence of a Jacksonian march of symptoms was more 
frequent in seizure patients (n=7; 50%) than in patients with definitive TIA (n=1; 9.1%) 
(Fisher's exact test, p=0.027, OR=14.00, 95% CI: 1.33-147.43).  
 
MRI was performed on eight (66.7%) patients with epileptic seizures and five (45.4%) 
patients with the final diagnosis of definitive TIA, four of whom (80%) had an acute vascular 
lesion in MRI.  
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3.4. Electroencephalographic characteristics in patients with epileptic seizure and 
definitive TIA diagnosis 
FSWA in the early EEG was differently distributed between final diagnosis groups 
(p=0.027). Furthermore, FSWA in the early EEG was associated with the final diagnosis of 
epileptic seizure or definitive TIA compared to other type of final diagnosis (19/23 patients 
versus 33/57 patients; p=0.041; OR 3.46; 95% CI 1.04-11.46). 
 
The only significant EEG difference between patients with epileptic seizures and definitive 
TIA was a different evolution of FSWA between the early and the late EEG (table 5). The 
chance of persistent FSWA in the late EEG was significantly greater (13.2 times higher) in 
a patient with an epileptic seizure than in a patient with TIA. In fact, the majority of patients 
with seizures (91.7%) maintained the FSWA between the two examinations while the same 
only occurred in less than half (45.5%) of TIA patients. Furthermore, absent or transient 
FSWA was less frequent in patients with seizures (8.3%) than with TIA (54.5%).  
 
Although a higher percentage of patients with epileptic seizures had EA, this difference was 
not statistically significant. Of the 13 patients who had the final diagnosis of epileptic 
seizures, six (46.2%) had EA in the early EEG.  
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4. DISCUSSION  
 
FSWA was the commonest EEG abnormality found in the early EEG of patients with 
possible TIA but did not distinguished between TIA and seizure patients. In patients with 
seizures, FSWA was more common than epileptiform activity and its presence in the EEG 
one month later was more likely in patients with epileptic seizures.  
 
In this work, EEG abnormalities were frequent, occurring in 73.8% of the patients. FSWA 
was the most common, although others could be identified. This percentage is similar to that 
found by De Reuck & Van Maele50 in patients with inhibitory  seizures (76%), but rather 
different from that of patients with definitive TIA (7.6%) in the same study. Unlike this 
Belgian study, we did not recognise early EEG differences between epileptic seizure and 
definitive TIA patients. There are some plausible explanations for this apparent discrepancy 
between the two studies, namely time until EEG and age. Neurological syndromes lasting 
less than 24 hours are, by definition, time-limited events of neurological dysfunction and, 
for that reason, time interval between clinical manifestations and EEG might influence the 
presence or the type of electroencephalographic abnormalities. In the De Reuck and Van 
Maele study, 100% of patients with seizures but less than half of patients with definitive TIA 
underwent an EEG in the first 24 hours. Furthermore, temporal slowing is a frequent finding 
in older patients213 and seizure patients were older than TIA patients in the same study. In 
our series, time until EEG and age were not significantly different in patients with seizures 
and with TIA.  
 
In this series of possible TIA patients, epileptic seizures were the most common final 
diagnosis, followed by definitive TIA. Approximately one half of the patients remained 
undiagnosed, clearly showing the differential diagnosis difficulty of possible TIA and the 
need for complementary strategies supporting the classification of these undefined events17. 
Sequential spread of symptoms according to the homunculus of the motor (or sensory) 
cortex were associated with the diagnosis of epileptic seizures, in agreement with the 
“Jacksonian march” characteristic of focal seizures214. 
In our work, patients with early FSWA had a higher probability of subsequent diagnosis of 
epileptic seizures or definitive TIA, not explained by a different mean age between final 
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diagnosis groups. Furthermore, a higher percentage of patients with these final diagnoses 
had early FSWA compared to early EA (82.6% vs. 26.1%, respectively). Although FSWA 
is not specific to the final diagnosis, it was informative and more sensitive than EA. In line 
with these results, a patient with a possible TIA with early FSWA should be further 
investigated and followed-up. 
 
Six patients (7.5%) had EA in the early EEG, a higher percentage than the reported 
frequency of false-positive (0.5-1%) in asymptomatic individuals215,216.  The percentage of 
patients with a definite diagnosis of epileptic seizures and EA in the early EEG (46.2%) is 
within the range of sensitivity reported for EEG (26 to 56%) as a diagnosis test for 
epilepsy8.  Still, it is possible that AED prescription in 14% of the patients reduced the 
probability of finding EA in the early EEG217–220. Furthermore, focal seizures arising from 
small foci or deep foci for the recording electrodes may not have a surface EEG correlate. It 
is known that the repetition of EEG can be useful when the diagnosis of epilepsy is not 
clear8,221. Salinsky and collaborators222 showed that 50% of epilepsy patients had EA in the 
first EEG, 84% in the third EEG and 92% in the fourth EEG. However, in our study, 
the repetition of the EEG did not improve the EEG value in EA detection, as would be 
expected. There are two possible reasons for this finding. On the one hand, there is 
the already discussed effect of AED in the intercritical EA217–220. In fact, the percentage of 
medicated epileptic seizures patients by the time of late EEG was greater than in early EEG 
(92.3%. vs. 38.5%). On the other hand, the likelihood of finding EA in the EEG seems to 
decrease over time after a paroxysmal event223. The lack of a significant difference in the 
incidence of EA in the EEG of patients with the final diagnosis of seizure and TIA is likely 
to be due to small patient numbers in each subgroup.  
 
The time evolution pattern of FSWA was significantly different between the two final 
diagnostic groups (seizures and TIA), as patients with seizures more often had FSWA 
persisting in the late EEG. The high percentage of epileptic seizure patients with early FSWA 
and the persistence of FSWA in the late EEG in these patients, may represent a 
neurophysiologic marker of the existence of an enduring predisposition to generate epileptic 
seizures93,146. In fact, FSWA has been described in patients with epilepsy as a good marker 
of the epileptogenic network and the ictal onset zone224–227. In contrast, patients with 
definitive TIA had a different FSWA time evolution pattern:  either they never had FSWA in 
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the early EEG or the FSWA was no longer present in the late EEG, in accordance with what 
was described in transitory cerebral ischaemia due to carotid compression228.  
 
This work has some strengths, such as: 1) it compares EEG differences between patients 
who initially had transient neurological symptoms and a not yet established neurological 
diagnosis, reflecting the clinical practice diagnostic question - is the EEG useful when the 
diagnosis is unknown?; 2) EEG readers were blind to the final diagnosis, which was 
established only after the EEG report; 3) no patients were lost for clinical follow-up and only 
a few (7.7%) for the EEG follow-up; and 4) the high final diagnosis interobserver agreement 
gives robustness to the results. Nevertheless, this study also has some limitations, in 
particular: 1) it was hospital-based limiting generalization to other clinical settings; 2) A 
time-based TIA definition was used, so these results may not apply to tissue-based defined 
TIA127,229; 3) Only two EEG abnormalities were variables of interest in this study but others 
could be considered; 4) the sample size was modest, which limits the statistical power for 
some comparisons. 
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5. CONCLUSIONS  
 
In the early EEG, the majority (58.3%) of patients with a final diagnosis of an epileptic 
seizure did not have EA. FSWA in the early EEG occurred whether the patient suffered a 
seizure or TIA (and was more often present than EA following a seizure), but in the EEG 
performed 1 month after the clinical episode was more likely to indicate that the initial event 
was a seizure. 
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V. PROJECT 2 
 
 
  
“The statistical analysis of a large collection of results from individual studies  
for the purpose of integrating the findings”  
Gene Glass 
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ABSTRACT 
Introduction: Cerebrovascular diseases are the most frequent risk factor for epilepsy in the 
elderly, and epileptic phenomenon following stroke is known to worsen the prognosis. 
Although electroencephalography is the gold standard epilepsy biomarker, it is rarely used 
in post-stroke studies, and the frequency of post-stroke epileptiform activity is still uncertain.  
Patients and methods: We analysed studies indexed to MEDLINE, Embase, Web of 
Science, PsycINFO and OpenGrey (up to March 2015), reporting post-stroke 
electroencephalographic epileptiform activity frequency in adults. Epileptiform activity was 
classified as ictal (electrographic seizures) and interictal (non-periodic spikes and sharp 
waves). Data selection, extraction and appraisal were done in duplicate. Random-effects 
meta-analysis was used to pool frequencies. 
Results: The pooled frequency of post-stroke ictal and interictal epileptiform activity was 
7% (95%CI 3%-12%) and 8% (95%CI 4%-13%), respectively. The use of continuous 
electroencephalogram was not associated with an increased frequency of electrographic 
seizures (p=0.05), nor did the management setting (Intensive Care Unit [ICU] versus non-
ICU, p=0.31). However, studies with continuous electroencephalogram showed a higher 
frequency of interictal epileptiform activity (p=0.01).  
Discussion: This study provides the best available estimates of the frequency of post-
stroke electroencephalographic epileptiform activity. Due to detection bias, it was not 
possible to correlate clinical and electrographic seizures.  
Conclusion: The frequency of ictal and interictal epileptiform activity in the EEG was 
comparable with previous frequency analyses of clinical seizures. The frequency of ictal 
epileptiform activity did not change with continuous record or clinical setting, while the 
frequency of interictal epileptiform activity increased with continuous record.  
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1. INTRODUCTION  
 
Cerebrovascular diseases are the most frequent risk factor for epilepsy19,  accounting for 
more than half of all cases in elderly patients20. On the other hand, epileptic seizures 
following stroke44,45 and electrographic seizures and interictal epileptiform discharges in 
critically ill patients46–48 are known to worsen the outcome.  
The current International League Against Epilepsy (ILAE) definition of epilepsy93 allows 
for the diagnosis of epilepsy after a single unprovoked seizure, provided that there is at least 
a 60% probability of recurrence, as it is the case of the first unprovoked seizure after the 
acute stroke phase44. This sensitivity-maximizing definition, and the fact that acute 
symptomatic seizures are described as risk factors for unprovoked seizures230, prompts 
discussion for the role of electroencephalogram (EEG) after stroke – as this technique can 
contribute to early and accurate detection of ictal and interictal epileptiform activity. 
The frequency of seizures and interictal epileptiform activity after stroke is uncertain27. This 
is the case because EEG is seldom used in studies investigating the frequency of post-stroke 
seizures, although being the gold standard for the identification of these phenomena5, and as 
little as 10% of all seizures are recognised without EEG in critically ill patients75.  
As so, we set out to estimate the frequency of post-stroke electroencephalographic 
epileptiform activity using meta-analytical techniques. 
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2. METHODS  
 
2.1. Protocol and registration 
The protocol followed the PRISMA-P guidelines and was registered at Prospero 
(CRD42015029362)231. We followed the MOOSE and PRISMA guidelines232. Statistical 
data reporting followed the SAMPL guidelines.  
 
2.2. Eligibility criteria 
We included published and unpublished (i.e. conference proceedings) observational studies 
reporting original data on the frequency of electroencephalographic epileptiform activity 
after stroke in adults (≥18-year-old). All observational study designs were accepted with the 
exception of case series with less than 10 participants to decrease the risk of selection bias. 
This threshold was established arbitrarily and excludes single case-reports and small case-
series. Studies reporting on patients diagnosed with silent cerebral infarcts and haemorrhages 
were excluded due to the low specificity to determine a time sequence between the cause 
and the effect. No study was dismissed a priori due to poor quality, language, or length of 
follow-up. Epileptiform activity in the EEG was classified as ictal activity (electrographic 
seizures212) and interictal activity (non-periodic spikes and sharp waves211). Stroke was 
defined as an episode of acute neurological dysfunction presumed to be caused by ischaemia 
or haemorrhage, persisting ≥24 hours or until death233. For data extraction and analysis, we 
followed the above-mentioned definitions.  
 
2.3. Information sources 
The electronic search was conducted in MEDLINE, Embase, Web of Science, and 
PsycINFO. Grey literature was searched via OpenGrey. No language, date/time, document 
type or publication type restriction was applied. The last search was done on 22 March 2015. 
Search results were de-duplicated in EndNote X7. Non-English reports were translated. 
Whenever needed, authors were contacted for further data. The reference lists of included 
studies were crosschecked for additional studies. 
 
2.4. Search 
The search strategies developed combine the terms (Cerebrovascular disorder OR Stroke OR 
Brain Ischaemia OR Brain Infarction OR Intracranial Embolism and Thrombosis OR 
Intracranial Haemorrhage OR Cerebral Haemorrhage OR Subarachnoid Haemorrhage OR 
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Cerebral Infarction OR Cerebellar Infarction OR Cerebellar Haemorrhage OR Brain Stem 
Infarction OR Brain Stem Haemorrhage) with (Partial Epilepsy OR Generalized Epilepsy 
OR Post-Traumatic Epilepsy OR Reflex Epilepsy OR Seizure OR Status Epilepticus). A 
filter was adapted to avoid retrieval of non-observational studies. The search strategy was 
restricted to humans as participants. All terms were searched as free-text and controlled 
vocabulary. The search strategies can be found in the Appendix B  
 
2.5. Study selection 
Reports retrieved through electronic identification were screened by title and abstract. The 
full-text of potentially eligible studies was screened for appropriateness for inclusion. Three 
independent screeners (CB, DS, and RP) conducted this process. Disagreements were solved 
by consensus, or by a forth party (FBR). 
 
2.6. Data collection process 
A pilot extraction form was tested with 5 studies by two independent reviewers (CB and 
FBR). Two independent parties (AF, DS, GSD, HN, RM, or ARP) extracted data from 
included studies to a predetermined and piloted electronic form using the online-based 
software Covidence (https://www.covidence.org/). Disagreements were solved by an 
independent party (CB or FBR). 
 
2.7. Risk of bias in individual studies 
The risk of bias of individual studies was evaluated in accordance with the Newcastle-
Ottawa Quality Assessment Scale234. Quality of reporting was independently analysed by 
two authors (AF, DS, GSD, HN, RM, or ARP). Disagreements were solved by a third party 
(CB or FBR). Studies having a star rating of more than 60% were considered of low risk of 
bias, as assumed by others.  
 
2.8. Summary measures 
The primary outcomes were the frequency of ictal and interictal epileptiform activity (as 
defined above) in stroke patients’ EEGs. To calculate frequencies, we adopted a conservative 
approach by determining the number of events divided by the number of participants in the 
study. This method underestimates events, since not all participants performed EEG. 
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2.9. Synthesis of results 
We used Stata/SE 14.0 software to conduct the analysis and to derive forest plots. Random-
effects meta-analysis weighted by the inverse-variance method was performed to estimate 
the pooled frequencies and respective 95% confidence intervals (95% CI). We used a 
random-effects model as substantial heterogeneity between studies results was expected. 
Heterogeneity was assessed with the I2 test. The limit for statistical significance was 
established at 0.05. 
 
2.10. Additional analysis 
Pre-specified sensitivity analyses were conducted by excluding: studies at high and unclear 
risk of bias; studies without continuous EEG (cEEG); and studies in settings other than the 
intensive care unit (ICU). We planned to estimate the frequency of events in different 
subgroups of patients according to study site, year, stroke type and location. Unfortunately, 
we could not retrieve enough data for the latter analysis. Two post-hoc analyses were 
performed: the first excluding studies only reporting on subarachnoid haemorrhage (SAH), 
to study the effect of this aetiology on the overall frequency of events; and the second solely 
including studies where EEG was performed in a consecutive cohort of stroke patients, to 
study the effect of selection bias. 
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3. RESULTS 
 
3.1. Study selection: The last electronic search was run from inception to March 22, 2015. 
A total of 2871 references were retrieved (MEDLINE 1985, Embase 425, PsycINFO 66, 
Web of Science 394, Open Grey 1). Two studies were included via hand-search. After de-
duplication, 2527 titles and abstracts were screened, and 2226 were excluded, as they were 
not relevant to our research question. We selected 301 studies for full text assessment, and 
284 studies were removed due to failure to comply with inclusion criteria. A total of 17 
studies where included (Figure 5, Table 6 and Appendix C). 
 
 
Figure 5. PRISMA flow chart  
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3.2. Risk of bias within studies: Four (23.5%) studies did not meet our definition of low 
risk of bias. The remaining were assessed as being at a low risk of bias. Only 2 (11.7%) 
included studies attained the maximum quality score (low risk of bias in all domains).  
 
3.3. Synthesis of results 
3.3.1. The pooled frequency of ictal epileptiform activity (electrographic seizures) 
The pooled frequency of ictal epileptiform activity (electrographic seizures) in the EEG was 
7% (95% CI 3% to 12%, I2= 93.5%, 14 studies, n=2711, Figure 6), without significant 
differences when considering only studies at low risk of bias (13 studies), studies exclusively 
enrolling participants with haemorrhagic stroke (8 studies), studies including ischaemic and 
haemorrhagic stroke (6 studies), or after excluding studies where only SAH were captured 
(13 studies). Studies where EEG was performed in a consecutive cohort of stroke patients 
showed a smaller frequency of events (4%, 95% CI 0% to 12%, I2=82.5%, 4 studies, n=339). 
No study exclusively enrolled participants with ischaemic stroke. Studies including 
exclusively SAH patient did not differ from the other included studies (p=0.77). The use of 
cEEG was not associated with an increased frequency of detected electrographic seizures 
(p=0.05), nor with the setting where the patients were tested (ICU versus non-ICU, p=0.31), 
or the year of publication (before versus after 2007, a threshold generated by splitting the 
included studies into two groups according to the year of publication) (p=0.72). Studies 
performed in the USA showed a higher frequency of electrographic seizures than studies 
performed outside the USA (13% (95% CI 10% to 17%) versus 1% (95% CI 0% to 2%); 
p<0.001) 
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Figure 6. Pooled frequency of ictal activity (electrographic seizures)  
 
Legend to figure 6: This graph shows the results of each individual study in each of the lines, 
and the results of the meta-analysis in the last line (lozenge). The left column presents the 
surname of the first author of each study, the year of publication, and the country where the 
study was performed, with the exception of the last line, where the results of the statistical 
heterogeneity tests employed are presented. The two middle columns show, from the left to 
the right, the graphical (forest plot) and numerical representation (percentage of participants 
with ictal activity and a 95% confidence interval [95% CI]) of the results of each individual 
study and, on the last line (lozenge), of the meta-analysis. The dotted vertical line represents 
the central estimate of effect. Finally, the right column depicts the weight each of the studies 
had on the meta-analysis. 
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3.3.2. The pooled frequency of interictal epileptiform activity  
The pooled frequency of interictal epileptiform activity (non-periodic spikes and sharp 
waves) was 8% (95% CI 4% to 13%, I2=86.0%, 7 studies, n=1874, Figure 7). When only 
analysing trials at low risk of bias, the estimated frequency increased to 10% (95% CI 5% to 
16%, I2=85.48%, 6 studies, n=1810). We found no difference for studies including ischaemic 
and haemorrhagic stroke (8%, 95% CI 3% to 13%, I2=87.2%, 5 studies, n=1839), though we 
found an increased frequency among studies exclusively enrolling haemorrhagic stroke 
patients (12%, 95% CI 7% to 13%, I2=96.8%, 2 studies, n=240). No study reported solely 
on patients with SAH. Studies where EEG was performed in a consecutive cohort of stroke 
patients showed a higher frequency of events (14%, 95% CI 9% to 21%, I2=0.0%, 2 studies, 
n=132). Studies with cEEG showed a higher frequency of interictal epileptiform activity 
detection (14%, 95% CI 10% to 20% vs. 6%, 95% CI 3% to 10%; p=0.01). No study 
performed in ICU reported these events and no differences were found between study site 
(p=0.26) or year of publication (p=0.29).  
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Figure 7. Pooled frequency of interictal activity (non-periodic spikes and sharp waves) 
 
Legend to figure 7: This graph shows the results of each individual study in each of the lines, 
and the results of the meta-analysis in the last line (lozenge). The left column presents the 
surname of the first author of each study, the year of publication, and the country where the 
study was performed, with the exception of the last line, where the results of the statistical 
heterogeneity tests employed are presented. The two middle columns show, from the left to 
the right, the graphical (forest plot) and numerical representation (percentage of participants 
with interictal activity and a 95% confidence interval [95% CI]) of the results of each 
individual study and, on the last line (lozenge), of the meta-analysis. The dotted vertical line 
represents the central estimate of effect. Finally, the right column depicts the weight each of 
the studies had on the meta-analysis.  
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4. DISCUSSION  
 
This systematic review and meta-analysis of observational studies shows that 7% and 8% of 
patients following a stroke have epileptiform ictal and interictal activity, respectively, in the 
EEG.  To the best of our knowledge, the frequency of post-stroke electroencephalographic 
events in observational studies was never pooled, and such results should prompt further 
discussion as to whether EEG should be used more frequently after stroke as a biomarker 
for epileptic manifestations.  
 
Previous systematic reviews have shown that intracerebral haemorrhages and SAH are 
associated with a significantly greater probability of epileptic seizures26,235.  In our study, 
studies exclusively enrolling haemorrhagic stroke patients showed a higher frequency of 
interictal epileptiform activity but not of electrographic seizures. Furthermore, the frequency 
of events was not different in studies solely focused on SAH. Importantly, the absence of 
studies exclusively enrolling ischaemic stroke patients may bias these results, since mixed 
population studies (i.e. including both ischaemic and haemorrhagic stroke) are expected to 
set the bar for this comparison much higher and decrease the likelihood of finding a 
statistically significant difference between populations. Also, the low number of studies 
analysing epileptiform activity in haemorrhagic stroke in general, and in SAH in specific, 
can also contribute to uncertainty and to unexpected results, as there is a pathophysiological 
rational for these stroke subtypes to be associated with more epileptiform activity. 
  
As expected, in studies where consecutive stroke patients underwent an EEG, the frequency 
of ictal events was lower than our general estimate. This analysis subtracts from the selection 
bias introduced by retrospective studies where it is methodologically difficult to avoid a 
systematic error of including participants more likely to have epileptiform activity, such as 
those with clinical seizures or with a lower or fluctuating consciousness level. Unfortunately, 
our confidence in these results is low due to limited statistical power and low precision. 
Unexpectedly, the frequency of interictal events in these studies exceeds the general 
estimate, though the reason for this finding may be the lack of power, since only 2 studies 
were included. 
 
In our study, cEEG did not increase the likelihood of detection of ictal epileptiform activity, 
which agrees with previous studies76, where it was stated that insufficient data exists to 
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support the benefit of cEEG over spot EEG recordings. That being said, the detection rate of 
interictal epileptiform activity with cEEG was twice as high without cEEG.    
 
The frequency of electrographic seizures was not different in ICU and non-ICU patients. 
However, the scarcity of studies and the imbalances between population characteristics may 
bias these results. 
 
Not unexpectedly, the year of publication did not influenced the frequency of events. On the 
other hand, it was interesting to note that studies conducted in the USA showed a statistically 
significant higher frequency of ictal events. We hypothesise that this can be explained by the 
population characteristics, since a great majority of the North American studies were based 
in an intensive care setting, while this was not true for the other studies. 
 
Finally, it is important to note that this study has several limitations. The quality assessment 
showed that almost 80% of the studies were at low risk of bias but only 12% had a high-
quality standard. Our methodological options probably underestimate 
electroencephalographic epileptiform activity. EEG is more likely to be requested if there is 
a clinical suspicion of seizures. This selection bias by indication is only avoidable in 
prospective studies where EEG is performed on all patients regardless of the clinical 
features. Studies reporting electroencephalographic epileptiform activity are not controlled 
with a group of participants without the pathological condition of interest, but who were 
subject to the same kind of clinical and diagnostic procedures. This invalidates the possibility 
of studying risks of events instead of frequency as we did. It would be interesting to 
understand how the frequency of clinical seizures relates to the frequency of electrographic 
ones. Unfortunately, due to diagnostic bias, since not all enrolled participants performed 
EEG, the available literature cannot reliably answer this question. Finally, we would like to 
have included the timing of the EEG in our analyses, since this variable seems to be closely 
related with the likelihood of detection of epileptiform events. Unfortunately, this data was 
rarely available. 
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5. CONCLUSION 
  
In conclusion, the frequency of ictal and interictal epileptiform activity in the EEG was 
comparable with previous frequency analyses of clinical seizures. The frequency of ictal 
epileptiform activity did not change with continuous record or clinical setting, while the 
frequency of interictal epileptiform activity increased with continuous recordings
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VI. PROJECT 3 
 
 
  
“It is not very uncommon to find when a patient has recovered or is recovering from 
hemiplegia, the result of embolism of the middle cerebral artery or of some branch of this 
vessel, that he is attacked by convulsion beginning in some part of the paralyzed region” 
John Hughlings Jackson (1864) 
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ABSTRACT  
Introduction: Cerebrovascular disease is the leading cause of epilepsy in adults, although 
post-stroke seizures reported frequency is variable and few studies used EEG in their 
identification.  
Objectives: To describe and compare EEG and clinical epileptic manifestations frequency 
in patients with an anterior circulation ischaemic stroke. 
Method: Prospective study of acute anterior circulation ischaemic stroke patients, 
consecutively admitted to a Stroke Unit over 24 months and followed-up for one year. All 
patients underwent standardized clinical and diagnostic assessment. Seizure occurrence was 
clinically evaluated during hospitalization and by a telephone interview at 6 months and a 
clinical appointment at 12 months after stroke. Video-EEG was performed in the first 72 
hours (1st EEG), daily after the 1st EEG for the first 7 days after the stroke, or later if 
neurological worsening, at discharge, and at 12 months.  
Results: 151 patients were included (112 men) with a mean age of 67.4 (11.9) years. In the 
1st year after stroke, 38 patients (25.2%) had an epileptic seizure.   
During hospitalization, 27 patients (17.9%) had epileptiform activity (interictal or ictal) in 
the EEG, seven (25.9%) of them electrographic seizures. During the first week after stroke, 
22 (14.6%) patients had a seizure and 4 (2.6%) non-convulsive status epilepticus criteria. 
Five (22.7%) acute symptomatic seizures were exclusively electrographic.  
At least one unprovoked seizure occurred in 23 (15.2%) patients. 
Conclusion: In the first 7 days after stroke, more than one-fifth of patients with seizures had 
exclusively electrographic seizures. Without a systematic neurophysiological evaluation the 
frequency of post-stroke seizures are clinically underestimated.  
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1. INTRODUCTION  
 
Post-stroke seizure identification has many implications for clinical practice. On the one 
hand, epilepsy diagnosis can be made of a patient with at least one unprovoked seizure after 
stroke93 since it has a recurrence probability of 71.5%44. On the other hand, although there 
is no quality evidence for the recommendation of acute symptomatic post-stroke seizures 
secondary prevention148, this seems to be common in many centres in the acute stroke 
setting, to prevent additional metabolic burden188.  
However, the reported frequency of seizures after an ischaemic stroke is variable (2-67%)21 
possibly due to different study methodologies. One limitation of this frequency analysis has 
been the lack (in the vast majority of studies) of an electroencephalographic record27. In a 
retrospective study of acute brain injury patients submitted to EEG monitoring, most seizures 
(92%) were electroencephalographic without apparent clinical manifestations75. More 
specifically, 9% of patients with an acute ischaemic lesion had non-convulsive seizures and 
7% had criteria for non-convulsive status epilepticus75.  Thus, in the absence of an EEG 
record, the frequency of post-stroke seizures may be underestimated. Moreover, the 
frequency of electrographic seizures in patients with ischaemic stroke who do not require 
admission to an intensive care unit and EEG monitoring is unknown, although epileptic 
seizures44,45 and ictal/interictal EEG discharges have been associated with stroke 
unfavourable outcome46–48.  
 
This paper aims to prospectively describe and compare the frequency of EEG and clinical 
epileptic manifestations in patients with an anterior circulation ischaemic stroke admitted to 
a Stroke Unit.   
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2. METHODS  
 
Prospective study of consecutive patients with an acute anterior circulation ischaemic stroke, 
admitted to the Stroke Unit of a Neurology Department over a period of 24 months (between 
October 2011 and October 2013) and followed-up for 12 months (October 2012 to October 
2014). The study was approved by the Ethics Committee of Centro Hospitalar Lisboa Norte 
(“Comissão de Ética para a Saúde”).  
 
The following inclusion criteria were used: 
(1) Acute anterior circulation ischaemic stroke, established by imaging (CT scan or MRI) 
obtained at any time during hospitalization (reviewed by a senior neuroradiologist), with 
less than 7 days of clinical evolution  
(2)  National Institutes of Health Stroke Scale (NIHSS) score70 ≥ 4 upon admission to the 
emergency department  
(3) Signed informed consent by the patients or their next-of-kin.  
The subsequent exclusion criteria were used: 
(3) Previous stroke with modified Rankin scale score (mRS)236–238 > 1 at the time of acute 
stroke    
(4) Brain imaging study (CT scan or MRI) with one of the following: contusion; 
subdural/epidural hematoma; subarachnoid haemorrhage; neoplastic lesion; 
infectious/inflammatory lesion; hydrocephalus  
(5) Previous history of head trauma with hospital admission  
(6) Previous neurosurgery   
(7) Previous history of epilepsy or epileptic seizures 
 
2.1. Standardized clinical and ancillary evaluation  
All patients were attended by a neurologist at the emergency department and admitted at the 
Stroke Unit with continuous surveillance of their neurological status and daily observation 
by a stroke neurologist. During hospitalization, the patients underwent diagnostic tests 
allowing stroke etiological classification239 and appropriate therapeutic approach, including 
blood tests, carotid and vertebral duplex scans, transcranial Doppler and ECG. All patients 
underwent a CT scan at the emergency department (1st CT scan) which was repeated 24 
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hours after stroke in patients submitted to intravenous thrombolysis with alteplase (rtPA) 
and when clinically indicated in all patients (2nd CT scan). In selected cases, patients also 
performed MRI with diffusion weighted imaging, transthoracic or transesophageal 
echocardiography, 24h Holter or cerebral angiography. NIHSS score at hospital admission, 
after rtPA perfusion, daily and at discharge was registered prospectively (CB and HM). 
During hospitalization, the following clinical, laboratory and treatment variables were 
recorded daily: fever / infection (respiratory, urinary, other) / organ failure (kidney, liver, 
heart) / withdrawal syndrome / hydroelectrolytic imbalance / hypoxemia / seizure occurrence 
/ other medical or neurological complication / pharmacological therapy (CB and HM).  
After discharge the patient maintained standard clinical follow-up at the cerebrovascular 
outpatient clinic. A neurologist with expertise in epilepsy (CB) performed a telephone 
interview 6 months after stroke accessing seizure occurrence by a free interview followed 
by a brief phone screening tool for identifying patients with epilepsy240. A scheduled 
appointment 12 months after stroke was also conducted (CB), recording the following 
clinical variables: NIHSS and mRS scores, occurrence of seizures and its type; other stroke 
or medical complications; final etiological classification of stroke239 and on-going therapy.  
 
2.2. Neurophysiological Evaluation 
All patients underwent a neurophysiological evaluation protocol that included a 64 channel 
video-EEG with a maximum duration of 60 minutes in different time frames after stroke:  
(1) As early as possible, in the first 72 hours after admission (1st EEG) 
(2) Daily, after the 1st EEG, for the first 7 days after stroke (except on weekend)  
(3) If neurological worsening unexplained by medical complications and with indication for 
repeating the imaging exam.  
EEGs referred in (2) and (3), were called serial EEG study during hospitalization  
(4) At time of clinical discharge (discharge EEG) 
(5) At 12 months after stroke (12M EEG)  
The EEG record followed national and international recommendations 3,207–210. Video-EEG 
was performed using a Nihon-Kohden device (Neurofax EEG-1200) with a sampling 
frequency of 1000 Hz. We used international 10/10 electrode placement system and recorded 
at least 64 EEG channels. The total recording period was at least 35 minutes of wakefulness, 
including activation tests. Sleep was recorded whenever possible at the end of the exam. All 
records were performed by neurophysiology technicians with expertise in video-EEG and 
EEG records in acute brain lesion patients. Further technical specifications and EEG protocol 
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can be read in Appendix D.  
 
2.3. Imaging Interpretation  
All imaging exams performed during the study period were reviewed by 2 senior 
neuroradiologists (CC and CM), blinded for clinical and electroencephalographic findings 
and trained for ASPECTS classification 241. Doubts were discussed by consensus.  
In patients with an infarct limited to the middle cerebral artery (MCA) territory in the 
imaging study (considering 1st CT scan, 2nd CT scan or MRI), the infarct size was quantified 
by ASPECTS42 in 1st and 2nd CT scan. Insula and M1 to M6 ASPECTS territories were 
considered “cortical territories of ASPECTS”.  Furthermore, any type of haemorrhage 
transformation242, cortical or subcortical infarct location, presence of cortical areas with 
normal attenuation coefficient (islands of preserved cortex) within the infarct165,243,244 were 
evaluated in 2nd CT.  
 
2.4. Operational definitions   
2.4.1. Epileptic seizures and status epilepticus (only the first event was considered), were 
defined as:  
- Epileptic seizure: clinical93 and/or electrographic seizure212,245 
- Acute symptomatic seizure: seizure occurring within the first 7 days of a stroke142. In these 
patients, cut-off values for metabolic disorders and febrile symptomatic seizures were not 
overreached and alcohol/drug withdrawal or intoxication142 were excluded.  
- Unprovoked seizure: seizure occurring after 7 days of a stroke in the absence of 
precipitating factors  
- Epilepsy: occurrence of one unprovoked seizure and a probability of further seizures 
similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring 
over the next 10 years93. The occurrence of at least one unprovoked seizure after stroke meets 
these criteria44 
- Status epilepticus: ILAE classification246 and Salzburg Consensus Criteria for Non-
Convulsive Status Epilepticus (NCSE)245,247 
  
Post-stroke seizures are clinically underestimated 
 
85 
 
2.4.2. Electroencephalographic abnormalities:  
2.4.2.1. Occurrence in the 1st EEG of:  
- Interictal epileptiform activity (IEA)211;  EEG transients distinguishable from 
background activity with a characteristic spiky morphology, namely sharp waves 
(duration of 70-200 msec) and spikes (duration of 20-70 msec) 
- Periodic discharges (PD)212; repetition of a waveform (with no more than 3 phases 
or any waveform lasting ≤0.5 seconds regardless of number of phases) with relatively 
uniform morphology and duration with a quantifiable inter-discharge interval 
between consecutive waveforms and recurrence of the waveform at nearly regular 
intervals 
- Electrographic seizures212,245; generalized spike-wave discharges at 3/s or faster or 
clearly evolving discharges of any type that reach a frequency >4/s, whether focal or 
generalized. Evolving was defined as at least 2 unequivocal, sequential changes in 
frequency, morphology or location lasting for at least 3 cycles each. Evolution in 
frequency was defined as at least 2 consecutive changes in the same direction by at 
least 0.5/s. Evolution in morphology was defined as at least 2 consecutive changes 
to a novel morphology. Evolution in location was defined as sequentially spreading 
into or sequentially out of at least two different standard 10-20 electrode locations 
2.4.2.2. Any EEG during hospitalization (1st EEG or serial EEG study during hospitalization) 
with IEA and/or Electrographic seizures 
 
2.5. Statistical analysis  
A descriptive analysis was used for nominal qualitative and quantitative (discrete and 
continuous) variables. Nominal variables are expressed in frequency, the discrete variables 
as medians and interquartile ranges (IQR) and continuous variables as means and standard 
deviations (SD).   
 
Statistical analysis was done using SPSS program version 24 for Mac.  
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3. RESULTS 
 
151 patients (112 men and 39 women) with an acute anterior circulation ischaemic stroke 
and a mean age of 67.4 (SD 11.9) years were included. Study flowchart is in Figure 8. 
Demographic, clinical and imaging characteristics of these patients are displayed in Table 
7.   
 
 
Figure 8. Study flowchart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hospital Discharge  
 
Clinical and neurophysiological evaluation 12 months after stroke  
 
Phone interview 6 months after stroke  
 
Patient admitted to the Stroke Unit with the clinical diagnosis of an anterior circulation acute 
stroke (October 2011 to October 2013)  
 
Acute anterior circulation stroke patient meeting 
inclusion and exclusion criteria: n=153 
 
Posterior circulation stroke: n=5 
No acute vascular lesion in image: n=3 
TIA: n=2 
Stroke mimic: n=11 
 
Previous stroke with mRS>1: n=7 
Previous severe head trauma: n=1  
Known epilepsy: n=2 
 
Anterior circulation stroke patient with: 
admission NIHSS < 4: n=57 
≥ 7 days after stroke: n=8 
 
Stroke Unit standardized investigation and medical care 
+  Neurophysiological evaluation during admission 
 
Patient refused to participate: n=1 
Informed consent not signed: n=1 
 
n=151  
 
n=144  
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Table 7. Demographic, clinical and imaging characteristics of anterior circulation stroke 
patients 
Demographic and clinical characteristics (n=151) 
Number of male / female patients (%) 112 / 39 (74.2% / 25.8%) 
Mean age (SDa)  67.4 (11.9)  
Median NIHSSb at admission (IQRc) 12 (10) 
Number of patients treated with intravenous alteplase (%) 101 (67.3%) 
Stroke aetiology:                                              Cardioembolism 
Large-artery atherosclerosis  
Small-vessel occlusion 
Undetermined aetiology  
Other determined aetiology  
                         77 (51.0%) 
37 (24.5%) 
4 (2.6%) 
29 (19.2%) 
4 (2.6%) 
Medical complications / infections during hospitalization (%) 39 / 32 (25.8% / 21.2%) 
Median time of hospitalization in days (IQR) 7 (6) 
Median NIHSS at discharge (IQR) 6 (10) 
Median NIHSS at 12 months (IQR) 3 (7) 
mRSd≤2 at discharge 52 (34.4%) 
mRS≤2 at 6 months 71 (47.0%) 
mRS≤2 at 12 months 73 (48.7%) 
mRS = 6 
Before the 7th day 
Between the 7th day and the 6th month 
Between the 6th and the 12th month  
23 (15.2%) 
7 
11 
5 
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Imaging stroke characteristics (n=151) 
Vascular territory:  
ACAe isolated infarct 
ACMf isolated infarct 
Simultaneous ACA and ACM infarct 
 
3 (2.0%) 
146 (96.7%) 
2 (1.3%) 
Median 1st CTg ASPECTSh (IQR) 9 (3)  
Median 1st CT Cortical ASPECTSi (IQR) 6 (3) 
Characteristics of isolated MCA infarct in patients with a 2nd CTj scan (n=124) 
Location: 
Number of exclusively cortical infarcts  
Number of cortico-subcortical infarcts  
Number of exclusively subcortical infarcts  
 
42 (33.9%) 
56 (45.2%) 
22 (17.7%) 
Median 2nd CT ASPECTS (IQR) 6 (4) 
Median 2nd CT cortical ASPECTS (IQR) 4 (4) 
Other features of the 2nd CT scan (n=129) 
Number of patients with islands of preserved cortex within the 
infarct 
26 (20.2%) 
Number of patients with any type of haemorrhage 
transformation (%) 
23 (17.8%) 
Legend to table 7: aSD - Standard Deviation; bNIHSS - National Institutes of Health Stroke 
Scale score; cIQR - Interquartile range;  dmRS - modified Rankin Scale; eACA - Anterior 
Cerebral Artery; fMCA - Middle Cerebral Artery; g1st CT - 1st CT scan obtained at the 
emergency department; hASPECTS - Alberta Stroke Program Early CT Score; iCortical 
ASPECTS - Score in ASPECTS considering only the 7 cortical territories of this scale; j2nd 
CT - CT scan obtain ≥ 24 h after the infarct  
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All patients performed at least one EEG during hospitalization. The 1st EEG was performed 
in a median time of 1 day (IQR 1). The median number of tests performed per patient was 5 
(IQR 3).  
Of the 144 discharged patients, 143 patients (99.3%) underwent an EEG on this date. One 
patient (0.7%) refused the exam. The discharge EEG was made on average 11.1 (10.9) days 
after stroke (median 7).  
Of the 127 patients who were alive at 12 months, 117 (92.1%) performed an EEG at this 
time and 10 patients (7.9%) refused to repeat the exam. One patient (0.66%) was lost for 
clinical and neurophysiological follow-up between month 6 and 12.    
 
3.1. Epileptic manifestations frequency 
In this study, 27 patients (17.9%) had EEG epileptiform activity (interictal epileptiform 
activity and/or Electrographic seizures) during hospitalization. Table 8 shows the frequency 
of studied electroencephalographic abnormalities. 
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Table 8. EEG abnormalities in different time frames after stroke 
 
1st EEGa        
n (%) 
Serial EEG 
study during 
hospitalizationb
n (%) 
Mc.Nemar´s 
test 1c             
p 
Discharge 
EEGd          
n (%) 
Mc.Nemar´s 
test 2e             
p 
12M EEGf  
n (%) 
Mc.Nemar’s 
test 3g             
p 
Total of patients with: 151 (100%) 151 (100%) - 143 (94.7%) - 116 (76.8%) - 
PD h  27 (17.9%) 38 (25.2%) 0.007 9 (6.3%) 0.002 3 (2.6%) 0.002 
IEAi 16 (10.6%) 18 (11.9%) nsl 12 (8.4%) ns 5 (4.3%) ns 
EEG seizures j 1 (0.7%) 6 (4.0%) ns 0 ns 0 ns 
NCSE criteriak  2 (1.3%) 2 (1.3%) ns 0 ns 0 ns 
Legend to table 8: a1st EEG - video-EEG (<60 minutes) performed in the first 72 hours after admission for acute anterior circulation ischaemic 
stroke; bSerial EEG during hospitalization - video-EEG (<60 minutes) performed daily for the first 7 days after stroke or if neurological worsening 
unexplained by medical complications and with indication for repeating the imaging exam (at least one EEG record during the hospitalization with 
one of the analysed features); cMc. Nemar´s test 1 - Mc. Nemar´s test defining the difference between 1st EEG and serial EEG during hospitalization; 
dDischarge EEG - video-EEG (<60 minutes) performed at clinical discharge; eMc. Nemar´s test 2 - Mc. Nemar´s test defining the difference 
between 1st EEG and discharge EEG; f12M EEG - video-EEG (<60 minutes) performed at 12 months after stroke; gMc.Nemar´s test 3 - Mc. 
Nemar´s test defining the difference between 1st EEG and 12 months EEG; hPD - Periodic discharges; iIEA - interictal epileptiform activity; JEEG 
seizures - Electrographic seizures; kNCSE - Non-convulsive status epilepticus. Four patients (2.6%) had NCSE criteria during hospitalization. Of 
these, 3 had Electrographic seizures and one patient periodic discharges ≥ 3Hz in the 1st EEG; lns - non-significant (p > 0.05) 
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Daily repetition of the EEG up to the 7th day after stroke allowed the identification of 6 more 
patients with electrographic seizures not shown in the 1st EEG. Clinical and imaging 
characteristics of patients with electrographic seizures during hospitalization are displayed 
in Appendix E. NCSE was diagnosed in 3 out of the 7 patients with electrographic seizures 
(42.8%) and to these patients anti-epileptic drugs were prescribed. The first electrographic 
seizure occurred until the 3rd day after stroke in 85.7% of patients (in 5 patients on the 2nd 
day and in 2 patients on the 3rd and 6th day after stroke, respectively).  
The frequency of clinical and electroencephalographic epileptic manifestations is displayed 
in Table 9.  
One year after stroke, 23 (15.2%) patients with an acute anterior ischaemic stroke had 
epilepsy diagnosis criteria. Seven of these epilepsy patients (30.4%) had had an acute 
symptomatic seizure in the first 7 days after stroke, 2 of which (28.6%) were exclusively 
electrographic seizures. Also, 31.8% of patients with acute symptomatic seizures (7 out of 
22) also had an unprovoked seizure and consequently an epilepsy diagnosis.   
In the first week after stroke, 4 patients (2.6%) had criteria for the diagnosis of NCSE 245,246. 
In 2 of them, this diagnosis was made on the 1st EEG performed on the 2nd day after stroke 
and on other 2 during the first week EEG serial study (on the 3rd and the 6th day after stroke). 
Of the patients who met criteria for this diagnosis at the time of the 1st EEG, one had a 
fluctuating aphasia and periodic discharges at 3.5Hz (NCSE without coma, focal, aphasic) 
and another had consciousness impairment on the 2nd day after stroke, neither explained by 
imaging nor by medical complications and electrographic seizures, condition which reverted 
with antiepileptic treatment (NCSE without coma, focal, with impaired consciousness). Of 
the 2 other patients who were in NCSE in the first week after stroke, 1 had repeated sensitive 
focal seizures, an EEG with periodic discharges at 2 Hz and electrical seizures with clinical 
and neurophysiological recovery after levetiracetam (NCSE without coma, focal, without 
impairment of consciousness, with sensory symptoms). The last patient who was in NCSE 
during hospitalisation had a malignant infarction with consciousness impairment (coma 
Glasgow scale score = 4) and multiple seizures in the electroencephalographic recording 
(NCSE with coma).  
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Table 9.  Frequency of clinical and EEG epileptic manifestations in anterior circulation 
stroke patients  
Type of epileptic manifestation  n (%) 
At least one epileptic seizure in the 
first year after stroke  
38 (25.2%) 
- 33 (86.8%) exclusively clinical seizures  
- 5 (13.2%) exclusively electrographic seizuresa  
Acute symptomatic seizure  
(at least one)  
22 (14.6%) 
- 17 (77.3%) exclusively clinical seizures 
- 5 (22.7%) exclusively electrographic seizures 
- 13 (59.1%) occurred in the first 24 hours  
Unprovoked seizure as the first 
seizure 
16 (10.6%) 
Unprovoked seizure  
(at least one unprovoked seizure, 
with or without a previous acute 
symptomatic seizure)  
23 (15.2%) 
- 7 also acute symptomatic seizures (5 clinical 
and 2 electrographic seizures)  
- 11 (47.8%) between day 7 and 6th month  
- 12 (52.2%) between the 6th and 12th month 
IEAa in the 1st EEG  16 (10.6%) 
Electrographic seizure within the 
first 7 days of stroke 
7 (4.6%) 
IEA or electrographic seizure 
during hospitalization  
27 (17.9%) 
Legend to table 9: a IEA - Interictal epileptiform activity   
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4. DISCUSSION  
In this work, 18% of anterior circulation ischaemic stroke patients had interictal or ictal 
epileptiform activity in the EEG during hospitalization and 25% at least one seizure in the 
first year after stroke. Furthermore, more than 20% of acute symptomatic seizures were 
exclusively electrographic and more than 40% of patients with electrographic seizures had 
NCSE criteria or unprovoked seizures. Our results support the hypothesis that in the absence 
of a neurophysiological evaluation, the frequency of acute symptomatic seizures after stroke 
is underestimated. 
Several strengths are identified in this work including the sample size of anterior circulation 
acute stroke patients, with prospective clinical and EEG follow-up, unlike previous studies 
(Appendix F and G), and the small number of patients lost for clinical follow-up (n=1). 
Another aspect that stands out is the use of internationally recognized terminology for EEG 
description212. This terminology not only shows a good inter-observer agreement248,249 but it 
is recommended for multicentre research on EEG patterns in acute neurological disease 
patients248 and for implementation in clinical practice249. Also, the time period for 
classification of seizures as acute symptomatic or unprovoked is in accordance with the 
ILAE recommendations142 and only acute anterior circulation infarcts established by 
imaging were included.  
There are some limitations in this study. The serial and non-continuous nature of the 
neurophysiological assessment may in fact be considered a constraint. However, using a 
single EEG with less than 60 minutes duration we found the same percentage of patients 
with periodic discharges and epileptiform activity as Carrera et al29 in patients undergoing 
continued EEG monitoring for over 17 hours. Thus, our work suggests that a briefer EEG, 
performed in a short time window after stroke, can provide similar information than a longer 
record, with the advantage of being technically easier and less expensive. Nevertheless, 
periodic discharges and epileptiform activity have different specificities in seizure 
prediction. Although periodic discharges have been described in the continuum between an 
interictal and ictal phenomenon250, this activity may be an acute cerebral lesion signature251. 
For this reason, we clearly defined and distinguished interictal epileptiform activity and 
periodic discharges. Nevertheless, the percentage of interictal epileptiform activity found in 
our study is not too different from Carrera et al.29 (10.6% vs. 14%). Future studies should 
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compare the performance of short duration (spot) EEG versus a continuous one in the 
detection of epileptic manifestations. 
In our series, 22.7% of acute symptomatic seizures were exclusively 
electroencephalographic and occurred for the first time in the majority (85.7%) of patient in 
the first 72 hours after stroke. An intensive care unit study, with continuous EEG also 
showed that 89% of seizures occurred within 72 hours252. These observations show the 
importance of a neurophysiological evaluation, particularly in the first 3 days after stroke. 
Furthermore, in our study, almost 1/3 (31.8%) of patients having a seizure in the first seven 
days after stroke had an epilepsy diagnosis one year after stroke, in accordance to Hesdorffer 
et al.44 which found a 33% risk of an unprovoked seizure in patients with a first post-stroke 
acute symptomatic seizure. Additionally, our results showed that more than ¼ (28.6%) of 
post-stroke acute symptomatic seizure patients who had a vascular epilepsy diagnosis in a 
one-year time period, would not have been identified without the EEG protocol that was 
used.   
However, in our study, the frequency of electrographic seizures (4.6%) is lower than that 
reported in continuous EEG studies in ischaemic stroke ranging between 6 to 27%29,75,252–256 
(Appendix F). This observation was expected since, compared with the 1st short duration 
EEG, a continuous record detected twice more seizures in a population of intensive care unit 
patients254. Nevertheless, it is possible that the low number of patients with electrographic 
seizures is not exclusively due to a shorter EEG duration but also to our study setting (a 
Neurology Department Stroke Unit) and to the inclusion of less severe stroke patients than 
intensive care units. Furthermore, different definitions of ictal epileptic activity can also 
account for the lower amount of detected Electrographic seizures in our study. The evidence 
favouring continuous versus spot EEG in detecting seizures is limited76, especially in 
patients with ischaemic stroke admitted to non-intensive profile services as was the case of 
our patients. Still, continuous EEG it is not accessible at all centres and its cost-benefit is not 
determined257.  
In our study, 42.9% of patients with electrographic seizures fulfilled criteria for the diagnosis 
of NCSE or had unprovoked seizures in the clinical follow-up. In fact, non-convulsive status 
epilepticus has been described as one of the major diagnostic and therapeutic challenges in 
modern Neurology258 and the EEG is essential for its diagnosis. The described association 
between post-stroke status epilepticus and functional prognosis81,82,259, reinforces the 
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importance of early recognition of this entity, allowing appropriate and timely treatment. 
Due to very low clinical evidence, current ESO guidelines148 only give weak 
recommendations on secondary prevention of acute symptomatic post-stroke seizures. Their 
treatment is frequently decided on an individual basis depending on the presence of an 
altered mental status, fluctuating neurological recovery or criteria for the diagnosis of status 
epilepticus188. In our study, more than 40% of patients with Electrographic seizures had 
NCSE criteria and 75% of patients with NCSE (3 out 4) had no obvious clinically acute post-
stroke symptomatic seizures, showing the usefulness of our electrophysiological study. 
 

The EEG in Acute Ischaemic Cerebrovascular Disease 
97 
 
 
VII. PROJECT 4 
  
 
 
“To differentiate from the ordinary cortical epilepsia, it may be called epilepsia 
corticalis sive partiallis, in that the convulsive manifestations are continuous”  
Aleksei Yakovlevich Kozhevnikov (1894) 
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ABSTRACT  
Background and purpose: Although cerebrovascular disorders are the main cause of 
Epilepsia Partialis Continua (EPC) in adulthood, the frequency of EPC after stroke is 
unknown. The aim was to prospectively ascertain its frequency one year after an ischaemic 
stroke.  
Methods: This was a prospective study of consecutive acute anterior circulation ischaemic 
stroke patients, previously independent with an admission NIHSS score ≥ 4, an acute 
ischaemic lesion on imaging and no previous seizures. During admission patients received 
standardized diagnostic and medical care and were submitted to a neurophysiological 
evaluation protocol. One year after stroke, patients were re-evaluated by an epilepsy expert 
neurologist and performed video-EEG with EMG co-registration whenever myoclonus was 
observed during neurological examination for jerk-locked back-average analysis (JLBA). 
EPC was defined as continuously repeated fragments of epileptic seizures, with preserved 
consciousness, lasting at least 1h, and representing locally restricted epileptic activity.  
Results: In all, 151 acute anterior circulation stroke patients were consecutively included, 
and prospectively evaluated, but 23 died in the first year. One year after stroke, from 127 
patients alive, 117 (92.1%) underwent clinical and neurophysiological evaluation. In 2 
(1.7%) patients, EPC diagnosis was made both by clinical and electroencephalographic 
criteria, namely JLBA. Both patients had a history of unprovoked seizures and one of them 
acute symptomatic seizures and non-convulsive status epilepticus criteria during the first 7 
days after stroke.  
Conclusions: Despite its low frequency, the high stroke incidence makes post-stroke EPC 
relevant.  This study draws attention to this recognizable condition with therapeutic and 
eventually prognostic implications.   
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Epilepsia partialis continua, status epilepticus, jerk-locked back-average analysis, cortical 
myoclonus, stroke, cerebral infarction  
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1. INTRODUCTION 
  
Cerebrovascular disorders are the main cause of Epilepsia Partialis Continua (EPC)260,261 in 
adulthood. However, to our knowledge, the frequency of this type of focal status 
epilepticus246 as a chronic post-stroke complication in large series, has not been reported. 
Our hypothesis is that the subtle clinical signs in motor EPC make this disorder under 
recognised.  
In this study, we aim to describe the frequency of this entity, one year after an anterior 
circulation ischaemic stroke.  
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2. METHODS  
 
Prospective study of consecutive patients admitted to our Stroke Unit from October 2011 to 
October 2013, with an acute anterior circulation ischaemic stroke. The Ethics Committee 
“Comissão de Ética para a Saúde” of the HSM-CHLN approved this study. Signed informed 
consent was obtained from all patients or their next-of-kin.  
 
Patients had to be previously independent (modified Rankin scale score <1), have an NIHSS 
score ≥ 4 at hospital admission and an acute ischaemic lesion identified by brain imaging 
(CT or MRI). Exclusion criteria were a previous history of epileptic seizures, traumatic head 
injury requiring hospital admission or brain surgery.  
Included patients were submitted to standard cerebrovascular clinical and complementary 
evaluation during admission and after discharge. Seizure occurrence during the first year 
after stroke was prospectively quantified and seizures were classified as acute 
symptomatic142  or unprovoked145  whenever they occurred within the first 7 days after stroke 
or after that time point in the absence of precipitating factors, respectively.  
 
All patients underwent a neurophysiological evaluation protocol that included a 64 channel 
video-EEG with a maximum duration of 60 minutes in the first 72h after stroke, during 
admission (daily until day 7 and after that if neurological worsening), at discharge and one 
year after stroke.  
 
A neurologist with expertise in epilepsy (CB) made a phone interview 6 months after stroke, 
accessing seizure occurrence by a free interview followed by a brief phone screening tool 
for identifying patients with epilepsy240 and a scheduled appointment 12 months after the 
cerebrovascular event. On this occasion neurological examination was always performed 
and special attention was given to the observation of face and limbs at rest, and to the 
performance of myoclonus activation manoeuvres such as posture maintaining, passive 
mobilization and tactile stimulation. On the same day as this appointment, a video-EEG with 
a sampling frequency of 1000 Hz, at least 64 channels placed according to the 10/10 
international system and 60 minutes maximum duration was performed. Whenever 
myoclonus was observed during the neurological examination, synchronized EMG record 
of the involuntary movement was added to the exam. The EEG record included eye-lid 
opening and closure, hyperventilation, photic stimulation and manoeuvres to elicit 
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myoclonus, as previously observed in the neurological medical evaluation. Experienced 
technicians under medical supervision performed the EEG. The procedure allowed 
subsequent offline “jerk-lock back-average”. This analysis was performed using the BESA 
software, version 6.0 with the aim of looking look for an electroencephalographic transient 
temporally related to the involuntary movement. The identification of a wave, with a 
coherent focal localization and a short latency to a myoclonus burst, lasting less than 100 
ms, was considered an argument for a cortical correlate of the registered myoclonus262. 
Primary outcome of this study was the presence of epilepsia partialis continua defined as a 
condition of continuously repeated fragments of epileptic seizures (motor or sensory), with 
preserved consciousness, lasting at least 1 h, and representing locally restricted epileptic 
activity263. The presence of a cortical correlate in “jerk-lock back-average” of suspect 
clinical motor phenomena was considered as evidence of motor cortex hyperexcitability, 
supporting the diagnosis of EPC. 
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3. RESULTS  
 
In all, 151 patients (112 men and 39 women) with an acute anterior circulation ischaemic 
stroke were included, with a mean age of 67.4 (SD 11.9) years.  
 
In 146 patients (96.7%) the acute imaging lesion was limited to middle cerebral artery 
(MCA) territory and in 3 (2.0%) to anterior cerebral artery (ACA) territory. Furthermore, in 
2 patients both ACA and MCA territories were involved. In a brain CT scan performed at 
least 24 hours after stroke, median ASPECTS42 was 6 (IQR 4) and median ASPECTS 
considering only the 7 cortical territories of this scale was 4 (IQR 4). The percentage of 
patients with middle cerebral artery territory limited stroke patients with involvement of each 
of ASPECTS territories is disclosed in Appendix H. 
 
In the first year after stroke, 23 patients had died (seven during admission and 16 after 
discharge) and one patient was lost to follow-up after the 6 months telephone interview. At 
12 months after stroke, 127 patients were alive and 117 (92.1%) agreed to come to the 
scheduled clinical appointment and underwent an EEG.  
 
At the one-year appointment, two patients (1,7%), both with previous acute symptomatic 
and/or unprovoked sensorimotor seizures (Table 10), presented with continuous and subtle 
involuntary movements of the upper limb contralateral to the ischaemic lesion, not 
spontaneously reported by the patient nor their family. Several fingers showed irregular, 
small amplitude, non-synchronized subtle and mainly jerky movements, suggesting 
described central minipolymyoclonus264. The involuntary movement semiology is shown in 
video 1 and 2 (Appendix I and J, digital only - 
https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.13310). A cortical correlate of the 
aforementioned involuntary movements was found by jerk-lock back-average technique 
(Figure 9), adding neurophysiological criteria of EPC to clinical observation. In these 
patients, no epileptiform activity was detected in the raw EEG analysis. Clinical, imaging 
and neurophysiological characteristics, as well as the treatment of patients with EPC are 
described in Table 10.  
In our series, sensory symptoms as a manifestation of EPC were not recorded.   
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Table 10. Clinical, imaging and neurophysiological characteristics of patients with post-
stroke Epilepsia Partialis Continua 
 Patient 1 Patient 2 
Clinical features 
Age (years) 71 77 
NIHSSa at admission 16 7 
NIHSSa after 
intravenous alteplase  
14 7 
NIHSSa at discharge 12 8 
Stroke aetiology after 
investigation 
Undetermined Undetermined 
Acute symptomatic 
seizuresb and its type 
No 
 
Yes 
Focal seizures (sensory) and 
non-convulsive status 
epilepticus criteria 247 
Unprovoked seizuresc 
and its type 
Yes 
Focal seizures (motor) of the 
left upper limb 
Yes 
Focal seizures (motor) of the 
left limbs during sleep 
Time of the 1st seizure Between 6 and 12 months 3rd day after stroke 
EPCd semiology (12 
months after stroke) 
Irregular, small amplitude, 
non-synchronized subtle 
mainly jerky movements of 
several fingers, accentuated 
by posture  
(video 1, online only)  
Irregular, small amplitude, 
non-synchronized subtle jerky 
movements of several fingers, 
accentuated by posture 
(video 2, online only)   
Anti-epileptic drugs 
Levetiracetam started by the 
time of the EPC diagnosis 
Levetiracetam started during 
admission, dose increased after 
EPC diagnosis 
Modified Rankin 
scale score at 12 
months  
3 3 
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Patient 1 Patient 2 
Brain-CT scane features 
Vascular territory Right middle cerebral artery Right middle cerebral artery 
ASPECTSf (total 
score) 
3 5 
ASPECTSg (infarct 
location)  
I, L, C, IC, M2, M3, M6  I, IC, M2, M3, M6 
Any type of 
haemorrhage 
transformation 
Yes Yes 
Islands of spared 
cortex within the 
infarct 
Yes No 
Neurophysiological features 
Raw EEG analysis  
(performed 12 months 
after stroke)  
Right fronto-temporal focal 
and rhythmic slow wave 
activity. 
No interictal epileptiform 
activity. 
Right fronto-temporal focal 
slow wave activity. 
No interictal epileptiform 
activity 
Jerk-locked back-
average  
A negative right central EEG 
transient preceding muscle 
activation (Figure 9) 
A negative right central EEG 
transient preceding muscle 
activation (Figure 9) 
Legend to table 10: aNIHSS, National Institute of Health Stroke Scale score (quantifying 
stroke clinical severity); bAcute symptomatic seizure, seizures occurring in the first seven 
days after stroke; cUnprovoked seizures, seizures occurring after the first seven days after 
stroke, in the absence of precipitating factors; dEPC: Epilepsia Partialis Continua; eBrain-
CT Scan, brain CT Scan performed 24 hours after stroke; fASPECTS - Alberta Stroke 
Program Early CT Score (quantifying infarct size and location in middle cerebral artery 
territory)  ; gASPECTS (infarct location) - I, insular ribbon; L, lentiform nucleus; C, caudate; 
IC, internal capsule; M1, anterior MCA cortex; M2, MCA cortex lateral to the insular ribbon; 
M3, posterior MCA cortex; M4, M5, M6, anterior, lateral and posterior MCA territories 
immediately superior to M1, M2 and M3, rostral to basal ganglia. 
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Figure 9.  Jerk-locked back-average analysis (JLBA)  
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Legend to figure 9:   
Patient 1 (a) - JLBA analysis of 49 activations of the left flexor digitorium superficialis. 
There is a negative electroencephalographic transient starting 50 msecs before the onset of 
the EMG activation (arrows). Top view arrangement of the average montage (EEG recorded 
with: sensitivity=5 microV/mm; high frequency filter (HFF)=70 Hz, low frequency filter 
(LFF)=0.53; Notch filter (50 Hz) on).  
Patient 2 (b) - JLBA of 259 activations of the left abductor pollicis brevis. There is a small 
amplitude negative electroencephalographic transient on the right central leads that starts 
45msecs before the EMG activation (arrow). Top view arrangement of the average montage 
(EEG recorded with: sensitivity=5 microV/mm; HFF=70 Hz; LFF off; notch filter off).  
Montage was reduced to 9 channels due to frequent artefacts in the remaining. 
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4. DISCUSSION 
 
In this study, the frequency of EPC as a remote complication of anterior circulation 
ischaemic stroke is very low. However, because stroke is a frequent neurological disorder, 
health professionals caring for patients with cerebrovascular disorders and aware of this 
disorder, will find EPC in a significant number of patients.  
Epilepsia partialis continua can be classified as a focal motor status epilepticus type246, 
although some authors extend the meaning of EPC to cover other type of focal seizures 
which are continuous without spreading to a larger seizure or with only occasional spread263. 
Its physiopathology is not completely understood but the hyperexcitability of the 
sensorimotor cortex, the presence of cortical generators and cortical-subcortical loops, can 
contribute to the persistence of a focal cortical epileptiform activity 265. The biologic changes 
associated with post-stroke gliosis and meningocerebral cicatrix formation may result in 
hyperexcitability and neuronal synchrony21 facilitating EPC. 
 
The diagnosis of EPC frequently implies a high level of clinical suspicion and requires a 
careful clinical evaluation including myoclonus activation manoeuvres. In this prospective 
study, the subtle involuntary movements of the fingers were not reported by the patient and 
were only detected at clinical inspection, increasing with activation manoeuvres, resembling 
minipolymyoclonus264. Minipolymyoclonus of central origin was first described by Wilkins, 
Hallet & Erba in 1985264 in 11 heterogeneous patients with different types of epilepsy 
syndromes and neurodegenerative disorders. To our best knowledge, this manuscript is the 
first to describe this phenomenology in a prospective cohort of stroke patients.  
 
Clinical suspicion of EPC must be corroborated by imaging and neurophysiology studies262, 
including jerk-lock back-average analysis, as in our patients. This neurophysiological 
technique is of utmost importance because raw data visual analysis does not necessarily 
show continuous or persistent epileptiform or periodic abnormalities, such as in other types 
of focal or non-convulsive status epilepticus245,247. However, we must reinforce that back-
average analysis only confirms the cortical origin of the involuntary movement. The clinical 
integration of this data is essential to the EPC diagnosis, since cortical myoclonus and 
minipolymyoclonus can be found in other pathologies262,264. The two patients of our study 
also had sporadic unprovoked focal motor seizures supporting the diagnosis of this form of 
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status epilepticus. In fact, clinical phenomenology of EPC can be seen as continuously 
repeated fragments of motor seizures263. Furthermore, one of our patients had a diagnosis of 
non-convulsive focal status epilepticus without impairment of consciousness in the first 
week after stroke.  
 
It should also be emphasised that, in stroke patients, involuntary movements can be caused 
by different mechanisms and that post-stroke focal myoclonus can additionally be a 
hyperkinetic movement disorder, where basal ganglia are most often involved. Although 
lesions in different parts of the brain can cause the same movement disorder, post-stroke 
myoclonus is usually associated with lesions in the midbrain, pons or thalamus and is 
frequently an acute stroke complication266,267. This was not the case of our patients. 
Furthermore, an involuntary movement cortical correlate was established in this work by 
back-average analysis.  
 
Regarding treatment of EPC, studies that included patients with ischaemic stroke as the 
aetiology show the use of different anti-epileptic drugs and variable clinical response, 
frequently requiring polytherapy or even being refractory to medical therapy260,261. As in our 
study, Mameniskiene and collaborators’ study showed that the control of EPC did not always 
correlate with control of other types of seizure in the same patient263.  
The consequences of post-stroke EPC are unknown although post-stroke epileptic 
phenomena (seizures and status epilepticus)45,79–82 have been associated with a worse infarct 
outcome.
The EEG in Acute Ischaemic Cerebrovascular Disease 
111 
 
 
VIII. PROJECT 5 
 
 
 
“Epileptic myoclonus is a transient (<100 ms), involuntary, muscle jerk due to abnormal 
excessive or synchronous neuronal activity in the brain”  
Chrysostomos Panayiotopoulos (2010) 
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CORTICAL MYOCLONUS DURING IV THROMBOLYSIS 
FOR ISCHAEMIC STROKE 
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ABSTRACT 
We describe a patient with an acute middle cerebral artery ischaemic stroke developing 
subtle involuntary movements of the paretic upper limb with cortical origin during rtPA 
perfusion. Despite the multiple potential pathophysiological mechanisms for the relationship 
between thrombolysis and epileptic activity, seizures during this procedure are scarcely 
reported. Our hypothesis is that subtle and transient clinical seizures, like those described in 
our patient, may not be detected or are misdiagnosed as nonepileptic involuntary 
movements. 
We aimed to draw attention to the recognition challenge of this paroxysmal motor behaviour, 
highlighting this clinical and neurophysiological identification using video recording and 
back-average analysis of the EEG. 
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1. INTRODUCTION 
 
Early post-stroke seizures (i.e. occurring within one week after stroke) are thought to result 
from cellular biochemical dysfunction leading to electrically irritable cerebral tissue. 
Intravenous thrombolysis (IVT) with recombinant tissue-type plasminogen activator (rtPA) 
is the gold standard treatment for acute ischaemic stroke, and, recently, Alvarez et al.28 
showed that this procedure may be independently associated with acute symptomatic 
seizures. However, and despite multiple potential pathophysiological mechanisms, seizures 
coincident with rtPA administration are seldom reported. Here, we describe a patient with 
an acute middle cerebral artery (MCA) ischaemic stroke who developed subtle involuntary 
movements of the paretic upper limb, with cortical origin as documented 
neurophysiologically, during rtPA perfusion. We aimed to draw attention to the recognition 
challenge of this paroxysmal motor behaviour, highlighting its clinical and 
neurophysiological identification using video recording and back-average analysis of the 
EEG. 
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2. CASE REPORT 
 
A 72-year-old male with a past history of hypertension, dyslipidaemia, chronic kidney 
disease, and an ischaemic stroke 15 years ago, with no post-stroke seizures and from which 
he had completely recovered, presented to the emergency department with sudden onset of 
left central facial palsy, hemiparesis, homonymous hemianopia, and right gaze deviation 
(NIHSS score = 10). Electrocardiogram showed atrial fibrillation, and blood analysis 
revealed acute renal failure (creatinine = 4 mg/dL, blood urea nitrogen = 134 mg/dL). Plain 
head computed tomography (CT) disclosed old occipital, parietal, and frontal ischaemic 
lesions and a right middle cerebral artery (MCA) hyperdensity. Intravenous alteplase (rtPA) 
was started 140 min after symptom onset. Twenty minutes after starting the infusion period, 
involuntary movements of the upper paretic limb were noticed. The movements involved 
either the distal or the proximal muscles, independently, and could be jerk-like, irregular, 
myoclonic like, or slow and brief (Video 3 - Appendix K, digital only - 
http://dx.doi.org/10.1016/j.ebcr.2014.09.004). During rtPA perfusion, a 72-channel EEG 
(International 10/10 System) with an EMG channel recording the left flexor digitorum 
superficialis (sample frequency of 1000 Hz) captured brief, repetitive, and almost periodic 
muscle activations (Figure 10A). No epileptiform activity was apparent in the raw EEG 
data. Back-average analysis of the EEG time-locked with the onset of the recorded 
myoclonus (538 activations) was performed (BESA software, version 6.0), revealing a right 
frontocentral negative wave. This EEG transient preceded muscle activation by 30 ms 
(Figure 10B). No antiepileptic drug was given, and the involuntary movements lasted 
approximately 40 min, stopping by the end of the rtPA perfusion. The neurological deficit 
did not improve after thrombolysis. Transcranial Doppler showed no recanalization. 
Computed tomography at 24 h disclosed an acute MCA infarct scoring 5 on ASPECTS, with 
spared cortical areas within the infarct zone (Figure 11). The patient partially recovered after 
7 days (NIHSS score=6). No further involuntary movements or clinically suspected seizures 
were observed despite transitory worsening of renal function during hospitalization. One 
year after stroke, the patient is alive and independent (NIHSS = 1 and mRS = 1), with no 
report of late post-stroke seizures. 
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Figure 10. Back-average analysis 
 
Legend to figure 10: A) EMG channel recording the left flexor digitorum superficialis 
capturing brief, repetitive, and almost periodic muscle activations (arrows). B) EEG back-
average analysis disclosing a negative transient (arrows) with a peak (yellow line) of 10 ms 
1 second 
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before EMG activations (dotted line) at right central electrodes (C4/FC4). 
 
 
Figure 11. Brain CT scan 
 
Legend to figure 11: Brain CT scan 24 h after intravenous alteplase disclosing an acute right 
MCA infarct, scoring 5 (I,M1,M2,M5,M6) on ASPECTS, with spared cortical areas within 
the infarct zone. 
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3. DISCUSSION 
 
We report a patient with an acute MCA ischaemic stroke who developed subtle involuntary 
movements of the paretic upper limb, with cortical origin as documented 
neurophysiologically, during rtPA perfusion. Because cortical myoclonus and epileptogenic 
discharges are generated by neuronal hypersynchronous activities sharing the same 
physiopathogenic mechanisms, the recorded myoclonus can be considered an acute 
symptomatic seizure. Because of the subtleness of the movements, the clinical stability of 
the patient, and the absence of clear epileptiform activity on the immediate raw EEG 
analysis, no antiepileptic medication was given. Back-average analysis, enlightening the 
cortical origin of the myoclonus, was only performed after the acute phase. 
 
Even though our patient had multiple risk factors for seizures (acute renal lesion, acute 
anterior stroke, cortical involvement), the close time relationship of this paroxysmal motor 
behaviour with the therapeutic intervention raises the possibility of an association. It has 
been documented that seizures during rtPA perfusion can occur even in the absence of a 
cerebral lesion, as described in 2 patients submitted to thrombolysis for acute myocardial 
infarction30. In fact, neurotoxic and epileptogenic properties31 of rtPA are known. Other 
postulated mechanisms for seizures during thrombolysis for ischaemic stroke include 
secondary cortical infarct from distal embolization or reperfusion/hyperperfusion 
syndrome32. Despite the multiple potential pathophysiological mechanisms for the 
relationship between rtPA and seizures, the frequency of seizures during thrombolysis is not 
well known. Besides a few reports of overt seizures occurring in close proximity to rtPA 
perfusion30,31, most larger studies looking at seizure frequency in patients submitted to 
thrombolysis report a global incidence of seizures within 7 days after stroke and not 
specifically during the therapeutic procedure. In these studies, patients submitted to 
thrombolysis have similar frequency of early seizures when compared with patients without 
thrombolysis. Only one study concluded that thrombolysis is an independent risk factor for 
early seizures after stroke28. These discrepancies may be related to the retrospective 
collection of the data. Additionally, reporting bias due to increased clinical vigilance in the 
acute phase of patients undergoing thrombolysis cannot be excluded. Finally, it is also 
possible that subtle and transient clinical seizures, like those described in our patient, may 
not be detected or are misdiagnosed as nonepileptic involuntary movements. 
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IX. PROJECT 6 
 
 
 
“Thrombolysis has, to our knowledge, not been investigated as a risk factor for early 
seizures, despite its potential neurotoxic and possible epileptogenic effects in animals.” 
Vincent Alvarez et al. (2012) 
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ABSTRACT  
Background: Intravenous alteplase (rtPA) may be associated with seizures and epileptic 
activity in the electroencephalogram (EEG). We aimed to compare seizures and EEG 
abnormalities frequency between stroke patients treated and not treated with rtPA.  
Methods: Prospective study of consecutive acute anterior circulation ischaemic stroke 
patients, with one-year follow-up. Patients were previously independent, had an admission 
National Institute of Health Stroke Scale score ≥ 4, an acute ischaemic lesion and no previous 
seizures. They received standardized diagnostic and medical care. Video-EEG was 
performed in 72h (1st EEG); during admission (daily until day 7 and after that if neurological 
worsening); at discharge and one year after stroke.  
Results: In all, 151 patients (101 treated with rtPA) were included. Acute and unprovoked 
seizures frequency was not significantly different between rtPA treated and non-treated 
patients (p=0.726 and p=0.748, respectively). Clinical paroxysmal phenomena during rtPA 
perfusion were observed in 5 (5%) patients.  
In the 1st EEG, rtPA treated patients had background diffuse slowing more often [43.6% vs. 
26.0%, p=0.036]. This difference was no longer observed at discharge [24.0% vs. 19.1%, 
p=0.517] nor one year after [11.8% vs. 10.0%, p=0.765].  No differences were found in 
epileptiform (p=0.867) or periodic discharges (p=0.381) frequency. 
Conclusions: rtPA is not associated with an increased risk of clinical or 
electroencephalographic epileptic phenomena.  
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1. INTRODUCTION  
 
Thrombolysis is the gold standard of acute ischaemic stroke treatment. However, it has been 
suggested that intravenous alteplase (rtPA) is associated with clinical seizures and the 
occurrence of epileptic activity in the EEG28,29. Several physiopathological mechanisms can 
be postulated for this association, including cortical reperfusion/hyperperfusion syndrome32, 
neurotoxicity and a possible epileptogenic effect of rtPA31,32,77,78, or the survival of islands 
of cortical viable tissue165. Intravenous alteplase related seizures30,32,33 and seizure frequency 
in patients treated with rtPA34,35 has been mostly described using retrospective and non-
controlled case series. Furthermore, the occurrence of seizures in rtPA patients has been 
associated with different stroke functional outcomes28,32,34,35,172.  
We aim to compare seizure frequency and electroencephalographic abnormalities between 
anterior circulation ischaemic stroke patients treated and not treated with rtPA and to know 
if post-stroke seizures are associated with functional outcome in these patients. 
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2. METHODS  
 
A prospective longitudinal study of consecutive adult patients with an acute anterior 
circulation ischaemic stroke, admitted to the Neurology Department Stroke Unit of a 
University Hospital, between October 2011 and October 2013, and followed for 12 months. 
The Ethics Committee “Comissão de Ética para a Saúde” of the HSM-CHLN approved this 
study.  
Included patients had to be previously independent [modified Rankin Scale (mRS) ≤1], score 
a value of at least 4 on National Institute of Health Stroke Scale (NIHSS) upon admission to 
the emergency department (ED), have had an acute ischaemic brain lesion in the internal 
carotid artery territory [in the computed tomography (CT) scan or magnetic resonance 
imaging (MRI)] and have no previous history of epileptic seizures nor traumatic head injury 
requiring hospital admission. All subjects or their next of kin gave written informed consent 
for participation in this study. Patients were treated with intravenous alteplase (rtPA) 
according to ESO guidelines72. Patients were not submitted to rtPA treatment if outside the 
4.5-hour time window, in the presence of minor stroke (NIHSS < 4) or if showing 
contraindications to this drug. All patients received a standardized cerebrovascular disease 
investigation and medical care during admission and after discharge. A neurologist with 
expertise in epilepsy (CB), blinded to the neurophysiological evaluation, conducted a phone 
interview at six months after stroke accessing seizure occurrence by a free interview, 
followed by a brief phone screening tool for identifying patients with epilepsy240. A 
scheduled clinical appointment 12 months after stroke was also conducted (CB), recording 
the following clinical variables: NIHSS and mRS score, occurrence of seizures and its type; 
other stroke or medical complications; final aetiological classification of stroke239 and 
ongoing therapy.  
 
2.1. Neurophysiological evaluation 
All patients underwent a neurophysiological evaluation protocol that included a 64 channel 
video-EEG with a maximum duration of 60 minutes in different time frames after stroke: in 
the first 72 hours (1st EEG), daily in the first 7 days after stroke, during admission after that 
time point if there was neurological worsening unexplained by medical complications, at 
discharge and 12 months after stroke.  
The record included an eyes closed wake resting condition and eyes open, hyperventilation 
and photic stimulation manoeuvres. The EEG review and classification was performed by a 
Epiletic manifestations in stroke patients treated with intravenous alteplase 
 
127 
 
certified clinical neurophysiologist (CB) using international criteria and terminology 
211,212,245, blinded for clinical and imaging findings. All doubts were decided by consensus 
with another clinical neurophysiologist (ARP).  
 
2.2. Imaging interpretation 
Two senior neuroradiologists (CM and CC), blinded for clinical and 
electroencephalographic findings, reviewed all imaging tests. Doubts were decided by 
consensus. In patients with an infarct limited to the middle cerebral artery (MCA) territory 
in the imaging study (considering 1st CT scan, 2nd CT scan or MRI), the infarct size was 
quantified by Alberta Stroke program Early CT Score (ASPECTS)42, in a repeated brain CT 
scan performed 24 hours after stroke (2nd CT scan). ASPECTS in the 2nd CT scan was rated 
as 10 whenever an acute vascular lesion in the middle cerebral artery territory was only 
identified by MRI. 
 
2.3. Predictors and Outcomes 
The following characteristics were compared between patients treated and not treated with 
rtPA:  
2.3.1. Demographic and stroke characteristics: age, gender, NIHSS 70 on admission and post-
rtPA (if applicable) and stroke aetiology 239 
2.3.2. Imaging characteristics: exclusively cortical and subcortical infarct, ASPECTS42, 
presence of normal attenuation coefficient cortical areas (islands of preserved cortex) within 
the infarct165 and any intracerebral haemorrhage transformation242. Insula and M1 to M6 
ASPECTS territories were considered “cortical territories of ASPECTS”.   
2.3.3. Occurrence of epileptic seizures and status epilepticus (only the first event was 
considered), with the following operational definitions:  
- Epileptic seizure: clinical 93 and/or electrographic seizure212,245 
- Acute symptomatic seizure: seizure occurring within the first 7 days of a stroke142. 
In these patients, cut-off values for metabolic disorders and febrile symptomatic 
seizures were not overreached and alcohol/drug withdrawal or intoxication142 were 
excluded  
- Unprovoked seizure: Seizures occurring after 7 days of a stroke in the absence of 
precipitating factors145 
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- Status epilepticus: ILAE status epilepticus classification246 and Salzburg Consensus 
Criteria for Non-Convulsive Status Epilepticus245,247 were used 
2.3.4. Electroencephalographic abnormalities:  
- In the 1st EEG: background activity slowing211; asymmetry212; suppression (focal, 
hemispheric or diffuse)212; focal slow wave activity (FSWA), including focal and 
regional concept211; rhythmic slow wave activity (RSWA), including rhythmic delta 
activity defined by ACNS212 and rhythmic delta/theta (>0.5 Hz)245, Interictal 
epileptiform activity (IEA)211; periodic discharges (PD)212; electrographic 
seizure212,245. 
- Any EEG during hospitalisation with IED and/or electrographic seizures 
2.3.5. Functional outcome: measured by modified Rankin Scale (mRS)236. Death or 
dependency (mRS ≥ 3) at discharge and 12 months after stroke was considered an 
unfavourable outcome 
 
The primary outcome of this study was the occurrence of epileptic seizures and EEG 
abnormalities.  
 
2.4. Statistical Analysis  
We compared demographic and stroke characteristics, imaging and EEG findings, epileptic 
seizure frequency and functional outcome, in patients treated or not treated with rtPA.  
 
In patients with post-stroke seizures age, admission NIHSS, ASPECTS and functional 
outcome at 12 months were compared between rtPA treated and not treated patients. 
Functional outcome at 12 months was also compared between patients with and without 
seizures in both groups. 
 
Bivariate analysis of qualitative variables was performed by the chi-square test, Fisher's 
exact test or the McNemar test, and quantitative variables by the t-test or Mann-Whitney U, 
as appropriate.  
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Significant bivariate analysis findings were adjusted for age, clinical (admission NIHSS) and 
imaging (ASPECTS) severity, in a logistic regression model. The calibration of the model 
was analysed by the Hosmer-Lemeshow test and its discriminative capacity measured by the 
area under the receiver operating characteristic curve.   
 
A p value <0.05 was considered significant. Odds ratios and the confidence interval at 95% 
were calculated. Statistical analysis used IBM SPSS Statistics for Mackintosh, version 21.   
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3. RESULTS 
 
In all, 151 patients (112 men and 39 women) were included, with a mean age of 67.4 (SD 
11.9) years. Of these patients, 101 were treated with intravenous rtPA.  
 
During this study 23 patients died (7 during admission before day 7, 11 between discharge 
and 6 months after stroke and 5 after that time point). One patient (0.66%) was lost for 
clinical and EEG follow-up in the last 6 months of the study. From the 127 alive patients 
with a clinical follow-up one-year after stroke, 117 (92.1%) repeated EEG by that time. 
Study flowchart is represented in Figure 8. 
 
Demographic, clinical, imaging and electroencephalographic findings, and functional 
outcome are compared between patients treated and not treated with rtPA in Table 11. 
Patients undergoing alteplase were significantly older and had a higher NIHSS score at 
admission. After the perfusion of rtPA, the NIHSS score of treated patients was not different 
from that obtained at hospital admission in non-treated patients.  
 
All (151) patients had at least one acute CT scan (1st CT). Furthermore, in the acute phase, 
a 2nd CT scan was performed in 129 (85.4%) patients and an MRI in 63 (41.7%) patients. 
Concerning imaging characteristics, in 146 patients (96.7%) the visible ischaemic lesion in 
the acute imaging study (1st CT scan, 2nd CT scan or MRI) was limited to the MCA territory. 
In 4 patients the MCA infarct was only identified by MRI. From MCA territory limited 
infarct patients, 124 (84.9%) performed a 2nd CT. Furthermore, in 2 patients an anterior 
cerebral artery (ACA) infarct was also present and 3 patients had an ACA acute lesion on 
CT scan study with no evidence of MCA involvement. For this reason, from the 129 patients 
who performed a 2nd CT scan, for 5 patients with ACA infarcts ASPECTS was not 
calculated. No statistically significant differences were found between CT scan features, 
except for a larger percentage of patients with subcortical infarcts in the group receiving 
rtPA. 
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Table 11. Clinical, imaging and neurophysiologic characteristics of patients treated and not 
treated with alteplase  
 
Patients treated 
with alteplase 
Patients not treated 
with alteplase 
p 
Clinical characteristics (n=151) 
Number of patients 101 50  
Age (years) Mean: 69.64; SD: 10.55 Mean: 62.72; SD: 13.26 0.002 
Sex (Men/Women) 
63/38 
(63.4%/37.6%) 
26/24 
(52.0% / 48.0%) 
0.223 
Stroke Aetiology  
Cardioembolism 
Large-artery 
atherosclerosis  
Small-vessel occlusion 
Undetermined aetiology  
Other determined 
aetiology 
 
52 (51.5%) 
25 (24.8%) 
2 (2.0%) 
19 (18.8%) 
3 (3.0%) 
 
25 (50.0%) 
12 (24.0%) 
2 (4.0%) 
10 (20%) 
1 (2.0%) 
 
NA 
NIHSS at admission Median: 14; IQR: 9 Median: 9; IQR: 12 0.007 
NIHSS after rtPA or at 
admission (for patients not 
treated) 
Median: 12; IQR: 10 Median: 9; IQR: 12 0.262 
NIHSS at discharge Median: 8; IQR: 13 Median: 5.5; IQR: 10 0.584 
NIHSS at 12 months Median: 6.5; IQR: 11 Median: 5.5; IQR: 9 0.572 
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Patients treated 
with alteplase 
Patients not treated 
with alteplase 
 
Imaging Characteristics  
Territory 
 ACA 
 MCA 
 
4 (4.0%) 
99 (98.0%) 
 
1 (2.0%) 
49 (98.0%) 
 
Characteristics of MCA strokes in the 2nd CT scan (n=124)  
Number of patients 93 31  
Exclusively cortical  30 (32.3%) 12 (38.7%) 0.511 
Exclusively subcortical  21 (22.6%) 1 (3.2%) 0.014 
Total ASPECTS  Median: 7; IQR: 4 Median: 5; IQR: 4 0.200 
Cortical ASPECTS Median: 5; IQR: 4 Median: 4; IQR: 3 0.087 
Other characteristics of the 2nd CT (n=129) 
Number of patients 97 32  
Islands of preserved cortex 
within the infarct 
20 (20.6%) 6 (18.8%) 0.819 
Haemorrhage 17 (17.5%) 6 (18.8%) 0.875 
EEG Characteristics 1 (n=151) 
Number of patients 101 50  
1st EEG BA diffuse 
slowing  
44 (43.6%) 13 (26.0%) 0.036 
1st EEG BA asymmetry  59 (58.4%) 28 (56.0%) 0.777 
1st EEG Suppression  8 (7.9%) 4 (8.0%) 1.000 
1st EEG FSWA 89 (88.1%) 45 (90.0%) 0.731 
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Patients treated 
with alteplase 
Patients not treated 
with alteplase 
 
EEG Characteristics 2 (n=151) 
Number of patients 101 50  
1st EEG RSWA  18 (17.8%) 8 (16.0%) 0.780 
1st EEG PD 11 (28.9%) 16 (14.2%) 0.381 
1st EEG IEA  20 (19.8%) 7 (14.0%) 0.867 
Any EEG during 
hospitalization with IEA 
and/or electrographic 
seizures 
19 (18.8%) 8 (16.0%) 0.671 
Functional outcome  
At discharge  (mRS  ≥ 3) 70 (69.3%) 29 (58.0%) 0.169 
At 12 months (mRS  ≥ 3) 58 (57.4%) 19 (38.8%) 0.032 
Legend to table 11: ACA - anterior cerebral artery; MCA - middle cerebral artery; ASPECTS 
- Alberta stroke program early CT score; BA - background activity; 2nd CT scan - brain CT 
scan performed 24 hours after stroke; 1st EEG - EEG performed in the first 72 hours after 
stroke; FSWA - focal slow wave activity; IEA - interictal epileptiform activity; IQR -
interquartile range; mRS - modified Rankin scale; NA - not applicable; NIHSS - National 
Institute of Health Stroke Scale score; PD - periodic discharges; RSWA - rhythmic slow 
wave activity; rtPA - intravenous alteplase; SD - standard deviation; Suppression - focal or 
diffuse EEG suppression; bold values - p<0.05  
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3.1. Epileptic events and Alteplase 
The frequency of epileptic events can be seen in Table 12. Of the 101 patients undergoing 
rtPA, only 5 (5.0%) had paroxysmal clinical events during the perfusion of rtPA (Appendix 
L)  
 
 
Table 12.  Intravenous alteplase and epileptic events  
  
  
Patients treated 
with alteplase 
n=101 
Patients not treated 
with alteplase 
n=50 
p 
Seizures during the study period 
(n=38) 
25 (24.8%) 13 (26.0%) 0.868 
Acute symptomatic 
seizures  (n=22) 
14 (13.9%) 8 (16.0%) 0.726 
Unprovoked seizures (n=23) 16 (16.7%) 7 (14.6%) 0.748 
Seizures in the first 24 hours 
(n=12) 
6 (5.9%) 6 (12.0%) 0.213 
Electrographic seizures (n=7) 6 (5.9%) 1 (2.0%) 0.426 
IEA and/or electrographic 
seizures in any EEG during 
hospitalization (n=27) 
19 (18.8%) 8 (16.0%) 0.671 
NCSE during hospitalization 
(n=4) 
3 (3.0%) 1 (2.0%) 1.000  
Legend to table 12:  IEA - interictal epileptiform activity; NCSE - nonconvulsive status 
epilepticus 
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3.2. EEG abnormalities and Alteplase 
In the 1st EEG, diffuse slowing of the background activity was significantly more frequent 
in patients treated with rtPA. This difference was no longer significant at discharge nor 12 
months after stroke (Table 13). In fact, comparing changes over time in the same group, in 
patients treated with rtPA a smaller proportion of records at discharge (compared to the 1st 
EEG) were diffusely slowed (p<0.0005). This difference was not observed in not treated 
patients (p=0.625). 
 
 
Table 13.  Intravenous alteplase and diffuse slowing of the background activity  
 
  
 
BA diffuse slowing in the:  
Patients treated 
with alteplase 
n=101 
Patients not treated 
with alteplase 
n=50 
p 
1st EEG  44 (43.6%) 13 (26.0%) 0.036 
Discharge EEG  23 (24.0%) 13 (19.1%) 0.517 
12 months EEG  9 (11.8%) 4 (10.0%) 0.765 
Legend to table 13: BA - background activity; 1st EEG - EEG performed in the first 72 hours 
after stroke, bold value - p<0.05   
 
In a logistic regression model, 1st EEG background activity diffuse slowing was no longer 
predicted by rtPA when adjusted for age, NIHSS on admission and ASPECTS. The variables 
that remained statistically significant were age (p=0.017, OR 1.05, 95%CI 1.01-1.10) and 
ASPECTS (p=0.001, OR 0.73, 95%CI 0.61-0.89). 
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3.3. Post-stroke Seizures, Alteplase and Outcome 
Age (p=0.236), admission NIHSS (p=0.605) and ASPECTS (0.886) were similar between 
seizure patients in rtPA treated and non-treated groups. The percentage of patients with 
seizures and an unfavourable outcome 12 months after stroke (n=29) was also similar 
(p=1.000, OR=0.95, 95%CI 0.20-4.63) between groups. Post-stroke seizures were 
associated with an unfavourable functional outcome, 12 months after stroke, both in rtPA 
treated (n=19 (76%) vs. n=6 (24%), p=0.03, OR=3.00, 95% CI: 1.08-8.35) and non-treated 
(n=10 (76.9%) vs. n=3 (23.1%), p=0.002, OR=10.00, 95% CI: 2.24-44.57) patients.  
 
In a logistic regression model, unfavourable functional outcome at 12 months was no longer 
predicted by post-stroke seizures when adjusted for age, clinical and imaging stroke severity, 
both in rtPA treated (p=0.834, OR 1.15, 95%CI 0.31-4.30) and not treated  patients (p=0.331, 
OR 3.16, 95%CI 0.310-32.27). 
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4. DISCUSSION 
 
In our study, patients with an anterior circulation stroke treated with rtPA had the same 
frequency of acute symptomatic and unprovoked seizures, and EEG epileptic phenomena, 
compared to patients not submitted to thrombolysis. This observation goes against previous 
studies. De Reuck and Van Maele162 in a retrospective observational study, suggest a 
"tendency" for patients submitted to thrombolysis to have fewer seizures (mainly 
unprovoked) than patients who did not receive this treatment. Vincent Alvarez and 
collaborators28, in a case-control study, identified intravenous thrombolysis as an 
independent risk factor for early seizures.  rtPA was also found to be of predictive value for 
electrical epileptic activity in the univariate analysis in Carrera and collaborators study29. 
Stroke severity and its cortical location are known risk factors for seizures after ischaemic 
stroke25,174. In our study, infarct clinical and imaging severity and its cortical involvement 
(all measured after rtPA treatment) were similar between groups, probably explaining our 
different results.  
In our sample of patients submitted to intravenous thrombolysis, 5% had paroxysmal clinical 
events during rtPA perfusion, similarly to four clinical cases previously reported in the 
literature30,32,33, one of which had proven cortical origin33. Although this observation may 
indicate a higher risk of cortical hypersynchronisation or epileptic phenomena in patients 
treated with rtPA in the first hours of ischaemic stroke, there is a possibility of detection 
bias, due to closer monitoring of the neurological condition in treated patients during 
intravenous rtPA perfusion.  
Seizures after stroke have been associated with higher risks of mortality and 
disability44,45,79,80,268. This has also been observed in rare clinical studies on the effect of 
post-stroke seizures in functional outcome in the subgroup of patients treated with 
intravenous alteplase. Vincent Alvarez et al.28 found that rtPA treated patients with post-
stroke seizures (n=12) have an unfavourable functional outcome at three months. In 
Gensicke et al’s study172, seizures (n=37) were independent predictors of long-term poor 
outcome in rtPA treated patients. In our study, seizures were not associated with death or 
functional dependency one year after stroke, when adjusted for known outcome predictors 
such as age and stroke (clinical and imaging) severity, both in rtPA treated and non-treated 
group.  
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Given the higher percentage of patients with subcortical infarcts in the rtPA treated group 
(vs. not treated group), the presence of diffuse background slowing in this group is not totally 
unexpected since subcortical lesions could result in diffuse slowing as compared to focal 
cortical lesions (with focal slowing). Nevertheless, we have shown that age and imaging 
stroke severity are independently associated with slowing of background activity of the 1st 
EEG. In our series, rtPA patients were older and had more severe strokes at admission than 
non-treated patients (measured by NIHSS at admission), justifying slowing of the 
background activity in 1st EEG of these patients. Furthermore, discharge and 12 months after 
stroke NIHSS scores were similar in rtPA treated and not treated patients, possibly 
explaining why this EEG characteristic ceases to be a differentiating factor between rtPA 
treated and not treated patients at these time points.  
The major strength of this prospective study is the large sample size of acute anterior 
circulation stroke patients with electroencephalographic evaluation and 1-year follow-up. 
There are potential limitations, however, including the lack of continuous EEG monitoring 
and universal MRI. Data supporting the benefit of continuous over spot EEG recordings to 
detect seizures is limited76, especially in patients admitted in non-intensive profile 
departments and its cost-effectiveness is still in debate257.  Furthermore, subtle seizures 
arising from small foci or deep foci for the recording electrodes, may not have surface EEG 
correlates and can potentially result in minor underestimation of seizure frequency.  
In summary, patients treated with rtPA had the same frequency of epileptic manifestations 
(either clinical or electroencephalographic) as non-treated patients. Functional outcome of 
patients with post-stroke seizures was not different between groups.
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X. PROJECT 7 
 
 
 
“EEG may be of value in  
 helping the clinician estimate the risk for seizures in the post infarction patient”  
Gregory Holmes (1980) 
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ABSTRACT  
Objective: Electroencephalography can identify biomarkers of epileptogenesis and 
ictogenesis. However, few studies used EEG in the prediction of post-stroke seizures.  Our 
main aim has to evaluate whether early EEG abnormalities can predict post-stroke epilepsy. 
Methods: A prospective study of consecutive anterior circulation ischaemic stroke patients, 
without previous epileptic seizures, admitted to a Stroke Unit over 24 months and followed-
up for one year. All patients underwent standardized clinical and diagnostic assessment 
during hospitalization and after discharge. Video-EEG was performed in the first 72 hours 
(1st EEG), daily for the first 7 days, in case of neurological deterioration, at discharge and at 
12 months after stroke. The occurrence of epileptic seizures in the 1st year after stroke was 
clinically and neurophysiologically evaluated during hospitalization and at 12 months. A 
telephone interview was also performed at 6 months. Primary outcome was the occurrence 
of at least one unprovoked seizure (post-stroke epilepsy). Secondary outcomes were the 
occurrence of at least one acute symptomatic seizure and (interictal and/or ictal) epileptiform 
activity on at least one EEG during the hospital stay for acute stroke. 1st EEG variables were 
defined using international criteria/terminology. Bivariate and multivariate analyses with 
adjustment for age, admission NIHSS and ASPECTS were performed.  
Results: 151 patients were included. 38 (25.2%) patients had at least one epileptic seizure 
and 23 (16%) an unprovoked seizure. First EEG background activity asymmetry and 1st EEG 
with interictal epileptiform activity were independent predictors of post-stroke epilepsy 
during the first year after stroke. (p=0.043 and p=0.043, respectively). No EEG abnormality 
independently predicted acute symptomatic seizures.  However, the presence of periodic 
discharges in the 1st EEG was an independent predictor of epileptiform activity (p=0.009) 
during hospital stay.  
Significance: An early post-stroke EEG can predict epilepsy in the first year after stroke, 
independently from clinical and imaging-based infarct severity.   
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1. INTRODUCTION  
 
Clinical stroke severity and infarct dimension are known risk factors for post-stroke epileptic 
seizures and vascular epilepsy27. Although EEG is a sensitive neurophysiological technique 
in the detection of acute cerebral ischaemia36 and a robust one in the functional assessment 
of the brain37, it is unclear whether electroencephalographic markers of acute vascular injury 
severity are independently associated with an increased risk of post-stroke seizures or useful 
for their prediction.  A single retrospective study51 showed an association between diffuse 
EEG background slowing in acute stroke phase and seizure occurrence. Furthermore, even 
though the presence of periodic discharges and frontal intermittent rhythmic delta activity 
have been associated with the occurrence of acute symptomatic seizures51, it is still unknown 
whether electroencephalographic markers of cortical hypersynchronisation and of an 
epileptogenic zone may be helpful in the prediction of unprovoked seizures or post-stroke 
epilepsy, according to the current definition93. 
 
Our primary aim was to investigate whether early EEG abnormalities are independent 
predictors of post-stroke epilepsy. 
The EEG in Acute Ischaemic Cerebrovascular Disease 
 
144 
 
2. METHODS  
 
Ours was a prospective study of consecutive patients with an acute anterior circulation 
ischaemic stroke, admitted to the Stroke Unit of a Neurology Department between October 
2011 and October 2013 and followed-up for 12 months. The Ethics Committee “Comissão 
de Ética para a Saúde” of the HSM-CHLN approved this study.  
The following inclusion criteria were used: 
(1) Acute anterior circulation ischaemic stroke, established by imaging (CT scan or MRI), 
with less than 7 days of clinical evolution  
(2) National Institutes of Health Stroke Scale (NIHSS) score ≥ 4 upon admission to the 
emergency department  
(3) Signed informed consent by the patients or their next-of-kin  
The subsequent exclusion criteria were used: 
(1) Posterior circulation vascular syndrome269 even if not confirmed by imaging  
(2) Acute posterior circulation ischaemic stroke, established by imaging (CT scan or MRI) 
obtained at any time during hospitalization  
(3) Previous stroke with modified Rankin scale score (mRS)236 > 1 at the time of acute 
stroke 
(4) Brain imaging study (any CT scan or MRI) with one of the following: contusion; 
subdural/epidural hematoma; subarachnoid haemorrhage; neoplastic lesion; 
infectious/inflammatory lesion; hydrocephalus 
(5) Brain CT scan performed in the emergency department (1st CT Scan) with intracerebral 
haemorrhage  
(6) Previous history of head trauma with hospital admission  
(7) Previous neurosurgery   
(8) Previous history of epilepsy or epileptic seizures 
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2.1. Standardized clinical and ancillary evaluation  
All patients were attended by a neurologist at the emergency department and admitted to our 
Stroke Unit with continuous surveillance of their neurological status and daily observation 
by a stroke neurologist. During the study period, this Stroke Unit admitted all patients treated 
with intravenous alteplase (rtPA) in our hospital (according to ESO Guidelines72) and, 
depending on bed availability, also patients not treated with rtPA. The NIHSS score and 
seizure occurrence were prospectively recorded. During hospitalization, the patient 
performed diagnostic tests allowing stroke etiological classification239 and appropriate 
therapeutic approach, including blood tests, carotid and vertebral duplex scans, transcranial 
Doppler and ECG. All patients underwent a CT scan at the emergency department (1st CT 
scan) which was repeated 24 hours after stroke in patients submitted to rtPA and when 
clinically indicated in all patients (2nd CT scan). Selected patients also performed MRI with 
diffusion weighted imaging, transthoracic or transesophageal echocardiography, 24h Holter 
or cerebral angiography.  
 
After discharge patients had a standard clinical follow-up at the cerebrovascular outpatient 
clinic. A neurologist with expertise in epilepsy (CB) performed a telephone interview 6 
months after stroke accessing seizure occurrence by a free interview followed by a brief 
phone screening tool for identifying patients with epilepsy240. A scheduled appointment 12 
months after stroke was also conducted (CB), recording the following clinical variables: 
NIHSS and mRS score, occurrence of seizures and type; other stroke or medical 
complications; final etiological classification of stroke239 and ongoing therapy.  
 
2.2. Neurophysiological Evaluation 
All patients underwent a neurophysiological evaluation protocol270 that included a 64 
channel synchronized video-EEG with a maximum duration of 60 minutes in different time 
frames after stroke:  
(1) As early as possible, in the first 72 hours after admission (1st EEG) 
(2) Daily, after the 1st EEG, for the first 7 days after stroke (except on weekend)  
(3) If neurological worsening, unexplained by medical complications, and with indication 
for repeating the imaging exam 
(4) At time of clinical discharge (discharge EEG) 
(5) At 12 months after stroke (12M EEG)   
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2.3. Imaging Interpretation  
All imaging exams performed during the study period were reviewed by 2 senior 
neuroradiologists (CM and CC), blinded for clinical and electroencephalographic findings 
and trained for ASPECTS classification. Doubts were discussed and final determination was 
reached by consensus.  
 
In patients with an infarct limited to the middle cerebral artery (MCA) territory in the 
imaging study (considering 1st CT scan, 2nd CT scan or MRI), the infarct size was quantified 
by ASPECTS42 in 1st and 2nd CT scan. Insula and M1 to M6 ASPECTS territories were 
considered “cortical territories of ASPECTS”. Furthermore, any type of haemorrhage 
transformation242, cortical or subcortical infarct location, presence of cortical areas with 
normal attenuation coefficient (islands of preserved cortex) within the infarct165,243,244 were 
evaluated in 2nd CT.  
 
2.4. Outcomes  
The primary outcome of this study was the occurrence of at least one unprovoked epileptic 
seizure (post-stroke epilepsy44,93), one year after stroke. 
The secondary outcomes were the occurrence of: at least one acute symptomatic seizure and 
EEG epileptiform activity in at least one EEG during hospitalization 
The following operational definitions were used:  
(1) Unprovoked seizures (or post-stroke epilepsy44,93): at least one clinical seizure93 
occurring 7 days after (and in the first year of) a stroke, in the absence of precipitating 
factors142  
(2) Acute symptomatic seizure: at least one epileptic seizure occurring within the first 7 
days of a stroke 142. In these patients, cut-off values for metabolic disorders and febrile 
symptomatic seizures were not overreached and alcohol/drug withdrawal or 
intoxication142 were excluded  
(3) Electrographic seizure; generalized spike-wave discharges at 3/s or faster or clearly 
evolving discharges of any type that reach a frequency >4/s, whether focal or 
generalized212. Evolving was defined as at least 2 unequivocal sequential changes in 
frequency, morphology or location lasting for at least 3 cycles each. Evolution in 
frequency was defined as at least 2 consecutive changes in the same direction by at least 
0.5/s. Evolution in morphology was defined as at least 2 consecutive changes to a novel 
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morphology. Evolution in location was defined as sequentially spreading into or 
sequentially out of at least two different standard 10-20 electrode locations and 
persisting for least 3 cycles212 
 
(4) EEG epileptiform activity during hospitalization (interictal or ictal): At least one EEG 
during hospitalization with interictal epileptiform activity (IEA) 211 and/or an 
electrographic seizure 212 
2.5. Predictors 
The following characteristics were studied:  
(1) Clinical characteristics: age, admission NIHSS70 and TOAST subgroups239 
(2) Imaging characteristics: 1st CT ASPECTS 42 (and cortical territories of ASPECTS), 2nd 
CT with islands of preserved cortex within the infarct165,243,244 (Figure 12) and any 
intracerebral haemorrhage242. 
(3) 1st EEG abnormalities: background activity slowing211; asymmetry212; suppression 
(focal, hemispheric or diffuse)212; Focal Slow Wave Activity211 (FSWA), defined as 
continuous or intermittent slow activity i.e. theta and/or delta band activity, without an 
approximately constant period,  limited to an area of the brain or scalp region (including 
focal and regional concept of the International Federation of Clinical 
Neurophysiology211; rhythmic slow wave activity (RSWA), including lateralized 
rhythmic delta activity (LRDA) definition by ACNS212 and rhythmic delta/theta (>0.5 
Hz) activity245, interictal epileptiform activity (IEA)211; periodic discharges (PD)212; 
electrographic seizure212. 
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Figure 12. Islands of preserved cortex within the infarct 
 
Legend to figure 12: Brain CT- scan showing an acute left middle cerebral artery ischaemic 
stroke. Black arrows indicate cortical areas with normal attenuation coefficient (islands of 
preserved cortex) within the infarct. 
 
2.6. Statistical analysis 
A descriptive analysis was used for nominal qualitative and quantitative variables. Nominal 
variables are expressed in frequency, discrete variables as medians and interquartile ranges 
(IQR) and continuous variables as means and standard deviations (SD).   
 
The bivariate analysis of qualitative variables was performed by χ2 test, Fisher exact test or 
McNemar test and of quantitative variables by t-student or Mann-Whitney U tests, as 
appropriate.  
 
Variables with a significant association in bivariate analysis were adjusted in a logistic 
regression model for known functional outcome predictors of stroke and post-stroke seizures 
27,39–42, namely age, clinical stroke severity (admission NIHSS) and imaging infarct size 
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(ASPECTS), when meeting the requirements for this analysis. The significance level was 
α<0.05. The odds ratios (OR) and the confidence interval of 95% were calculated. 
 
Defined characteristics of outcome prediction models encompassing predictors with the 
highest odds to impact outcome were studied. The percentage of patients correctly identified 
by the models was calculated. Model calibration was analysed by Hosmer-Lemeshow test 
and discriminative capacity measured by the area under the ROC curve. In all models, the 
study of the assumptions associated with logistic regression showed the existence of a 
multicollinearity problem between the variables “ASPECTS” and “cortical territories of 
ASPECTS”. Only the first was included in the logistic regression models. 
 
Statistical analysis was done using SPSS program version 24 for Mac. 
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3. RESULTS 
A total of 151 patients (112 men) with a mean age of 67.4 (SD 11.9) years was included. 
The study flowchart was previously described 271 (Figure 8) . Median NIHSS was 12 (IQR 
10) at admission.  
An infarct limited to middle cerebral artery territory (MCA) was observed in 146 (96.7%) 
patients and to anterior cerebral artery territory (ACA) in 3 (2.0%) patients. Two patients 
had simultaneously MCA and ACA infarcts. Patients with an exclusively MCA infarct had 
a median 1st CT ASPECTS of 9 (IQR 3), scoring 6 (IQR 3) in the cortical territories of this 
scale.  
All patients performed at least one EEG during hospitalization in a median time of 1 day 
(IQR 1) after stroke (1st EEG). The median number of records performed per patient was 5 
(IQR 3).  
Seven patients died during hospitalization. Of the 144 discharged patients, 143 patients 
(99.3%) performed an EEG on this date. One patient (0.7%) refused to undergo this exam. 
The discharge EEG was made on a median time of 7 days after stroke.  
Of the 127 patients who were alive at 12 months, 117 (92.1%) performed an EEG at this 
time and 10 patients (7.9%) refused to repeat the exam. One patient (0.66%) was lost to 
clinical and neurophysiological follow-up between month 6 and 12.    
The frequency of EEG abnormalities is described in Table 14. Clinical and imaging 
characteristics associated with early EEG abnormalities are described in Appendix M. In 
the first 7 days after stroke, 7 patients had at least one electrographic seizure (5 of which had 
exclusively electrographic seizures and 2 patients both clinical and electrographic seizures). 
Clinical, imaging characteristics and EEG abnormalities associated with these events are 
disclosed in Appendix N. 
During the study period, 38 (25.2%) patients had at least one epileptic seizure, 22 (14.6%) 
an acute symptomatic seizure and 23 (16%) an unprovoked seizure. Furthermore, 5 patients 
had pure electrographic seizures during hospital stay.  
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3.1. Defined outcome predictors 
Clinical, imaging and 1st EEG variables associated with defined outcomes are disclosed in 
Table 15 to 16 and Appendix O. 
3.1.1. 1st EEG independent predictors of defined outcomes  
1st EEG background activity asymmetry was an independent predictor of unprovoked 
seizures during the first year after stroke.  The occurrence of interictal epileptiform activity 
in the 1st EEG was also an independent predictor of unprovoked seizures. No EEG 
abnormality independently predicted acute symptomatic seizures.  However, the presence of 
periodic discharges in the 1st EEG was an independent predictor of epileptiform activity 
(interictal and/or ictal) in at least one EEG during the hospital stay. No other studied 1st EEG 
abnormality was an independent predictor of defined outcomes. 
3.1.2. Imaging independent predictors of defined outcomes  
ASPECTS was an independent predictor of unprovoked seizures and also acute symptomatic 
seizures. The presence of islands of preserved cortex within the infarct was an independent 
predictor of the presence of interictal epileptiform activity and/or electrographic seizures in 
at least one EEG during the hospital stay. 
3.1.3. Other independent predictors of defined outcomes  
Unprovoked seizures were also independently associated with the occurrence of a previous 
acute symptomatic seizure. 
Table 17 displays the characteristics of prediction models for defined outcomes.  All models 
have a good to very good discriminative capacity. 
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4. DISCUSSION  
In this work, post-stroke epilepsy could be predicted by EEG findings, extracted from visual 
analysis of an early and short duration EEG, independently from clinical and imaging–based 
infarct severity. Indeed, for the same age, clinical and imaging infarct severity, the risk of 
post-stroke unprovoked seizures was 3.2 times higher in patients with 1st EEG background 
activity asymmetry and 3.8 times higher if interictal epileptiform activity was displayed in 
this exam. Furthermore, we found early neurophysiological markers of an increased risk of 
EEG epileptiform activity during hospital stay, identifying patients who might benefit from 
an extended neurophysiological study. A previous analysis of our group270 already showed 
that the frequency of post-stroke seizures is clinically underestimated without a systematic 
neurophysiological evaluation. The present study further enlarges the importance of EEG in 
stroke patients defining those with an increased risk for epilepsy and also for paroxysmal 
EEG events during hospital stay. 
Strengths of this work include the sample size with prospective clinical assessment and 
rigorous electroencephalographic acute evaluation and follow-up. Furthermore, this work 
includes standardized imaging evaluation of MCA infarct dimension and the presence of 
islands of preserved cortex within the infarct. Another aspect that stands out is the use of 
internationally recognized terminology212 showing good inter-observer agreement248 for 
describing the electroencephalographic features. The consideration of clinical and imaging 
parameters in the statistic models is also very pertinent.  
In this study, the non-continuous nature of the neurophysiological assessment may be 
considered a limitation. However, we identified early neurophysiological and imaging 
markers that can guide the need for a more prolonged study (serial or even continuous) only 
in some patients, presumably improving the cost-benefit of such a procedure. Continuous 
EEG requires large quantities of time, specialized human resources (physicians and 
technicians) and is not accessible at all centres. In accordance, studies about the performance 
of a short duration EEG for epileptiform activity detection are important. In fact,  the search 
for EEG markers suggesting the need and helping to identify patients for a more prolonged 
or frequent record, as analysed in this paper, is a current trend in electroencephalography 
research255,256,272,273.  Furthermore, anti-epileptic drug prescription was not analysed in this 
study. Although (theoretically) anti-epileptic drug treatment could impact outcome 
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measures, primary and secondary prophylaxis of an index acute symptomatic seizure is not 
routinely performed in our Stroke Unit, in accordance to the recently published ESO 
guidelines148. Furthermore, even when repeated acute symptomatic seizures occur during 
hospitalization leading to antiepileptic drug prescription, their withdrawal after the acute 
stroke phase is encouraged. Therefore, the occurrence of unprovoked seizures one year after 
stroke is probably not greatly affected by anti-epileptic drug prescription in our study.  
In the present work, unprovoked seizures or epilepsy (according to the current ILAE 
definition93) in the year following an anterior circulation ischaemic stroke were 
independently predicted by 1st EEG asymmetry (reflecting asymmetrical cerebral 
dysfunction) even when adjusted for age, admission NIHSS and ASPECTS. This data adds 
a neurophysiological risk factor to post-stroke seizures, reflecting not only their association 
with large and disabling ischaemic strokes2 but also the importance of EEG for brain 
functional assessment. In fact, recently 1st EEG asymmetry was also reported as an 
independent predictor of unfavourable stroke functional outcome even when adjusted for 
age, clinical and imaging stroke severity274. 
Furthermore, post-stroke epilepsy was also independently predicted by the presence of 
interictal epileptiform activity in the 1st EEG. This observation seems physiopathologically 
coherent, since spikes and sharp waves are neurophysiological markers of epileptogenesis4 
and therefore of an increased susceptibility for seizures. This result is also of great clinical 
relevance, helping to identify patients with an increased risk of post-stroke epilepsy.  
There is currently no high quality evidence providing strong support for the primary 
prophylactic use of anti-epileptic drugs for post-ischaemic stroke unprovoked seizures148. 
However, we think that our EEG findings can, at least, lead to stricter clinical monitoring, 
oriented towards an early recognition of seizures in these higher risk patients and may help 
earlier identification, prevention of associated risks and timely prescription of appropriate 
secondary prophylaxis of post-stroke unprovoked seizures. On the other hand, one should 
note that the European Stroke Organization “weak recommendation” against primary 
prophylaxis of unprovoked seizures is based on their low risk of occurrence in most stroke 
patients (approximately 10%)148. While lacking external validation, our model might help to 
consider the need for anti-epileptic drugs when EEG and other independent predictors of 
post-stroke epilepsy are present, that is, whenever the estimated risk of an unprovoked 
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seizure occurrence is at least similar to its recurrence risk148, i.e. higher than 60% (95% CI 
= 59.7–81.9%)44.  
 
In our study, 1st EEG periodic discharges were an independent predictor of epileptiform 
activity (interictal and/or ictal) during hospitalization, reinforcing the concept that periodic 
discharges are in the continuum between an interictal and ictal phenomenon250 and in 
accordance with the association of this neurophysiological feature to clinical and EEG 
epileptiform manifestations both in studies using short duration51,165,275 and continuous 
EEG75,255,256. Another independent predictor of epileptiform activity in our study was the 
presence of islands of preserved cortex within the infarct. Although suggested by two case-
control studies from the 90s165,243, this association has not yet been prospectively associated 
with EEG epileptiform activity during hospitalization for acute stroke. It has been postulated 
that this finding reflects regional cerebral blood flow reduction, although at a threshold 
higher than that of ischaemia243, providing a state of neuronal hyperexcitability to these 
regions. Peri-infarct depolarisations have been observed in stroke animal models276 and PET 
studies have shown that most patients with unprovoked seizures have hypermetabolism in 
the infarct boundaries277. In addition, a recent study278 demonstrated that interictal 
epileptiform activity is associated with several separated cortical microinjuries postulating 
that its presence may interrupt the connectivity between deep and superficial cortical layers 
and induce hypersynchronisation of the latter.
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 XI. PROJECT 8 
 
 
 
“While the overall risk of stroke has declined by 25% in the last decade,  
disability from stroke is now emerging as a major public health problem,  
particularly in the elderly, as we observe an increase in aging of the population” 
Rachel Dreyer (2014)
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ABSTRACT  
Objective: Seizures and electroencephalographic (EEG) abnormalities have been associated 
with an unfavourable stroke functional outcome. However, this association may depend on 
clinical and imaging stroke severity. We aim to analyse whether epileptic seizures and early 
EEG abnormalities are predictors of stroke outcome after adjustment for age and clinical / 
imaging infarct severity.   
Methods: A prospective study was made on consecutive and previously independent acute 
stroke patients with a National Institutes of Health Stroke Scale (NIHSS) score ≥4 on 
admission and an acute anterior circulation ischaemic lesion in brain imaging. All patients 
underwent standardized clinical and diagnostic assessment during admission and after 
discharge, and were followed for 12 months. Video-EEG (<60 minutes) was performed in 
the first 72h. The Alberta Stroke Program Early CT Score quantified middle cerebral artery 
infarct size. The outcomes in this study were an unfavourable functional outcome (modified 
Rankin Scale [mRS] ≥3) and death (mRS=6) at discharge and 12 months after stroke.  
Results: Unfavourable outcome at discharge was independently associated with NIHSS 
score (p=0.001), EEG background activity slowing (p<0.001) and asymmetry (p<0.001). 
Unfavourable outcome one year after stroke was independently associated with age 
(p=0.001), NIHSS score (p<0.001), unprovoked seizures (p=0.046), EEG background 
activity slowing (p<0.001) and asymmetry (p<0.001). Death in the first year after stroke was 
independently associated with age (p=0.028), NIHSS score (p=0.001), acute symptomatic 
seizures (p=0.015) and EEG suppression (p=0.019). 
Significance: Acute symptomatic seizures were independent predictors of vital outcome and 
unprovoked seizures of functional outcome, in the first year after stroke. Therefore, their 
recognition and prevention strategies may be clinically relevant. Early 
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electroencephalographic abnormalities were independent predictors and comparable to age 
and early clinical / imaging infarct severity in stroke functional outcome discrimination, 
reflecting the concept that EEG is a sensitive and robust method in the functional assessment 
of the brain. 
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1. INTRODUCTION  
 
Post-stroke epileptic phenomena (seizures and status epilepticus)44,45,79–82 have been 
associated with ischaemic stroke unfavourable outcome. However, while EEG is essential 
for the detection of interictal and ictal epileptiform activity it is unknown whether these EEG 
activities per se are also associated with stroke prognosis.  
 
Previous work, mainly retrospective and without standardized imaging analysis, showed that 
raw EEG abnormalities (other than epileptiform discharges) are associated with post-stroke 
functional outcome, essentially in the short-term64,85–88. Additionally, a few small sample 
studies using quantitative EEG indexes showed that these might be better than a clinical 
scale in functional outcome prediction89 or have a higher correlation with the residual 
neurological deficit after stroke, than acute magnetic resonance imaging (MRI) lesion71.  
 
However, it is unknown whether the association between seizures or EEG abnormalities and 
stroke functional outcome is independent from known cerebral infarct outcome predictors, 
namely age and stroke (clinical and imaging) severity 39–42. Thus, we aimed to prospectively 
assess whether seizures and post-stroke EEG abnormalities are outcome predictors at 
discharge and 12 months after stroke after adjustment for age and stroke severity.  
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2. METHODS 
2.1. Study design 
We performed a prospective longitudinal study of consecutive anterior circulation ischaemic 
stroke patients admitted to the Stroke Unit of the Neurology Department of a University 
Hospital over a period of 24 months and followed for 12 months. The Ethics Committee 
“Comissão de Ética para a Saúde” at our hospital approved this study. All subjects or their 
next of kin gave written informed consent for participation.  
All included patients had to be previously independent (modified Rankin Scale [mRS] ≤1), 
score a value of at least 4 on National Institutes of Health Stroke Scale (NIHSS)70 upon 
admission to the emergency department (ED), had an acute ischaemic brain lesion 
(noncontrast computed tomography [CT] scan or MRI) in the internal carotid artery territory 
and no previous history of epileptic seizures, traumatic head injury requiring hospital 
admission, or brain surgery. 
 
2.2. Clinical assessment  
All patients received standardized clinical and diagnostic assessment, during hospitalization 
and after discharge. An investigator blinded to the neurophysiological evaluation conducted 
a phone interview at six months and a clinical appointment 12 months after stroke to access 
the occurrence of epileptic seizures and functional outcome. 
NIHSS score at admission assessed clinical stroke severity. The functional outcome at 
discharge and at 12 months was assessed by the mRS236.  
 
2.3. Neurophysiological evaluation 
Patients underwent a neurophysiological evaluation protocol that included a 64-channel 
video-EEG with a maximum duration of 60 minutes in the first 72 hours after stroke (EEG). 
The record included an eyes closed wake resting condition and eyes open, hyperventilation 
and photic stimulation manoeuvers. EEG review and classification were performed by a 
certified clinical neurophysiologist (CB) using international criteria and 
terminology211,212,245, blinded for clinical and imaging findings. All doubts were decided by 
consensus with another clinical neurophysiologist (ARP).  
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2.4. Neuroimaging interpretation 
A senior neuroradiologist, (CM or CC) blinded for clinical and electroencephalographic 
findings analysed all the neuroimaging studies performed during hospitalization. Doubts 
were decided by consensus. In patients with an isolated middle cerebral artery (MCA) stroke 
in the imaging study (considering non-contrast-enhanced CT scan or MRI), the infarct size 
was quantified in the 1st CT performed after stroke by the Alberta Stroke Program Early CT 
Score (ASPECTS)42.  Whenever there was a brain CT scan performed at least 24 hours after 
stroke onset (2nd CT scan) ASPECTS was also quantified in this exam in patients with an 
isolated MCA infarct. 
 
2.5. Predictors and Outcomes 
The following predictors were registered: 
2.5.1 Clinical predictors: age, gender, Trial of Org 10172 in Acute Stroke Treatment 
(TOAST) subgroups239, NIHSS on admission, occurrence of post-stroke 
seizures93,142,145 (either acute symptomatic: in the first 7 days after stroke142 or 
unprovoked: after that time point145), and status epilepticus245–247 
2.5.2 Neuroimaging predictors: ASPECTS in the 1st and 2nd CT scans and any type of 
haemorrhage transformation242 in the 2nd CT scan 
2.5.3 EEG predictors (categorical variables, dichotomized in present or absent): 
background activity slowing211; asymmetry212; suppression (focal, hemispheric or 
diffuse)212; focal slow wave activity (including focal and regional concept)211; 
rhythmic slow wave activity, including rhythmic delta activity definition by the 
American Clinical Neurophysiology Society (ACNS)212 and rhythmic delta/theta 
(>0.5 Hz)245, interictal epileptiform activity211 and periodic discharges212  
The outcomes in this study were an unfavourable functional outcome (mRS≥3) and death 
(mRS=6) at discharge and 12 months after stroke.  
 
2.6. Statistical Analysis 
A descriptive analysis was used for nominal qualitative and quantitative variables (discrete 
and continuous). Nominal variables are expressed in frequency, discrete variables as 
medians and interquartile ranges (IQR) and continuous variables as means and standard 
deviations (SD). 
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Bivariate analysis of dichotomous data was performed by chi-square test or Fisher's exact 
test and quantitative variables by t-test or Mann-Whitney U, as appropriate. Variables with 
a significant association in bivariate analysis were adjusted for known functional outcome 
predictors of stroke39–42, namely age, clinical stroke severity (admission NIHSS) and 
imaging infarct size (ASPECTS), using a logistic regression model. The significance level 
was α≤0.05. Odds ratios (ORs) and 95% confidence interval (95%CIs) were calculated.  
Outcome prediction model characteristics encompassing post-stroke seizures or EEG 
abnormalities with the highest odds to impact outcome were compared with the model 
including exclusively known stroke outcome predictors. The percentage of patients correctly 
identified by the models, was calculated. Models calibration was analysed using the Hosmer-
Lemeshow test and its discriminative capacity measured by the area under the ROC curve 
(95%CI).   
Statistical analysis was done using SPSS program version 24 for Mac. 
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3. RESULTS  
One hundred and fifty-one patients (112 men and 39 women) were included, with a mean 
age of 67.4 (SD 11.9) years. During this study 23 patients died (seven during admission 
before day 7, 11 between discharge and 6 months after stroke and five after that time point). 
One patient (0.66%) was lost for clinical and EEG follow-up in the last 6 months of the 
study. From the 127 living patients with a clinical follow-up one-year after stroke, 117 
(92.1%) had repeated EEG by that time. Study flowchart was previously described271 
(Figure 8). All (151) patients had at least one acute CT scan (1st CT). Furthermore, in the 
acute phase, a 2nd CT scan was performed in 129 (85.4%) patients and an MRI in 63 (41.7%) 
patients. From the 129 patients who performed a 2nd CT scan, only 124 had an isolated MCA 
infarct.  
 
3.1. Variables associated with stroke outcome at discharge  
Table 18 describes clinical, imaging and neurophysiological features of included patients, 
comparing unfavourable outcome (mRS≥3) patients with those with a favourable one 
(mRS<3), at discharge.  In bivariate analysis, an unfavourable outcome was more frequent 
in older patients, patients with a higher admission NIHSS, a lower ASPECTS, presence of 
haemorrhagic transformation and an EEG with background activity slowing, asymmetry, 
focal slow wave activity and periodic discharges. After adjustment of these variables for 
known functional outcome predictors of stroke, admission NIHSS, EEG background activity 
slowing, asymmetry and periodic discharges predicted functional outcome. 2nd (but not 1st) 
CT ASPECTS was an independent discharge outcome predictor from age and NIHSS.  
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In the logistic regression model encompassing known functional outcome predictors of 
stroke and EEG background activity asymmetry (Table 19), the variables that remained as 
independent predictors were NIHSS score (OR 1.16, 95%CI 1.07-1.27, p=0.001) and 
background activity asymmetry (OR 11.90, 95%CI 3.73-38.46, p<0.001). This model 
correctly classified 76.7% of the subjects and the area under the ROC curve was 0.86. The 
prediction model including this EEG variable did not have a different discriminative capacity 
compared to the model encompassing the already known outcome predictors.  
Clinical, imaging and neurophysiological features of patients who died during 
hospitalization can be seen in Table 20. In bivariate analysis an association was found with 
admission NIHSS, occurrence of acute symptomatic seizures and EEG background activity 
slowing and suppression. Adjustment for known functional outcome predictors of stroke was 
not performed due to the low number of events (n=7) 
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Table 20. Clinical, imaging and neurophysiological features and vital outcome of anterior 
circulation ischaemic stroke patients at discharge 
At discharge Death Alive 
Bivariate 
analysisi 
p 
Clinical Features (n=151) 
Number of patients 7 144  
Male (%) 5 (71.4%) 84 (58.3%) 0.701 
Mean Age (SDa) 71.14 (8.80) 67.17 (12.06) 0.391 
Median admission NIHSSb (IQRc) 20 (9)  12 (10)  0.032  
IV alteplase 5 (71.4%) 96 (66.7%) 1.000 
Stroke Aetiology: 
Cardio-embolism 
Atherosclerosis 
Small vessels 
Unknown  
Other 
 
1 (14.3%) 
1 (14.3%) 
0 (0%) 
5 (71.4%) 
0 (0%) 
 
76 (52.8%) 
36 (25.0%) 
4 (2.8%) 
24 (16.7%) 
4 (2.8%) 
NA 
Acute symptomatic seizures 6 (85.7%) 16 (11.1%) <0.001  
Non-convulsive status epilepticus 1 (14.3%) 3 (2.1%) 0.175 
Imaging Features I 
Isolated MCAd territory infarct patients with a 1st CT (n=146) 
Number of patients 6 140  
Median ASPECTSe (IQR) 8.5 (5) 9 (2)  0.343 
The EEG in Acute Ischaemic Cerebrovascular Disease 
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Imaging Features II 
Isolated MCAd territory infarct patients with a 2nd CT(n=124) 
Number of patients 5 119  
Median ASPECTSe (IQRc) 3 (7) 6 (4)  0.125 
Anterior circulation ischaemic stroke patients with a 2nd CT (n=129) 
Number of patients 6 123  
Haemorrhagic transformation  1 (16.7%) 22 (17.9%) 1.000 
1st EEG findings (n=151) 
Number of patients 7 144  
Background activity slowing  7 (100%) 50 (34.7%) 0.001 
Background activity asymmetry 5 (71.4%) 59 (41.0%) 0.135 
EEG suppression 4 (57.1%) 8 (5.6%) 0.001 
FSWAf 6 (85.7%) 128 (88.9%) 0.574 
RSWAg 2 (28.6%) 24 (16.7%) 0.346 
Periodic discharges 2 (28.6%) 25 (17.4%) 0.609; 
IEAg 1 (14.3%) 15 (10.4%) 0.551 
Legend to table 20: aSD - standard deviation; bNIHSS - National Institutes of Health Stroke 
Scale; cIQR - interquartile Range; dMCA - middle cerebral artery; eASPECTS - Alberta 
Stroke Program Early CT Score; fFSWA - focal slow wave activity; gRSWA - rhythmic slow 
wave activity; hIEA - interictal epileptiform activity; iBivariate analysis - bivariate analysis 
of dichotomous data performed by chi-square test or Fisher's exact test and quantitative 
variables by t-test or Mann-Whitney U, as appropriate; bold values - p<0.05 
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3.2. Variables associated with stroke outcome at 12 months  
Table 21 describes clinical, imaging and neurophysiological features of included patients, 
comparing those with an unfavourable (mRS≥3) and favourable outcome (mRS<3). An 
association with an unfavourable outcome was found in bivariate analysis for age, admission 
NIHSS, treatment with intravenous alteplase, occurrence of an acute symptomatic or 
unprovoked seizure, ASPECTS and EEG background activity slowing, asymmetry, 
suppression, focal and rhythmic slow wave activity, periodic discharges and interictal 
epileptiform activity. After adjustment for known functional outcome predictors of stroke 
age, admission NIHSS, occurrence of an unprovoked seizure and EEG background activity 
slowing, asymmetry and periodic discharges remained significant. 2nd (but not 1st) CT 
ASPECTS was an independent discharge outcome predictor from age and NIHSS.  
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In the logistic regression model encompassing known functional outcome predictors of 
stroke and EEG asymmetry (Table 22A), the variables remaining independent predictors 
were age (OR 1.09, 95%CI 1.09-1.04, p=0.001), NIHSS score (OR 1.18, 95%CI 1.07-1.29, 
p=0.001) and EEG background activity asymmetry (OR 22.73, 95%CI 7.30-71.43, p<0.001). 
This model correctly classified 84.8% of the subjects and the area under the ROC curve was 
0.91. The prediction model including this EEG variable did not have a significantly different 
discriminative capacity compared to the model encompassing the already known outcome 
predictors. 
In the logistic regression model encompassing known functional outcome predictors of 
stroke and unprovoked seizures (Table 22A), the variables remaining independent 
predictors were age (OR 1.08, 95%CI 1.04-1.14, p<0.001), NIHSS score (OR 1.18, 95%CI 
1.09-1.28, p<0.001) and unprovoked seizures (OR 3.76, 95%CI 1.02-13.83, p=0.046). This 
model correctly classified 74.8% of the subjects and the area under the ROC curve was 0.83. 
The prediction model including this type of post-stroke seizures did not have a significantly 
different discriminative capacity compared to the model encompassing the already known 
outcome predictors.  
 
Clinical, imaging and neurophysiological features of patients who died in the first year after 
stroke are disclosed in Table 23. An association with death in the first year after stroke was 
found in bivariate analysis for age, admission NIHSS, occurrence of an acute symptomatic 
seizure and EEG background activity slowing, asymmetry, suppression and periodic 
discharges. After adjustment for known functional outcome predictors of stroke age, 
admission NIHSS, occurrence of an acute symptomatic seizure and EEG suppression 
remained significant. 
In the logistic regression model encompassing known functional outcome predictors of 
stroke and EEG suppression (Table 22B), the variables remaining independent predictors 
were age (OR 1.06, 95%CI 1.01-1.12, p=0.032), NIHSS score (OR 1.18, 95%CI 1.07-1.31, 
p=0.001) and EEG suppression (OR 7.48, 95%CI 1.40-39.99, p=0.019). This model 
correctly classified 89.0% of the subjects and the area under the ROC curve was 0.84. The 
prediction model including this EEG variable did not have a significantly different 
discriminative capacity compared to the model encompassing the already known outcome 
predictors. 
The EEG in Acute Ischaemic Cerebrovascular Disease 
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In the logistic regression model encompassing known functional outcome predictors of 
stroke and acute symptomatic seizures (Table 22A), the variables remaining independent 
predictors were age (OR 1.06, 95%CI 1.00-1.12, p=0.039), NIHSS score (OR 1.19, 95%CI 
1.07-1.31, p=0.001) and acute symptomatic seizures (OR 4.55, 95%CI 1.34-15.47, p=0.015). 
This model correctly classified 91.0% of the subjects and the area under the ROC curve was 
0.82. The prediction model including this type of post-stroke seizures did not have a different 
discriminative capacity compared to the model encompassing the already known outcome 
predictors. 
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4. DISCUSSION 
 
In this work, acute symptomatic seizures were independent predictors of death and 
unprovoked seizures independent predictors of an unfavourable outcome in the first year 
after an anterior circulation ischaemic stroke. We also demonstrated that EEG abnormalities 
extracted from visual analysis of a single, early (<72 hours after stroke) and short duration 
EEG, are strong predictors of functional outcome, even when adjusted for previously known 
(early clinical and imaging) stroke outcome predictors. 
We think that the strengths of this work, standing out from previous research in this area, 
include the sample size of consecutive anterior circulation stroke patients, the prospective 
nature of a multimodal (clinical, neurophysiological and imagiological) study and the 12 
months follow-up with only one patient lost during this period, as well as, the adjustment to 
clinical and infarct severity.   
As a limitation, we did not analyse the value of EEG as a functional outcome predictor 
compared with 2nd CT scan or brain MRI, avoiding the inclusion of variables with a high 
percentage of missing data (17.9% and 58.3%, respectively) in our regression models. 
Sillipaa et al.279 showed the superior of ASPECTS quantified at 24h after stroke (over on-
admission) non-contrast-enhanced CT in outcome prediction.  In our analysis, 2nd CT 
ASPECTS (but not 1st CT ASPECTS) was a predictor of stroke functional outcome 
independently from age and admission NIHSS. Nevertheless, this result must be cautiously 
interpreted because of the missing data. We acknowledge that our 1st CT ASPECTS median 
reflects the difficulty of estimating stroke size from early non-contrast-enhanced CT 
reducing the value of this score in functional outcome assessment. Nevertheless, in the 
clinical practice of a significant proportion of Stroke Units (such as ours), a 2nd CT scan is 
not routinely performed in all patients, unless they had been treated with intravenous 
alteplase or had a neurological worsening. In our study, using an easy, non-invasive, short 
duration and bedside EEG examination, available in the great majority of neurological 
departments and intensive care units, we identified neurophysiological independent 
predictors of stroke outcome in models already including well-established clinical and early 
imaging outcome prognostic factors. 
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4.1. Post-stroke seizures and stroke outcome  
In our bivariate analysis, seizures were associated with an unfavourable functional outcome 
one year after stroke, as previously suggested in the literature44,45,80,280. It has been postulated 
in the animal model that post-stroke seizures may contribute to tissue damage281,282. In 
addition, De Reuck et al.79 showed that unprovoked seizures are associated with lesion 
increase and worsening of disability. As a novel finding, we show that the association 
between unprovoked seizures and an unfavourable functional outcome 12 months after 
stroke does remain significant when adjusted for age, clinical and imaging stroke severity. 
Furthermore, in our work, acute symptomatic seizures remained as an independent predictor 
of death in the first year after an anterior circulation stroke, even after adjustment for known 
stroke outcome predictors. Hesdorffer et al.44 similarly showed that patients with acute 
symptomatic seizures (of different aetiologies) had an 8.9 times higher chance of dying 
within 30 days. More recently, Huang et al.45 also found that patients with seizures during 
admission for stroke had a higher mortality at 30 days and 1 year. This finding was not 
observed in Hamidou et al. study283 using, however, a population based registry and a 
different definition of early seizures.  
 
4.2. EEG abnormalities and stroke outcome 
EEG background activity slowing was associated with stroke clinical severity by Kayer-
Gatchalian and collaborators85 and, as in our study, with an unfavourable stroke outcome by 
Cillessen et al.87. The originality of our study resides in the definition of 
electroencephalographic independent predictors of stroke functional outcome, either at short 
and at long term, even when adjusted for age and clinical and imaging severity of stroke.  
The neurophysiological feature with the highest odds to impact functional outcome was 
background activity asymmetry. Quantitative EEG studies support our observation. Brain 
symmetry index (BSI) obtained from continuous EEG records has been correlated with 
NIHSS score62 and lesion volume in MRI284. In an easier and more simply way, we showed 
that background activity asymmetry in raw analysis of a single and short duration EEG, is 
an independent predictor of an unfavourable stroke outcome. Cuspineda and collaborators, 
using quantitative EEG in 28 patients, showed that this is better than the Canadian 
Neurological Scale score in residual functional disability prediction89 and than mRS in the 
prediction of functional outcome89,285. In our study, the prognostic models including raw 
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EEG abnormalities correctly classified a higher percentage of patients than the model 
including exclusively the already known stroke outcome predictors. We believe that our 
results show that some early electroencephalographic characteristics are comparable to the 
clinical stroke severity and better than early CT infarct severity in the determination of post-
stroke functional outcome and reflects the concept that the EEG is a sensitive neurological 
diagnosis technique in the detection of acute cerebral ischaemia36 and a robust one in the 
functional assessment of the brain37.  
The association between EEG suppression and death deserves attention. Even though the 
low number of patients who died in the hospital does not allow a multivariate analysis, this 
neurophysiological characteristic has been associated with larger infarcts with a higher risk 
of becoming malignant64, and may draw attention to the need for an early start of medical 
and/or surgery therapy. In line with our results on focal cerebral ischaemia outcome, EEG 
suppression was recently ranked within malignant EEG patterns and as a poor prognostic 
predictor of post-cardiac arrest diffuse cerebral ischaemia286. Indeed, in our study, this 
electroencephalographic feature was an independent predictor of the vital outcome one year 
after stroke when controlled for age and stroke severity.  
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XII. PROJECT 9 
 
 
 
“But the electroencephalogram can detect changes in brain activity a thousand times faster 
than most biochemical indices, and they are not measures of cell metabolism but the 
summation of cortical postsynaptic potentials themselves,  
a distant eavesdrop on the brain's inner workings”  
Fernando Lopes da Silva
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QUANTITATIVE EEG AND FUNCTIONAL OUTCOME FOLLOWING ACUTE 
ANTERIOR ISCHAEMIC STROKE 
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Objective: To identify the most accurate quantitative electroencephalographic (qEEG) 
predictor(s) of unfavourable post-ischaemic stroke outcome, and its(their) discriminative 
capacity compared to already known demographic, clinical and imaging prognostic markers. 
Methods: Prospective cohort of 151 consecutive anterior circulation ischemic stroke 
patients followed for 12 months. EEG was recorded within 72 hours and at discharge or 7 
days post-stroke. QEEG (global band power, symmetry, affected/unaffected hemisphere and 
time changes) indices were calculated from mean Fast Fourier Transform and analysed as 
predictors of unfavourable outcome (mRS≥3), at discharge and 12 months poststroke, before 
and after adjustment for age, admission NIHSS and ASPECTS.  
Results: Higher delta, lower alpha and beta relative powers (RP) predicted outcome. Indices 
with higher discriminative capacity were delta-theta to alpha-beta ratio (DTABR) and alpha 
RP. Outcome models including either of these and other clinical/imaging stroke outcome 
predictors were superior to models without qEEG data. In models with qEEG indices, infarct 
size was not a significant outcome predictor. 
Conclusions: DTAABR and alpha RP are the best qEEG indices and superior to ASPECTS 
in post-stroke outcome prediction. They improve the discriminative capacity of already 
known clinical and imaging stroke outcome predictors, both at discharge and 12 months after 
stroke. 
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Significance:  qEEG indices are independent predictors of stroke outcome. 
 
KEY-WORDS 
ischaemic stroke, functional outcome, quantitative EEG, alpha relative power, delta-theta to 
alpha-beta ratio  
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1. INTRODUCTION 
  
Stroke is a leading cause of disability and mortality worldwide, and despite advances in 
disease prevention, acute treatment and rehabilitation, global stroke burden is expected to 
rise in the future287. Early post-stroke prognostication is essential both in the short-term (e.g. 
in guiding treatment strategies) and in the long-term (to aid in rehabilitation management, in 
order to improve recovery and minimize disability). Predictors of stroke disability and 
associated death consistently include age and clinical / imaging related stroke severity39–
42,288–291. However, despite the existence of demographic, clinical and imaging factors that 
can be associated with functional outcome, early prediction of short and long-term post-
stroke outcome is challenging since there is large interindividual variability43. Therefore, 
there is still a need to identify reliable, inexpensive biomarkers that can add prognostic 
information in these patients. Due to accumulating evidence regarding neuro-vascular 
uncoupling in acute ischemic stroke, neurophysiological biomarkers seem increasingly 
relevant for predicting outcome49. 
EEG is a non-invasive, inexpensive diagnostic method, with high temporal resolution, 
contributing to a rapid evaluation of instantaneous brain function. However, its visual 
interpretation requires technical experience, and may be subject to interrater variability. 
Hence, quantitative EEG (qEEG) techniques have emerged and have been proven 
informative in stroke prognostication292. These techniques have the advantage of providing 
objective, rater-independent information, which can be used in a variety of settings, 
including intensive care units. Previous studies have also shown they can be equal to or even 
more informative than visual EEG interpretation for detecting cerebral pathology58,60,293,294.  
In general, EEG parameters such as total power, relative delta and alpha power, ratios 
between slower and faster frequencies (such as the delta/alpha ratio [DAR] and the 
[delta+theta/alpha+beta] ratio [DTABR]), and brain symmetry indices (such as the Brain 
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Symmetry Index [BSI] and pair-derived BSI) have been strongly associated with stroke 
outcome for up to 12 months292. These measures have also been shown, in some studies, to 
be more reliable in prognostication than standard clinical evaluation295–299 or imaging 
biomarkers298–300.  
However, direct comparison of these measures and indices for predicting stroke outcome 
has yielded conflicting results292. Moreover, few previous studies attempted to control for 
independent known outcome factors, such as age at stroke onset, clinical severity at 
admission or infarct size.   
Therefore, the principal objectives of this study were: 1) to identify the most accurate qEEG 
measure(s) associated with outcome at discharge and 12 months after stroke, 2) to compare 
the discriminative capacity of outcome models based exclusively on already known 
demographic, clinical and imaging prognostic markers and including one qEEG variable, 
and 3) to compare qEEG and visual EEG analysis in stroke outcome prediction, in a large, 
well defined cohort of acute anterior circulation ischemic stroke patients. 
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2. METHODS  
 
2.1. Study design 
Study design has been previously described301. We performed a prospective longitudinal 
study of consecutive anterior circulation ischaemic stroke patients admitted to the Stroke 
Unit of the Neurology Department of a University Hospital, over a period of 24 months 
(from October 2011 to October 2013) and followed for 12 months. The Ethics Committee 
“Comissão de Ética para a Saúde” of our hospital approved the study. All subjects or their 
next of kin gave written informed consent for participation. All included patients had to be 
previously independent (modified Rankin Scale [mRS] ≤1), have a National Institutes of 
Health Stroke Scale Score (NIHSS) ≥470 upon admission to the emergency department, have 
an acute ischaemic brain lesion (CT scan or MRI) in the internal carotid artery territory and 
no previous history of epileptic seizures nor traumatic head injury requiring hospital 
admission. 
 
2.2. Clinical Assessment 
All patients received standardized clinical and diagnostic assessment, during admission and 
after discharge. An investigator blinded to the neurophysiological evaluation conducted a 
phone interview at six months and a clinical appointment 12 months after stroke to access 
the occurrence of epileptic seizures and functional outcome. Clinical stroke severity was 
assessed by NIHSS at admission. The functional outcome at discharge and at 12 months was 
assessed by the mRS scale236.  
 
2.3. Neuroimaging interpretation 
A senior neuroradiologist, (CM or CC) blinded for clinical and electroencephalographic 
findings analysed the neuroimaging studies. Doubts were decided by consensus. In patients 
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with middle cerebral artery stroke, infarct size was quantified by the Alberta Stroke Program 
Early Computed Tomography Score (ASPECTS)42 in an acute brain CT (computed 
tomography) scan performed in the first 24 hours after stroke.  
 
2.4. Neurophysiological evaluation 
Patients underwent a neurophysiological evaluation protocol that included a 64-channel 
video-EEG with a maximum duration of 60 minutes in the first 72 hours after stroke (first 
EEG). A similar EEG was also collected at discharge or on the 7th day post-stroke (second 
EEG). The neurophysiological protocol was previously described302. The record included an 
eyes-closed, wake resting condition and eyes-open, hyperventilation and photic stimulation 
activation manoeuvers. Raw EEG review was performed by a certified clinical 
neurophysiologist (CB) using international criteria and terminology212,245,303, blinded for 
clinical and imaging findings. All doubts were decided by consensus with another clinical 
neurophysiologist (ARP).  
 
2.4.1. EEG acquisition 
The EEG was recorded in a Nihon-Kohden device with a sample frequency of 1000Hz. 
Consecutive samples of EEG, acquired in similar technical conditions (eyes closed, resting 
condition outside hyperventilation, photic stimulation or sleep) and with the best possible 
technical quality, were selected forming an EEG segment of 1-10 minutes.   
 
2.4.2. EEG Processing 
EEG segments (high cutoff filter 70 Hz; low cutoff filter 0.5 Hz; notch filter 50 Hz, average 
montage) were exported for FTT analysis in BESA software (BESA Research 6.0, June 
2013, BESA GmbH, Graefelting, Germany). In BESA, visual and automatic rejection of 
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artefacts was done. When present, blinking artefacts were also removed by principal 
component analysis. The EEG was then segmented into 2.05 seconds mini-epochs and FFT 
analysis was performed for each of these segments. Mean Fast Fourier Transform (FFT) of 
all the 2.05 seconds mini-epochs of the selected EEG segment was computed in the 
following frequency bands: Delta – 1-4 Hz; Theta – 4-8 Hz; Alfa – 8-12 Hz; Beta – 12-30 
Hz. Relative (RP) and absolute power (AP) in these frequency bands was obtained. 
 
2.4.3. Computed Indices (qEEG predictors) 
Several qEEG indices were calculated from both hemispheres, the affected and unaffected 
hemisphere, from the first and second EEG recordings, and in the frequency bands described 
in section 2.4.2. Details for qEEG index calculation are presented in Appendix P.  
Computed indices were: global relative power indices including delta, theta, alpha and beta 
relative power, as well as ratios between slow and fast frequencies (slow (delta-theta) and 
fast (alfa-beta) frequencies ratio (DTABR), delta and alpha ratio (DAR)). Furthermore, 
symmetry indices included the brain symmetry index (BSI) and the ratio between affected 
and unaffected hemisphere RP. We also calculated affected and unaffected hemisphere 
indices. Lastly, we computed time changes indices, reflecting the dynamic changes between 
the first (0-72h) and second EEG (discharge or 7th day post-stroke): Acute Symmetry Change 
Index (ASCI), Acute Delta, Alpha, Theta and Beta Change Indices, and Acute DTABR 
Change Index. For simplicity purposes, only results concerning the global relative power 
indices are reported in the main document. Results from other indices can be found in 
Appendix B. EEG indices were, whenever necessary, transformed to their natural logarithm 
or square root in order to have normal distribution and homogeneity of variances, as required 
for logistic regression models.  
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2.5. Outcomes 
The outcomes in this study were an unfavourable functional outcome (mRS≥3) at discharge 
and 12 months after stroke.  
 
2.6. Statistical Analysis 
EEG spectral indices were evaluated using descriptive statistics (mean and standard 
deviation) in patients with unfavourable and favourable outcome at discharge (D1 EEG 
indices) and 12 months (first EEG, second EEG and dynamic EEG evolution indices) post-
stroke. Bivariate analyses were performed between groups using t-test after confirming their 
normal distribution (Shapiro Wilk and Kolmogorov Smirnov tests) or Mann-Whitney test in 
non-normal variables. Prognostic models were constructed using logistic regression. 
Homogeneity of variances was confirmed with the Levene test, and model calibration was 
analysed by Hosmer-Lemeshow. QEEG variables with a significant association in the 
bivariate analysis were adjusted for known functional outcome predictors of stroke 39–42, 
namely age, clinical stroke severity (admission NIHSS) and imaging infarct size 
(ASPECTS). All logistic models were constructed with only one qEEG variable plus these 
previously known outcome predictors, in order to avoid the multicollinearity between qEEG 
variables. Logistic models were performed with the neurophysiological variables in their 
natural logarithm (Ln) or square root transformation to comply with the model requisites.  
Additionally, to assess the overall internal validation of each model, a 10-fold cross-
validation technique was implemented. After dividing the dataset into 10 random folds, we 
used N-1 (9) folds to calculate the model coefficients, which were then applied to the 
remaining fold to yield fitted values for these observations. The process was repeated 10 
times using different folds of the data. Finally, we used the fitted values to obtain a cross-
validated area under the ROC curve (cvAUC) and corresponding 95% confidence intervals.  
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Using DeLong tests, the outcome prediction model including the qEEG index with highest 
cvAUCs was compared with the model including exclusively known stroke outcome 
predictors, as well as with models using known predictors and visual EEG analysis variables, 
namely background activity asymmetry. EEG background asymmetry was chosen in 
accordance with a previous report where it was shown that this was the variable most 
strongly associated with anterior circulation ischaemic stroke outcome274. Cut-off values 
were calculated for various sensitivities and specificities. The significance level was α≤0.05. 
Statistical analysis was performed using SPSS program version 24 for Mac, and STATA 
14.2 for Mac (Statacorp). 
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3. RESULTS  
 
3.1. Study Population 
One-hundred-and-fifty-one patients (112 men and 39 women) were included, with a mean 
age of 67.4 (SD 11.9) years. During the study period, 23 patients died (seven during 
admission before day 7). One patient (0.66%) was lost for clinical follow-up at 12 months. 
All patients had at least one acute CT scan and D1 EEG. In 8 patients, D7 EEG was not 
performed. One patient had bilateral middle cerebral artery stroke and was not included. 
Study flowchart and further details of the sample studied have been previously described304. 
 
3.2. Functional Outcome at discharge and at 12 months 
3.2.1. Bivariate analyses 
All patients were included in the analysis. The average duration of the EEG segments used 
for FFT calculation, after artifact removal was 248 (SD 222) seconds (median 213 seconds). 
Tables 24 and 25 show the main qEEG indices calculated for patients who were alive and 
independent at discharge and at 12 months, respectively, as compared to patients who died 
or were dependent at these time points. Most qEEG indices show significant differences 
between these two groups. Overall, dependence or death at discharge is associated with 
EEGs with higher slow frequency (delta) and lower high frequency (alpha and beta) powers, 
both in overall EEG power and in each hemisphere separately (affected and unaffected). 
Further results from the bivariate analysis are found in Appendix Q
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3.2.2. Multivariate analyses 
On multivariate analysis, after controlling for admission NIHSS, age and ASPECTS, most 
of the neurophysiological variables remained as independent predictors of outcome 
(Appendix Q).  
  
After 10-fold cross-validation, the variables rendering models with highest cvAUC were 
DTABR, and alpha RP. Therefore, models including DTABR or alpha RP were chosen for 
ROC comparison with both the known functional outcome predictor model and the model 
with visual EEG analysis of background asymmetry (Figure 13). While DTABR is 
associated with the highest cvAUC both at discharge and 12 months, alpha RP was chosen 
because it is easy to calculate and is less prone to interference from artifacts than qEEG 
indices including lower frequencies.  
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Table 26, displays the comparison between stroke outcome prediction models’ 
characteristics at discharge and 12 months poststroke. For discharge outcome, compared 
with the known functional outcome predictors model (cvAUC 0.752, 95% CI 0.671-0.834), 
both models including DTABR (cvAUC 0.827, 95% CI 0.758 - 0.895) or alpha RP (cvAUC 
0.814, 95% CI 0.742 – 0.885) preform significantly better (DeLong tests: p=0.009 and 
p=0.023, respectively). The discriminative capacity of models including DTABR or alpha 
RP was similar (DeLong tests p=0.3525) 
Analogously, for 12-month outcome, compared with the model with known functional 
outcome predictors (cvAUC 0.794, 95% CI 0.722 - 0.865), both models including DTABR 
(cvAUC 0.859, 95% CI 0.800 - 0.919) and alpha RP (cvAUC 0.852, 95% CI 0.790 – 0.913) 
had significantly higher discriminative capacity (DeLong tests: p=0.009 and p=0.015, 
respectively). As for discharge, the predictive power of models including DTABR or alpha 
RP was similar (DeLong tests p=0.5482) 
Moreover, for both discharge and 12-month unfavourable outcome, NIHSS remains as the 
only independent predictor together with any of the two qEEG indices. 
 
Finally, visual analysis of EEG background asymmetry was also an independent prognostic 
marker of poor functional outcome at discharge (cvAUC 0.831, 95% CI 0.762 - 0.900) and 
12 months (cvAUC 0.890, 95% CI 0.837 - 0.943) and performed significantly better than 
the known functional outcome predictors model alone (DeLong test: 0.010 for discharge and 
0.001 for 12 months). The discriminative capacity of the model incorporating visual EEG 
analysis was not significantly different compared with models with either qEEG index 
(DTABR - DeLong test: 0.767 for discharge and 0.185 for 12 months; alpha RP - DeLong 
test: 0.190 for discharge and 0.100 for 12 months). 
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3.2.2.1 Cutoff values for alpha relative power in the first EEG  
Table 27 shows the sensitivity and specificity values for alpha RP obtained from the first 
EEG, for predicting unfavourable outcome. This neurophysiological variable, in isolation, 
predicts unfavourable outcome with an area under the ROC curve of 0.750 (95% CI 0.669-
0.832) at discharge and 0.769 (95%CI 0.695-0.844) at 12 months. For both discharge and 
12-month outcomes, an alpha RP lower than 10% on an EEG performed in the first 72h post-
stroke shows high specificity to predict unfavourable outcome (87-89%), despite low 
sensitivity (37-46%). Alpha RP below 20% have higher sensitivity to predict patients with 
unfavourable outcome (86 and 90%, respectively) albeit low specificity. 
 
 
Table 27. Sensitivity and specificity of different Ln D1 alpha RP values for predicting 
unfavourable outcome. 
Legend to table 27: Ln - natural logarithm; RP - relative power 
  
Death or functional dependency at discharge (mRS≥3) 
1st EEG (0 – 72 hours) Sensitivity Specificity 
Ln alpha RP ≤ -2.3 (alpha RP ≤ 10%) 37-46% 87-89% 
Ln alpha RP ≤ -1.9  (alpha RP ≤ 15%) 66-70% 67-71% 
Ln alpha RP ≤ - 1.6  (alpha RP ≤ 20%) 86% 52-54% 
Death or functional dependency at 12-month post-stroke (mRS≥3) 
Ln alpha RP ≤ -2.3 (alpha RP≤10%) 46-53% 86-89% 
Ln alpha RP ≤ -1.9 (alpha RP ≤15%) 71-77% 53-66% 
Ln alpha RP ≤ -1.6 (alpha RP ≤20%) 90% 44-45% 
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4. DISCUSSION  
 
To the best of our knowledge, this is the largest study evaluating quantitative EEG 
parameters for prediction of post-stroke functional outcome. In a consecutively selected, 
well defined, acute anterior circulation ischaemic stroke cohort, the predictive accuracy of 
qEEG measures was examined while controlling for clinical and imaging variables, which 
are available and easily determined in clinical practice in a stroke unit.  
In this study, comparing absolute and relative frequency band power indices, symmetry 
measures and dynamic time changes, we have shown that most qEEG indices previously 
reported in the literature are independent prognostic markers for poor functional outcome. 
Additionally, DTABR and alpha RP are some of the most accurate neurophysiological 
markers for outcome prediction, both at discharge and 12 months after stroke.  Lower alpha 
RP, higher DTABR and higher NIHSS scores were sufficient to predict poor functional 
outcome, rendering age and ASPECTs scores non-significant in our models. Furthermore, 
these qEEG indices seem to provide additional prognostic information to already known 
clinical and imaging-related predictors, and with similar performance to previously reported 
visual EEG analysis of background asymmetry. Finally, we report that alpha RP below 10% 
is highly specific for a poor functional outcome at both timelines. 
Negative correlation between alpha activity and stroke outcome is in accordance with several 
previous studies285,293,296,297,305,306. Alpha frequencies are thought to derive from cortical 
layers IV and V, whereas slower delta or theta frequencies are generated by the thalamus 
and cortical layers II-VI307. Therefore, it is not surprising that alpha activity disturbances 
reflect direct cortical injury308. Furthermore, the change in faster frequencies, such as alpha, 
is thought to precede the increase in slower frequencies, as shown in patients undergoing 
carotid endarterectomy with continuous EEG and cerebral blood flow measurements66. In 
47 patients with unilateral cerebral infarction, relative alpha frequency positively correlated 
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with regional cerebral blood flow and oxygen metabolism, as measured by positron emission 
tomography52. The same variable has been positively correlated with cognitive outcome (in 
a functional assessment scale), as well as with improvement in post-stroke aphasia305,306. 
This assessment might even be extended to critical care ventilated patients, where a decrease 
in faster frequency activity has been associated with a drop in cerebral perfusion pressure309. 
In patients presenting with subarachnoid haemorrhage, relative alpha power was able to 
predict the development of delayed cerebral ischaemia310. Moreover, alpha activity may 
rapidly increase after successful reperfusion due to rt-PA administration in acute stroke311. 
In a previous study we have shown that, in visual EEG analysis, the variables most strongly 
associated with outcome were background activity slowing and background activity 
asymmetry304. On visual analysis, background slowing is usually related to a decrease in 
alpha frequency or absent alpha activity. Therefore, the qEEG findings are in accordance 
with the visual analysis. 
Other neurophysiological variables (DTABR, DAR, delta RP), also strongly and 
independently associated with outcome, incorporate lower frequencies, such as delta power. 
Delta oscillations usually emerge and have higher voltage in the core lesion of ischaemic 
stroke patients60. They may be more predominant in the affected hemisphere, but their 
presence in the unaffected side, as measured by EEG and magnetoencephalography, has 
been described as an important prognostic factor296,312,313. In our sample, the DTABR was 
the qEEG index that was associated with higher AUC to predict short and long–term poor 
prognosis after stroke. DTABR correlates negatively with cerebral perfusion accessed by 
Position Emission Tomography in stroke patients52 and has been shown to be very sensitive 
and specific for discriminating between cerebral ischemia and controls314 and to be an 
independent prognostic factor for short-term disability after lacunar stroke315. Sub-acute 
DTABR also predicted 6 months-disability in an unselected population of stroke patients299. 
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Our data reinforces the importance of this qEEG parameter as a strong predictor for short 
and long term functional stroke outcome, when obtained as early as the first 72h after stroke.  
To the best of our knowledge, no previous study directly compared the accuracy of alpha RP 
and DTABR as functional stroke outcome predictors. Our data suggests that they are not 
significantly different. In our study, we focused on reporting the predictive value of alpha 
RP for several reasons. Firstly, our data has shown that models with DTABR and alpha RP 
have similar discriminative capacities. DTABR, besides requiring a more specific 
computation, incorporates the delta frequency band that is more frequently interfered by 
artifacts such as blinking, slow shifts or sudation. In the clinical setting, where continuous 
EEG signal might not be submitted to the strict scrutiny for artifacts, as in this research, its 
value may not be comparable. Overall, alpha RP seems a preferable neurophysiological 
marker as it analyses the brain oscillatory activity with higher signal to noise ratio on scalp 
EEG. Furthermore, some EEG patterns, such as Rapid Attenuation Without Delta, may not 
be detected by analysing delta frequencies, and may be present in large occlusive infarcts 
with poor outcome316. 
 
In other studies, qEEG brain symmetry parameters have been associated with functional 
outcome62,284,298,299,317. In our study, however, qEEG symmetry indices were not significant 
on multivariate analysis. We used an average montage before performing spectral analysis, 
which may reduce asymmetries between oscillatory brain activities.  
We have also shown that the discriminative capacity of EEG characteristics obtained from 
visual EEG analysis is similar to qEEG indices. This is an important finding, as visual EEG 
analysis is cumbersome and dependent on trained neurophysiologists. In contrast, qEEG 
indices can be readily and easily available in a stroke unit and can be interpreted by all health 
personnel. 
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One important finding in our study is the weaker effect of CT imaging lesion size 
(ASPECTS), obtained from the first CT scan after stroke, when compared to DTABR and 
alpha RP in outcome prediction. To date, no previous study has compared ASPECTS with 
qEEG parameters in outcome prediction. Although neuroimaging with CT adds invaluable 
diagnostic information for stroke patients, this technique has several limitations regarding 
lesion volume determination especially in the acute/hyperacute phase279. During this period, 
qEEG data may be more reliable and easy to monitor, especially in intensive care settings. 
Several limitations of this work are common to other qEEG studies. Effective identification 
and exclusion of EEG artifacts may be a challenge, such as muscle artifacts interfering with 
faster activities, or eye movements with delta activity. In our study, besides using an 
automatic method for artifact removal, an additional visual rejection was done. This may 
render the results less applicable to qEEG measures in intensive care units, when depending 
solely upon automatic artifact removal. These results were also obtained from 62-channel 
EEG that are not routine for EEG monitoring. Further studies are necessary to validate these 
data.   
 
In conclusion, in a large, well defined cohort of acute anterior ischaemic stroke patients, we 
found that the alpha RP or DTABR are qEEG variables that contribute significantly for post-
stroke outcome prediction, at discharge and 12 months after stroke, when controlled for 
demographic, clinical and imaging variables.  
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XIII. SUMMARY of PROJECTS MAIN FINDINGS  
 
 
 
“I am among those who think that science has great beauty” 
Marie Curie 
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PROJECT 1 
Question 1. What is the frequency of electroencephalographic abnormalities in patients with 
possible TIA and to which clinical/imaging characteristics are they associated? 
- Focal slow wave activity was the commonest EEG abnormality in patients with possible 
TIA, being found in 65% of early exams and was independently associated with age.  
- 7.5% of patients with possible TIA had epileptiform activity in the early EEG. Epileptiform 
activity was significantly associated with consciousness disturbance.  
 
Question 2. What is the percentage of patients with possible TIA having a final diagnosis of 
epileptic seizure or definitive TIA and which electroencephalographic characteristics 
differentiate these diagnoses?   
- 16.3% of patients with possible TIA had a final diagnosis of an epileptic seizure and 13.3% 
of definitive TIA.  
- The majority (53.8%) of patients with a final diagnosis of epileptic seizures did not have 
epileptiform activity in the early EEG. However, all patients with epileptiform activity had 
the diagnosis of an epileptic seizure during the follow-up study. 
- In patients with epileptic seizures, focal slow wave activity in the early EEG was more 
common than epileptiform activity. However, focal slow wave activity in the early EEG did 
not distinguished between TIA and seizure diagnosis. 
- Focal slow wave activity in the EEG one month after the clinical episode was more likely 
in patients with epileptic seizures than with a TIA (91.7% vs. 45.4%). 
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PROJECT 2 
Question 3. What is the frequency of post-stroke EEG epileptiform activity, both ictal and 
interictal in observational studies? 
- The pooled frequency of post-stroke ictal and interictal epileptiform activity was 7% 
(95%CI 3%-12%) and 8% (95%CI 4%-13%), respectively.  
- The frequency of ictal EEG epileptiform activity did not change with continuous record or 
clinical setting, while the frequency of interictal EEG epileptiform activity increased with 
continuous recordings.  
- Only 2 studies (11.7%) attained the maximum quality score. 
- No study exclusively enrolled patients with ischaemic stroke. 
- The available literature does not answer how the frequency of clinical seizures is related to 
the frequency of electrographic seizures.  
 
PROJECT 3 
Question 4. Is the frequency of electrotrographic and clinical seizures different in stroke 
patients admitted to a Stroke Unit?  
- In the first 7 days after an anterior circulation stroke, more than one-fifth of patients 
(22.7%) with seizures had exclusively electrographic seizures.  
 
PROJECT 4 
Question 5. What is the frequency of epilepsia partialis continua as a remote stroke 
complication?  
- The frequency of epilepsia partialis continua as a remote complication of anterior 
circulation ischaemic stroke is very low (1.7%). 
 
PROJECT 5 (clinical vignette) 
Question 6. Are involuntary movements observed during intravenous alteplase perfusion of 
cortical origin?  
- During intravenous alteplase perfusion, a patient with an acute middle cerebral artery 
ischaemic stroke developed subtle involuntary movements of the paretic upper limb with 
cortical origin, as documented neurophysiologically by back-average analysis.  
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PROJECT 6 
Question 7. Is the frequency of seizures and electroencephalographic abnormalities different 
between stroke patients treated and non-treated with rtPA?  
- Patients treated with intravenous alteplase had the same frequency of epileptic 
manifestations (either clinical or electroencephalographic) as non-treated patients.  
- Functional outcome of patients with post-stroke seizures was also not different between 
groups.  
 
PROJECT 7 
Question 8. Are early electroencephalographic abnormalities independent predictors of post-
stroke epilepsy? 
- Early EEG abnormalities (background activity asymmetry and interictal epileptiform 
activity) could predict epilepsy in the first year after stroke, independently from age and 
clinical and imaging infarct severity. 
 
Question 9. Which are the predictors of EEG epileptiform activity in acute ischaemic stroke?  
- An early EEG with periodic discharges and a CT scan with islands of preserved cortex 
within the infarct, independently predicted the occurrence of EEG epileptiform activity 
during hospitalization for acute stroke. 
 
PROJECT 8 
Question 10. Are seizures and early electroencephalographic abnormalities independent 
predictors of stroke functional and vital outcome? 
- Unprovoked seizures (post-stroke epilepsy) were independent predictors of unfavourable 
outcome and acute symptomatic seizures of vital outcome, 1 year after an anterior circulation 
ischaemic stroke.  
- Early raw EEG abnormalities (background activity slowing and asymmetry) were 
independent predictors of an anterior circulation ischaemic stroke functional outcome at 
discharge and 1 year after stroke. Early EEG asymmetry had the highest odds of impacting 
stroke functional outcome.  
- Early EEG suppression was an independent predictor of anterior circulation ischaemic 
stroke vital outcome.  
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PROJECT 9 
Question 11. Are qEEG abnormalities independent predictors of stroke functional outcome? 
- EEG spectral powers in the alpha, beta and delta bands are unfavourable outcome 
predictors after acute anterior ischaemic stroke. 
- Delta-theta to alpha-beta ratio (DTABR) and alpha relative power (RP) obtained within the 
first 72h post-stroke are good qEEG predictors of post-stroke short and long-term outcome. 
- Outcome models that incorporate DTABR or alpha RP are better than models based 
exclusively on clinical and imaging-related ischaemic stroke severity at hospital admission.  
 
Question 12. Is qEEG superior to visual analysis in the prediction of stroke functional 
outcome? 
Outcome prediction models including variables extracted from visual and quantitative 
analysis of the EEG showed similar characteristics.  
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XIV. DISCUSSION  
 
 
 
“What we know is a drop, what we don´t know is an ocean” 
Isaac Newton
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1. GENERAL DISCUSSION  
 
In this work, different electroencephalography technics were used in the clinical workup of 
patients with possible and definite cerebrovascular disease as tools for the differential 
diagnosis and for brain functional assessment, concerning not only epileptic seizures and 
epileptiform activity detection, but also the identification of independent post-stroke 
epilepsy and stroke (functional and vital) outcome predictors.  
A short duration video-EEG protocol supported epileptic seizure diagnosis in 7.5% of 
patients with possible TIA and identified 22.7% of acute symptomatic seizures in patients 
with an anterior circulation ischaemic stroke that were exclusively electrographic, and 
therefore could not otherwise be recognised. It also allowed the conclusion that seizure 
frequency is not significantly different between intravenous alteplase treated and non-treated 
patients. The frequency of electrographic seizures (4.6%) and interictal epileptiform activity 
(11.9%) found in our acute stroke patients cohort was in line with the pool frequency 
determined, also in this thesis, by systematic review and meta-analysis technics. 
Furthermore, we were able to overcome some identified limitations of the existing literature 
by prospectively studying an exclusively ischaemic stroke cohort consecutively submitted 
to clinical and EEG assessments. This methodology helped to answer how the frequency of 
clinical seizures is related to the frequency of electrographic seizures, drawing attention to 
their recognition in a Stroke Unit, the current standard of care for stroke patients.  
EEG back-average analysis was also used to document the cortical origin of involuntary 
movements during intravenous alteplase perfusion in a patient with acute stroke and also 
epilepsia partialis continua as a chronic anterior circulation stroke complication in 1.7% of 
patients. These results clearly showed the importance of neurophysiology as an adjunctive 
tool for attentive clinical observation during stroke care. 
Furthermore, this work established early post-stroke visual EEG features as independent 
predictors (adjusted for age and clinical/imaging stroke severity) of epilepsy one year after 
stroke. Also, an independent association between post-stroke epilepsy and stroke 
unfavourable outcome was found, setting epilepsy diagnosis as one aspect of clinical 
importance in stroke patient care and the ultimate role of neurophysiology in its prediction 
during Stroke Unit hospitalization.  
Additionally, early post-stroke visual EEG features and qEEG parameters (from time and 
frequency domains EEG analysis, respectively) were also recognized as independent 
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predictors of functional outcome at hospital discharge and at 12 months after stroke. In fact, 
they were better than a brain CT Scan performed at the emergency department in outcome 
prediction, adding a further role to the EEG performed in a Stroke Unit. 
 
This research shows the value of EEG in the current paradigm of stroke patient standard care 
and, as postulated, it expands knowledge both about the role of the EEG as a complementary 
neurophysiological tool in Neurology and about different aspects of the diagnosis and 
outcome of Cerebrovascular Diseases and Epilepsy.  
 
1.1. Integrated discussion of research projects  
 
This thesis work started by attempting to answer a clinical question that frequently emerged 
in our EEG laboratory: is the EEG useful for the diagnosis of possible TIA? In 2012, the 
majority of EEG requests aiming to help the differential diagnosis of transient neurological 
symptoms were from patients attending the TIA clinic every weekday. In Project 1318, we 
determined the frequency of EEG interictal epileptiform activity in patients with possible 
TIA, setting out the EEG utility as a differential diagnose tool in a TIA outpatient clinic. We 
found that in the majority of possible TIA cases (92.5%) an early EEG after the clinical event 
does not distinguish between a TIA and an epileptic seizure and that it supports the clinical 
diagnosis of an epileptic seizure only in 46.2% of the cases. Nevertheless, we found clinical 
characteristics of possible TIA significantly associated with the presence of EEG interictal 
epileptiform activity, namely a transient neurological syndrome with consciousness 
disturbance. A possible different time evolution of focal slow wave activity between a TIA 
and an epileptic seizure was also postulated, although with a low statistical power. This 
project was an exploratory study which emerged from a frequent and important clinical 
problem, the difficulty of the differential diagnosis of possible TIA, and was prospectively 
performed in a clinical setting. These are distinctive methodological differences from De 
Reuck & Van Maele study50 which looked for EEG findings only in TIA and inhibitory 
seizure elderly patients. Our study clearly reflects the differential diagnosis difficulty of 
possible TIA, even when this diagnosis attempt is made by two different expertize 
neurologists, and the need for other complementary strategies supporting the classification 
of these undefined events17. Although, theoretically, an EEG during the clinical event could 
be more informative, the transient nature of these events makes the feasibility of this 
procedure in clinical practice very unlikely. Other increasing EEG sensibility procedures for 
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detecting epileptiform activity such as acute and brief sleep deprivation can eventually be 
explored in the clinical practice in the future3,8. Our data, although modest, provide a clear 
message to practising clinicians and increase clinical awareness and scientific interest for 
this common and clinically significant, although poorly explored, topic in daily Neurology 
practice. 
 
We moved forward exploring the frequency of epileptiform activity in established 
cerebrovascular disease. Our systematic review and meta-analysis of observational studies 
(Project 2319) documented that the frequency of ictal and interictal epileptiform activity in 
the EEG after stroke (7%, 95%CI 3%-12% and 8%, 95%CI 4%-13%, respectively) was 
comparable with previous frequency analysis of clinical seizures320. However, these values 
might have been underestimated due to methodological limitations previously discussed. 
Furthermore, only 12% of the observational studies reporting the frequency of post-stroke 
epileptiform activity had high quality standard, clearly showing the need for higher quality 
studies regarding this subject. Different caveats to the interpretation of clinical data related 
to post-stroke epileptiform manifestations27 became evident and increased our motivation 
for the next studies. Examples of encountered limitations include the accuracy of stroke 
diagnosis, the prevalence of different types of stroke in a given study population, the 
different epilepsy and seizure definition in accordance to their time of occurrence after 
stroke, the follow-up duration time, the sample size, the heterogeneity in study designs, the 
availability and analysis of CT and MRI scans for diagnosis and follow-up, the accuracy 
regarding the location and type of primary lesion, the previous diagnosis of epileptic seizures 
and epilepsy and the availability, the type, the time after stroke, and the duration of the EEG 
record for detection of epileptiform activity. In fact, the data in large post-stroke seizures 
studies derives mainly from investigations done during routine clinical practice27. EEG is 
usually performed when the nature of the post-stroke paroxysmal event is uncertain or if 
consciousness impairment is not fully explained by the structural brain lesion. Moreover, 
when analysing the frequency of electrographic seizures and interictal epileptiform activity 
after stroke it was not possible to include studies enrolling exclusively participants with 
ischaemic stroke. We realized that although it is the most frequent stroke type, it was a poorly 
explored clinical model in this context. Our Project 2 strongly argued for the need for better 
quality prospective studies to understand how the frequency of clinical seizures relates to the 
frequency of electrographic ones and to evaluate if the presence of interictal epileptiform 
activity could be an independent predictor of clinical seizures. Furthermore, we did not find 
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high quality evidence to strongly recommend the use of continuous versus spot EEG in 
patients with cerebrovascular disorders not admitted to an intensive care unit.  
 
The limitations of the studies recognised in the systematic review and meta-analysis 
reinforced the value of our study design to evaluate the potential role of EEG in stroke 
patients concerning both the detection of interictal epileptiform activity and epileptic 
seizures after stroke. In Project 3270, we found that in the first 7 days after stroke more than 
one-fifth of patients with seizures had exclusively electrographic seizures and more than one 
fourth of acute symptomatic seizure patients having a vascular epilepsy diagnosis in 1-year 
time period would not have been identified without the EEG protocol that was used. Our 
results reinforce the concept that the exclusively clinical definition of a seizure146 can be 
insufficient both in clinical and research settings321.  It is important to say that our study was 
performed in a Stroke Unit, where (it is recommended that all stroke patients should be 
treated72) patients receive organised inpatient care from a devoted and specialised 
multidisciplinary team. So, even with the best clinical care available, an important fraction 
of post-stroke seizures was not diagnosed, further increasing the value of EEG in this 
context. Additionally, the meaning of electroencephalographic evaluation was reinforced in 
the follow up of our cohort (Project 4322), as one year after the cerebrovascular event, 1.7% 
of patients had clinical and neurophysiological criteria for the diagnosis of epilepsia partialis 
continua. The place of the EEG in the diagnosis of the clinical presentation subtlety of 
cortical hypersynchronisation manifestations was also shown in our clinical vignette 
(Project 533). During intravenous alteplase perfusion, one of our cohort patients developed 
subtle involuntary movements of the paretic upper limb, with proven cortical origin by the 
neurophysiological evaluation, suggesting the existence of a hypersynchronisation cortical 
area. These results (of projects 3, 4 and 5) show the importance of EEG in the diagnosis of 
epileptic manifestations, since clinical evaluation cannot always make the diagnosis by itself. 
One could argue that this inference is not a new concept in the epileptology community. 
However, this statement has been proven only for critically ill stroke patients, more 
frequently admitted to an intensive care unit and with clinical indication for a 
neurophysiological recording75, mainly given the suspicion (or during treatment) of non-
convulsive status epilepticus. The originality of our work was to prospectively ascertain the 
veracity of this assumption in a prospective and consecutive ischaemic stroke cohort 
admitted to a Stroke Unit of a Neurology Department. Although, in our study, the percentage 
of patients with exclusively electrographic seizures is apparently different from the study of 
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Claassen et al.75 (22.7% vs. 92%), these data cannot be compared due to a different 
methodological workup, including study design, population characteristics and the 
neurophysiological method performed in each study. Furthermore, another innovative aspect 
was to document the importance of the EEG for the recognition of epileptic manifestations 
not only in the acute stroke phase but also 1 year after stroke with EEG back-average analysis 
allowing the recognition of epilepsia partialis continua patients. Our studies increase 
awareness of and scientific interest in the EEG as a tool for the identification of epileptic 
manifestations in stroke patients. In addition, even if some of these manifestations were rare, 
the global prevalence of cerebrovascular diseases make these events important not only in 
terms of frequency but also because different epileptiform manifestations (such as epileptic 
seizures and status epilepticus) have been associated with an unfavourable prognosis after 
stroke 44,45,79–82.  
 
Previous studies28,29 and our clinical vignette (Project 533) prompt the hypothesis that 
intravenous alteplase treatment could be associated with a different frequency of epileptic 
manifestations after stroke. This hypothesis was also tested in this thesis (Project 6271). 
Intravenous alteplase treatment is recommended for acute stroke72 and the hypothesis that 
this treatment could affect acute symptomatic seizures or post-stroke epilepsy frequency was 
thought to have a great clinical impact. However, in our study, intravenous alteplase was not 
associated with an increased risk of clinical seizures or electroencephalographic epileptiform 
activity. The fact that (alteplase) treated and non-treated patients had a similar clinical and 
imaging severity of the infarct (two important risk factors for post-stroke seizures140,141) 
might explain why post-stroke seizures during or after hospitalization were not significantly 
different between the two groups of patients and justify why our results are more reassuring 
than previous ones28,29. Moreover, the occurrence of seizures in intravenous alteplase treated 
patients has been associated with different stroke functional outcomes28,32,34,35,172. This 
project also showed that the percentage of patients with seizures and an unfavourable 
outcome after 12 months was similar between treatment groups. Likewise, this was an 
important observation, also driving our subsequent work on the effect of seizures in stroke 
outcome (Project 8274).  
In this study, another interesting finding was that the diffuse slowing of background activity 
in the 1st EEG was significantly more frequent in treated patients. However, this difference 
was no longer significant at discharge nor 12 months after stroke. This result can be partially 
explained by the fact that treated patients had more severe strokes at admission than those 
The EEG in Acute Ischaemic Cerebrovascular Disease 
240 
 
non-treated. However, this should not be the only factor because alteplase treatment took 
place at the emergency department and the first EEG was performed the next day at Stroke 
Unit, when NIHSS score was not significantly different between treated and non-treated 
patients. Therefore, we showed that diffuse slowing (an EEG sign of cerebral dysfunction) 
recorded in the first 72 hours after stroke was temporary and reversible, and as such, a 
possible neurophysiological correlate of the already described "stunned brain" 
syndrome166,167.  
 
Pitkänen and Engel323 defined a biomarker for epilepsy as “an objectively measurable 
characteristic of a biological process that reliably identifies the development, presence, 
severity, progression, or localization of an epileptogenic abnormality”. Because an EEG 
identifies biomarkers of epileptogenesis and ictogenesis4,5,324, the role of an early EEG in the 
prediction of post-stroke epilepsy and in the recognition of patients who will have 
epileptiform activity in the EEG in the Stroke Unit (as described in Project 3), seemed a very 
pertinent clinical question. In Project 7325, neurophysiological independent risk factors for 
epilepsy in the year after an anterior circulation ischaemic stroke were added to previously 
known ones (namely clinical and imaging stroke severity140,141), helping to identify patients 
with an increased risk for post-stroke epilepsy. One of these risk factors was the presence, 
in an early post-stroke EEG, of interictal epileptiform activity. Notwithstanding, one 
question should be asked: why do patients with an acute stroke have interictal epileptiform 
activity? Does it mean that epileptogenesis has already started? Epileptogenesis refers to the 
development and extension of tissue capable of generating spontaneous seizures, resulting 
in the development of an epileptic disorder or progression after the disorder is established326. 
In our study patients with a previous stroke plus a mRS >1 and also with previous seizures 
were excluded. However, the hypothesis that previous lesions, although minor or 
asymptomatic, may have a relevant role in the epileptogenic process (starting years before), 
cannot be excluded in our study. In fact, different levels of evidence support this hypothesis. 
First, earlier studies230,327 (and also Project 7) showed that the occurrence of a previous acute 
symptomatic seizure is a risk factor for an unprovoked seizure, probably reflecting that there 
is an individual predisposition for seizures. Indeed, not only injury severity, location and 
type of pathological changes but also genetic factors and pre-injury and post-injury exposure 
to non-genetic factors (i.e., the exposome) can divide patients with ischaemic stroke into 
different endophenotypes with a variable risk for epileptogenesis27. Second, different studies 
have shown that previous vascular lesions including leukoaraiosis can be associated with a 
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higher risk of seizures. In addition to the primary ischaemic injury, existing difficult-to-
detect microscale changes in blood vessels and white matter present as epileptogenic 
pathologies27. Maxwell et al.156 showed that radiological cerebrovascular disease including 
signs of both large vessel and small vessel disease (periventricular or subcortical white 
matter lesions including leukoaraiosis) is significantly more prevalent in patients with late 
onset epilepsy. Furthermore, Gasparini and colleagues328 studying patients with epilepsy 
with or without a clinically identified stroke event, but for whom the cause of epileptogenesis 
was probably vascular, showed that those with leukoaraiosis frequently displayed clinical 
and EEG signs suggesting temporal lobe epilepsy. Third, data from both animal models and 
patients with different types of brain injury support the proposal that epileptogenesis and 
often subclinical epilepsy can start immediately after brain injury without any appreciable 
latent period147. Finally, seizures or epilepsy heralding stroke have been documented152,329, 
suggesting that epileptogenesis can begin before stroke.  
In Project 7, background activity asymmetry could also predict epilepsy in the first year after 
stroke, independently from clinical and imaging infarct severity. Because our subsequent 
work (Project 8) also disclosed that background activity asymmetry was superior to 
ASPECTS in the prediction of functional outcome one year after stroke, this variable seems 
to reflect the real extent of the neurophysiological severity of the infarct.  
Project 7 was also original in finding neurophysiological and imaging features that 
independently predicted the occurrence of EEG epileptiform activity during hospitalization 
for acute stroke. The presence of periodic discharges in an early EEG after stroke and the 
presence of islands of preserved cortex within the infarct, can help to identify patients with 
an anterior circulation ischaemic stroke who will need a more extensive or repetitive 
neurophysiological assessment in the Stroke Unit, including those patients with exclusively 
electrographic seizures, which corresponds to 1/5 of patients with acute symptomatic 
seizures, as found in Project 3. Although current guidelines for the treatment of post-stroke 
seizures148 recommend that isolated acute symptomatic seizures should not be treated with 
antiepileptic drugs, there are other reasons why their recognition is important. As also 
showed in this project, acute symptomatic seizures were independent risk factors for epilepsy 
in the year after stroke and some previous studies have shown that they might have an impact 
on stroke, vital and functional, outcome44,45. A more personalized medical approach to these 
patients, aimed at early recognition of unprovoked seizures or counselling about seizure-
provoking factors (such as sleep deprivation) could be considered and individually weighted. 
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In Project 8274, the influence of seizures and early EEG abnormalities in patients outcome, 
both at discharge and 12 months after stroke, was evaluated controlling for age and 
clinical/imaging severity of the infarct. Although previously suggested by the 
literature44,45,64,79,80,85–88, their independency from other important stroke outcome predictors 
was not established. We thought that, if they had such a value, the importance of their 
recognition will be reinforced, adding greater clinical meaning to our previous projects 
(Project 2, 3, 4, 5 and 7) and to this thesis. As a matter of fact, not only were acute 
symptomatic seizures and early EEG suppression independent predictors of vital outcome 
but also post-stroke epilepsy and early EEG asymmetry were independent predictors of 
functional outcome of patients one year after stroke. Moreover, post-stroke seizures and 
early EEG abnormalities were better than the CT scan performed at the emergency 
department in this outcome prediction, adding another value to EEG in the Stroke Unit.  
 
The hypothesis behind Project 9 was also that from EEG analysis, namely quantitative EEG 
analysis in this particular project, indexes could be extracted that will prove to be 
independent stroke outcome predictors. In a world increasingly grounded on automatic and 
computer-based big data analysis, using EEG outcome variables that are wholly dependent 
on human long-trained expert visual interpretation could also be a limitation of our work, 
even in a global internet age. It was possible to conclude that delta-theta to alpha-beta ratio 
and alpha relative power obtained within the first 72h post-stroke were good qEEG 
predictors of outcome and superior to ASPECTS in predicting unfavourable outcome of an 
acute middle cerebral artery infarct.  
Another important aspect of this EEG quantitative analysis (Project 9) was the observation 
that outcome prediction models including variables extracted from visual and quantitative 
analysis of the EEG showed similar characteristics. This ultimate finding of our project 
sequence can be interpreted as a validation of EEG visual analysis, giving robustness to 
previous findings of our research. 
 
1.2.  Integrated discussion of neurophysiological methodology  
 
The EEG is an exam that can include different technical procedures to meet the needs of the 
clinical problem7. In this thesis, we used multi-channel and high sampling rate EEG, with 
synchronised video recording and supplemental surface EMG, ECG and EOG channels. This 
methodological option allowed us to increase spatial resolution of this neurophysiological 
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technique, to perform back-average and quantitative EEG analysis and to make the clinical 
correlation of recorded neurophysiological events. Furthermore, prospective and systematic 
use of standardized international nomenclature and classification systems212, recommended 
for multicentre research on EEG patterns in patients with acute neurological disease248 was 
implemented. This procedure has several advantages such as an increase in inter-rater 
reliability248,249 and quality assurance330 and an easier building of research data bases330. 
Furthermore, it follows common neurological and clinical practice terms understandable to 
other physicians not specialized in EEG331.  For all these reasons, the reproducibility of our 
results in future studies and a possible multicentre collaboration is facilitated. 
 
However, there are some limitations in the neurophysiological workup used in this study. 
The serial and non-continuous nature of the EEG record might be considered a constraint. 
Interest in and enthusiasm for continuous EEG monitoring of critical neurological patients 
has increased, a fact that is evident in the literature and in different intensive care 
departments332,333. One of the present indications for its use is the detection of seizures and 
non-convulsive status epilepticus in patients with a supratentorial lesion and consciousness 
disturbance332. One of the arguments for its preferential use is the observation that seizures, 
mostly non-convulsive, are frequent in patients admitted to intensive care units75. This non-
convulsive nature means that they will not be diagnosed without an EEG record. However,  
neither the optimal duration nor when a continuous recorded should be started for more 
accurate electrographic seizure detection has been completely defined as yet. Furthermore, 
the clinical evidence favouring a continuous EEG versus a short duration EEG in detecting 
seizures is in fact limited76, especially in patients with ischaemic stroke admitted to non-
intensive care profile services (Appendices F and G) and its cost-benefit is not 
determined257. Continuous EEG requires considerable resources including time, specialized 
physicians and technicians333, and is not accessible at all centres, which limits its use in 
several Stroke Units. In patients admitted to non-intensive care profile departments, there is 
no robust evidence of continuous EEG superiority versus one or several short duration EEG 
records. In the recent consensus about continuous EEG332 it is not clear what is the best EEG 
technique for functional assessment of the brain, including epileptiform activity detection, 
in non-sedated conscious patients admitted to non-intensive care profile departments. In this 
work, early neurophysiological markers of an increased risk of EEG epileptiform activity 
during hospitalization were found in a single and short duration EEG. This result might guide 
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the need for a more prolonged study (serial or even continuous) only in some patients. In 
fact, studies about the performance of one or more short duration records for EEG 
epileptiform activity detection, like ours, have great clinical impact and the search for EEG 
markers, suggesting the need for a more prolonged or frequent record, a current trend of 
electroencephalography research255,256,272,273,334. An intensive care unit study with 
continuous EEG showed that 89% of seizures occurred within 72 h after an ischaemic or 
haemorrhage cerebral lesion252 and for that reason all of our stroke patients performed the 
first EEG within this time window. Besides this, the majority of seizures in critically ill 
patients in Claassen et al.75 study occurred in the first hour and in Westfall et al.256 in the 
first 30 minutes of the EEG monitoring study. Furthermore, Shafi et al.273 have showed that 
the absence of epileptiform activity in the first 30 minutes of an EEG record is associated 
with the absence of seizures in the rest of the continuous monitoring period of at least 18 
hours. 
The discussion about whether continuous EEG might have identified more electrographic 
seizures is not equivalent to the discussion on whether continuous EEG might have identified 
more patients with electrographic seizures. In fact, it is known that electrographic seizures 
repeat themselves in the absence of treatment335 and can have a cyclic pattern of repetition336. 
In the rat model of middle cerebral artery occlusion, animals had a mean of 10.6 seizures 
within 2 h. However, in Pandian et al study254 a cyclic pattern was only observed in 6.25% 
of the patients and in our series 2 out of 7 patients had repeated electrographic seizures during 
serial EEGs.  
In our study, EEG was not only used to detect ictal and interictal epileptiform manifestations 
in different time windows after stroke but also as a tool to identify cerebral dysfunction and, 
as such, as a predictor of stroke functional outcome. It can be argued that analysis of a 60 
minutes EEG might affect stroke outcome prediction in a different way than a continuous 
neurophysiological record, even admitting the same neurological status of the patient, 
including conscious state and pharmacological influences. Despite being called continuous 
EEG record, its interpretation is most frequently intermittent. In the clinical practice, visual 
analysis of continuous EEG is usually performed in time-limited segments for time saving 
reasons. Furthermore, EEG has essentially a non-stationary nature (i.e. EEG signal's 
statistical characteristics change with time)337. For that reason, some quantitative EEG 
technics including FFT analysis computes the discrete Fourier transform of different short 
EEG segments.  
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In our work, the decision to perform a serial EEG study instead of a continuous one mainly 
relied on our technological, human and logistic capacities and was based on factors of daily 
clinical practice. Continuous EEG in the first week after stroke was thought to be difficult 
to implement in a neurological department with no intensive care profile. The maintenance 
of multiple scalp EEG electrodes for such a long-time period is laborious and not easily 
tolerate by the non-sedated patient. In fact, in the study of Carrera et al. 29, 18% of continuous 
EEG records with only 10 electrodes were interrupted by patient agitation. Also, a 
continuous EEG might have been disruptive in the daily routine of a Neurology Department, 
where patients are carried to other departments and laboratories to complete the stroke 
diagnostic workup and complementary exams, some of which are incompatible with the 
presence of silver scalp EEG electrodes like MRI.    
 
1.3.  Integrated discussion of study limitations and strengths  
Specific study limitations have been discussed in the corresponding project chapter of this 
thesis. In an integrated approach, one could say that our sample sizes were a limitation for 
some analysis, as well as the lack of a non-contrast–enhanced acute CT scan, a systematic 
control CT scan and/or an MRI study during hospitalization. The serial and non-continuous 
nature of the EEG might also be considered a constraint and was already discussed. 
However, it is also important to realize that a convenience sample was used and that it was 
a daily clinical practice-based study, using the possible (although standardized) ancillary 
assessment. Actually, being a daily clinical practice-based study lends strength to our results 
in terms of internal value for the clinical practice in our Stroke Unit and EEG Laboratory.  
Also, the multidisciplinary constitution, the interdisciplinary involvement and the quality of 
the working clinical team provide further robustness to our results. Joining together a 
nationally recognised Stroke Unit and a Reference Center for Epilepsy, was a win-win 
situation, both for clinical practice and research. However, the generalization of results is 
unsuitable, as they only should be inferred to similar units and to patients with similar 
inclusion and exclusion criteria.  
Our rational for studying epileptic seizures and epileptiform activity in the 2nd decade of the 
21st century was based on the rapid evolution of stroke care in the years before. This rapid 
evolution also caused a limitation for our study due to the fact that, during the years of this 
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study, other acute stroke standards of care have emerged, such as endovascular therapy. So, 
research will continue on this topic in the years to come. 
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2.  CLINICAL IMPLICATIONS 
 
This thesis data allows some clear clinical messages:  
 
2.1. In the TIA Clinic: 
 
Epileptic seizures were the most frequently defined final diagnosis in patients with possible 
TIA, but the chance of an early EEG reporting interictal epileptiform activity was low 
(7.5%). 
 
2.2. In patients with an acute anterior circulation ischaemic stroke, admitted to the 
Stroke Unit:  
 
Clinical recognition of seizures was underestimated in more than 1/5 of cases. An EEG 
protocol can be used to increase the accuracy of this diagnosis.  
 
EEG with back-average analysis allowed the diagnosis of epilepsia partialis continua one 
year after an anterior circulation ischaemic stroke and the recognition of the cortical origin 
of involuntary movements in one patient during rtPA perfusion.  
 
Patients treated and non-treated with intravenous alteplase had the same frequency of 
epileptic seizures. 
 
An early post-stroke EEG helped to identify patients with a higher risk of post-stroke 
epilepsy and also an unfavourable stroke outcome, independently from clinical and imaging 
severity of the infarct.  
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3. RESEARCH PERSPECTIVES 
 
From this thesis, several other research questions about EEG and seizures in ischaemic 
cerebrovascular disease emerge and represent potential possibilities of future research.  
 
One type of research problem that deserves to be explored is, undoubtedly, the performance 
of different EEG methodologies aiming to increase the sensibility for epileptic 
manifestations diagnosis and also the prognostic power of this neurophysiological technique 
in cerebrovascular disorders. Other neurophysiological techniques (such as sleep deprived 
EEG, sleep quantitative EEG or EEG connectivity analysis) should be used to study the 
value of EEG in the differential diagnosis of transitory neurological symptoms, in post-
stroke epilepsy prediction and in stroke prognostication.  Furthermore, a research design can 
be established evaluating the performance and cost-effectiveness of continuous EEG record, 
in the detection of electrographic seizures and EEG epileptiform activity, compared to a spot 
or a serial EEG protocol.  
 
On the other hand, other imaging variables deserve analysis as post-stroke seizure predictors. 
A detail cerebral lesion study namely of haemorrhagic transformation type or severity and 
of previous vascular lesions / leucoaraiosis association with epileptic seizures occurrence, 
can be performed. Likewise, analysis of the relation between some Doppler sonography 
variables, such as collateral flow and vessel recanalization status merits investigation.   
 
In the present study, posterior circulation infarcts or other types of cerebrovascular diseases 
such as intracerebral haematomas or venous thrombosis were not included. However, the 
validation of our study in other types of stroke patients will be of clinical interest.  
 
Furthermore, endovascular therapy for acute stroke was recently included in our clinical 
practice and one (recently published) study338 found that haemorrhagic transformation 
following this procedure is associated with a nearly 5 times higher rate of developing post-
stroke seizures within 2 years. Therefore, the frequency of post-stroke seizures in patients 
with haemorrhagic transformation submitted and non-submitted to endovascular treatment 
deserves to be studied. 
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The influence of acute antiepileptic drug prescription in post-stroke epilepsy frequency and 
stroke outcome also merits further studies. Moreover, the post-stroke epilepsy impact on the 
quality of life of stroke patients is still an unanswered question. 
 
The advantage of including a neurophysiological variable, such as those identified in this 
thesis work, in the recently developed post-stroke epilepsy prediction model175, also deserves 
to be studied.  
 
Additionally, other epileptogenesis biomarkers (besides those analysed in this thesis) should 
be studied in the acute cerebrovascular disease clinical model, as they may be clinically 
valuable. These biomarkers include electrophysiological ones, such as high frequency 
oscillations and microseizures5, imaging biomarkers derived from PET, SPECT and 
functional MRI5 and genetic biomarkers of brain vulnerability to acquired epilepsy after 
insult324. As a matter of fact, several genetic variants, specifically involved in GABAergic 
neurotransmission, have been linked to the modulation of seizure threshold after injury 324 
and deserves to be studied in post-stroke patients in a translational collaborative study. Also, 
the study of epigenetic changes in stroke patients seems to be a new opportunity for the 
comprehension of the epileptogenesis process. Different epigenetic mechanisms have been 
already implicated in epilepsy339,340 and have also started to emerge as important players in 
stroke-induced endogenous brain recovery events such as angiogenesis, neurogenesis, 
oligodendrogenesis, synaptogenesis and axonal outgrowth341. Nevertheless, microRNAs are 
the leading epigenetic biomarker candidates for the early detection of epilepsy due to their 
differential expression and ready accessibility in blood samples339.  A new avenue of 
research in post-stroke epilepsy is also the study of neuroinflammation and microvascular 
injury biomarkers 324. 
 
Last but not least, multicentric studies should also be encouraged allowing external 
validation of these study results, power increase of statistical analysis and fruitful inter-peer 
discussion.  
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XVI. APPENDICES  
 
 
 
“There is no real ending. It’s just the place where you stop the story” 
Frank Herbert
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From Project 1 (Usefulness of EEG for the differential diagnosis of possible transient 
ischaemic attack): 
 
Appendix A. Antiepileptic drugs, epileptiform activity in the early EEG and the final 
diagnosis of epileptic seizures 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend to appendix A: EA - Epileptiform Activity / TIA - Transient Ischaemic Attacks / 
AED - antiepileptic drug (including benzodiazepine) / EA - epileptiform activity / * Three 
patients were under AED for neuropathic pain, two medicated with phenytoin due to well-
controlled and semiologically different seizures from the possible TIA under study and six 
with benzodiazepines for anxiety or insomnia. 
 
 
 
 
 
 
AED before the early EEG 
 
Yes 
n=1 
 
 
EA on the early EEG 
 
No 
n=10 
 
 
Possible 
TIA n=80 
 
Final diagnosis of 
epileptic seizures 
 
Yes
n=1 
 
Yes 
n=4 
 
Yes 
n=5
* 
Yes 
n=3 
 
Yes 
n=5 
 
 
No 
n=46 
 
 
No 
n=69 
 
 
Yes* 
n=11 
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From Project 2 (Frequency of post-stroke EEG epileptiform activity - a systematic review 
and meta-analysis of observational studies): 
 
Appendix B. Search Strategies: 
Embase 
1. exp cerebrovascular disease/ or ((Cerebrovascular$ adj1 Disorder$) or stroke$ or 
((intracran$ or cereb$ or brain or Subarachno$) adj1 (Infarct$ or Ischemi$ or Ichaemi$ 
or Hematom$ or Haematom$ or Hemorrhag$ or Haemorrhag$ or thrombos$ or 
emboli$))).ti,ab. 
2. exp focal epilepsy/ or exp generalized epilepsy/ or exp traumatic epilepsy/ or exp 
reflex epilepsy/ or exp seizure/  or exp epileptic state/ or (((partia$ or focal) adj2 
epilep$) or (genera$ adj4 epilep$) or (traumatic adj2 epilep$) or (reflex$ adj2 epilep$) 
or seizur$ or (statu$ adj2 epilep$)).ti,ab. 
3. exp cohort analysis/ or exp longitudinal study/ or exp prospective study/ or exp follow 
up/ or exp case control study/ or (cohort$ or (case$ adj10 control$)).tw. 
4. 1 and 2 and 3 
5. (animal$ not human$).sh,hw. 
6. 4 not 5 
7. limit 6 to exclude medline journals 
 
MEDLINE 
1. exp Cerebrovascular Disorders/ or ((Cerebrovascular$ adj1 Disorder$) or stroke$ or 
((intracran$ or cereb$ or brain or Subarachno$) adj1 (Infarct$ or Ischemi$ or Ichaemi$ 
or Hematom$ or Haematom$ or Hemorrhag$ or Haemorrhag$ or thrombos$ or 
emboli$))).ti,ab. 
2. exp Epilepsies, Partial/ or exp Epilepsy, Generalized/ or exp Epilepsy, Post-Traumatic/ 
or exp Epilepsy, Reflex/ or exp Seizures/  or exp Status Epilepticus/ or ((partia$ adj2 
epilep$) or (genera$ adj4 epilep$) or (post-traumatic adj2 epilep$) or (reflex$ adj2 
epilep$) or seizur$ or (statu$ adj2 epilep$)).ti,ab. 
3. exp cohort studies/ or exp case-control studies/ or (cohort$ or (case$ adj10 
control$)).tw. 
4. epidemiologic methods/ 
5. limit 4 to yr=1966-1989 
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6. 3 or 5 
7. 1 and 2 and 6 
8. Animals/ not Human/ 
9. 7 not 8 
 
PsycINFO 
1. exp Cerebrovascular Disorders/ or ((Cerebrovascular$ adj1 Disorder$) or stroke$ or 
((intracran$ or cereb$ or brain or Subarachno$) adj1 (Infarct$ or Ischemi$ or Ichaemi$ 
or Hematom$ or Haematom$ or Hemorrhag$ or Haemorrhag$ or thrombos$ or 
emboli$))).ti,ab. 
2. exp Epilepsy/ or exp Seizures/ or ((partia$ adj2 epilep$) or (genera$ adj4 epilep$) or 
(post-traumatic adj2 epilep$) or (reflex$ adj2 epilep$) or seizur$ or (statu$ adj2 
epilep$)).ti,ab. 
3. exp Cohort Analysis/ or (cohort$ or (case$ adj10 control$)).tw. 
4. 1 and 2 and 6 
5. Animals/ not Human/ 
6. 7 not 8 
 
Web of Science 
TOPIC: (Cerebrovascular Disorder* OR Cerebrovascular Disease* OR stroke* OR 
((intracran* OR cereb* OR brain OR Subarachno*) NEAR/1 (Infarct* OR Ischemi* OR 
Ichaemi* OR Hematom* OR Haematom* OR Hemorrhag* OR Haemorrhag* OR 
thrombos* OR emboli*))) AND TOPIC: (((Generali OR Partial OR Focal OR Trauma* OR 
Reflex OR Stat*) NEAR/2 Epilep*) OR Seizure*) AND TOPIC: (Cohort* OR Case-
Control* OR (case* NEAR/10 control*))  
Timespan: All years. Indexes: SCI-EXPANDED, CPCI-S.  
 
Open Grey 
(Cerebrovascular Disorder* OR Cerebrovascular Disease* OR stroke* OR ((intracran* OR 
cereb* OR brain OR Subarachno*) NEAR/1 (Infarct* OR Ischemi* OR Ichaemi* OR 
Hematom* OR Haematom* OR Hemorrhag* OR Haemorrhag* OR thrombos* OR 
emboli*))) AND (((Generali OR Partial OR Focal OR Trauma* OR Reflex OR Stat*) 
NEAR/2 Epilep*) OR Seizure*) AND (Cohort* OR Case-Control* OR (case* NEAR/10 
control*)  
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From Project 2 (Frequency of post-stroke EEG epileptiform activity - a systematic review 
and meta-analysis of observational studies): 
 
Appendix C. Included studies 
1. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E. Predictive factors 
of early seizures after acute cerebrovascular disease. Stroke; a journal of cerebral 
circulation. 1997;28:1590-1594 
2. Carrera E, Michel P, Despland PA, Maeder-Ingvar M, Ruffieux C, Debatisse D, et 
al. Continuous assessment of electrical epileptic activity in acute stroke. Neurology. 
2006;67:99-104 
3. Chen Y, Chen L, Tao Y, Han M, Cui C, Liu S. Post-stroke seizures in consecutive 
elderly stroke patients. Neural Regeneration Research. 2011;6:717-720 
4. Claassen J, Hirsch LJ, Frontera JA, Fernandez A, Schmidt M, Kapinos G, et al. 
Prognostic significance of continuous eeg monitoring in patients with poor-grade 
subarachnoid haemorrhage. Neurocritical Care. 2006;4:103-112 
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From Project 3 (Post-stroke seizures are clinically underestimated): 
 
Appendix D. Video-EEG technical protocol 
The EEG record followed the recommendations of the IFCN 207, ILAE 208, ACNS 209,210 and 
LPCE 3. Video-EEG was performed by a Nihon-Kohden device (Neurofax EEG-1200) with 
a sampling frequency of 1000 Hz. We used the international 10/10 electrode placement 
system and recorded at least 64 EEG channels. An electrode cap adapted to the patient’s 
head size was used and the correct position of the electrodes was confirmed. Two 
electrooculogram channels and one chin electromyogram channel were also recorded using 
silver chloride electrodes. If involuntary movements were observed, additional EMG 
electrodes were placed allowing EMG/EEG synchronized recording. The electrode 
impedance was less than 5 KOhms at the beginning of the record and was revaluated 
whenever a compatible artifact was detected. The total recording period was at least 35 
minutes of wakefulness, including activation tests. Sleep was recorded whenever possible at 
the end of the exam. The maximum duration of the test was 60 minutes. The acquisition 
parameters were: sensitivity at 10 µV/mm; time constant at 0.3s; high frequency filter at 70 
Hz. 50Hz filter was used when other attempts to eliminate electric artifact failed. The record 
included 3 different montages (bipolar longitudinal, bipolar transverse and referential). All 
attempts to fix EEG artifacts by the technical team were annotated in the record itself. Except 
in the final phase of the record, the technician tried to keep the patient awake or at his/her 
maximum alert level. Changes in consciousness level were also recorded. For patients in 
stupor/coma, the auditory and somatosensory stimulation was used systematically (and 
recorded). In the event of repetitive epileptiform or periodic discharges, delta rhythmic 
activity and spatiotemporal evolution of rhythmic or periodic activity, even in the absence 
of obvious behavioural manifestations, the EEG technician called medical staff who looked 
for subtle clinical epileptiform manifestations and systematically assessed consciousness 
level, orientation, response to simple motor orders (open and close your eyes, open and close 
both hands), naming of objects (pen, clock), numbers count in descending order, verbal 
memory and muscle strength of the upper limbs during the event.    
All records were performed by EEG technicians with experience in video-EEG and EEG 
records in acute brain lesion patients, under medical supervision, using the following 
technical protocol:  
Appendices 
279 
 
I. In the longitudinal bipolar montage: 
1st Lying patient with eyes closed: 5 minutes   
2nd Opening eyelids for 5 seconds and ocular fixation on one point, then closing eyelids 25 
seconds (opening/closing of the eyelids was done manually by the technician for an 
uncooperative patient). Twice repeated. 
3rd Patient lying with eyes closed: 5 minutes  
4th Hyperventilation for 3 minutes (the patient’s effort was graduated: weak, medium, good, 
excellent). It was not made in the presence of contraindications. 
 
II. In bipolar transverse montage: 
5th Patient lying with eyes closed: 5 minutes  
6th Opening eyelids for 5 seconds and ocular fixation on one point, then closing eyelids 25 
seconds (opening/closing of the eyelids was done manually by the technician for an 
uncooperative patient). Twice repeated. 
 
III. In “average” montage: 
7th Patient lying with eyes closed: 5 minutes  
8th Intermittent photic stimulation performed with eyes open and closed with a photic 
stimulator at 30 cm in front of the eyes and using stimulation frequencies between 1 and 30 
Hz, with 10 seconds range between stimuli.  
9th Patient lying with eyes closed: 5 minutes 
10th Patient lying with eyes closed until the end of the exam. Sleep was allowed in this period. 
Can be registered in the transverse bipolar montage. 
Whenever myoclonus was observed during the neurological examination, synchronized 
EMG record of the involuntary movement was added to the exam. The EEG record in that 
situation included not only eye-lid opening and closure, hyperventilation, photic stimulation, 
but also manoeuvres to elicit myoclonus, as previously observed in the neurological 
evaluation to allow “jerk-lock back-average” analysis.  
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From Project 3 (Post-stroke seizures are clinically underestimated) 
 
Appendix E. Clinical and imaging characteristics of patients with electrographic seizures 
during hospital admission  
 Pt1 Pt2 Pt3 Pt4 Pt5 Pt6 Pt7 
Age (years) 74 69 78 49 66 77 78 
Admission NIHSSa  17 15 23 12 18 7 8 
Intravenous alteplase treatment no yes yes yes yes yes yes 
Exclusively cortical lesion  no no no no no no no 
Exclusively subcortical lesion  no no no no no no no 
Cortical and subcortical lesion  yes yes yes yes yes yes yes 
1stCTb ASPECTSc 
- Total 
- Cortical territories of this scale  
 
4 
1 
 
6 
6 
 
9 
6 
 
5 
2 
 
7 
4 
 
9 
3 
 
9 
6 
Day after stroke with seizures  2.nd  
6.st 
3rd 2.nd 2.nd 2.nd 
6.th   
7.th 
8.th  
2.nd 
Acute symptomatic seizures 
(clinically)  
no no no no no yes yes 
NCSEd criteria  no yes no yes no yes no 
AEDe at discharge  no NAg no yes no yes no 
mRSf at discharge  4 6 5 4 4 4 1 
Unprovoked seizures  no NA no yes yes yesh no 
mRS at 12 months  6 6 6 4 3 3 0 
Legend to appendix E: aNIHSS - National Institutes of Health Stroke Scale score ; b1stCT - 1st 
CT scan obtain at the emergency department; cASPECTS - Alberta Stroke Program Early 
CT Score; dNCSE - Non-convulsive status epilepticus; eAED - Antiepileptic drug ; fmRS -
modified Rankin Scale score ; gNA – Non applicable; hAt 12 months after stroke this patient 
had focal motor seizures of the left limbs and myoclonus of the upper left limb (contralateral 
to the ischaemic lesion) with cortical correlate by back-average analysis technique, 
according to the diagnosis of EPC [1] 
Appendix E reference: 1. Bentes C, Franco AC, Peralta AR, et al (2017) Epilepsia partialis 
continua after an anterior circulation ischaemic stroke. 1–6. doi: 10.1111/ene.13310
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From Project 4 (Epilepsia Partialis Continua after an anterior circulation ischaemic 
stroke): 
 
Appendix H. ASPECTS vascular territory in patients with middle cerebral artery territory 
limited infarct  
ASPECTS  Vascular Territory Number (%) of 
patients 
Subcortical Lentiform nucleus 73 (58.9%) 
Caudate 45 (36.3%) 
Internal Capsula  48 (38.7%) 
Cortical Insular ribbon 81 (65.3%) 
M1 39 (31.5%) 
M2 63 (50.8%) 
M3 36 (29.0%) 
M4 30 (24.2%) 
M5 71 (57.3%) 
M6 48 (38.7%) 
Legend to appendix H: M1 - anterior middle cerebral artery (MCA) cortex; M2 - MCA 
cortex lateral to the insular ribbon; M3 – posterior MCA cortex; M4, M5, M6 - anterior, 
lateral and posterior MCA territories immediately superior to M1, M2 and M3, rostral to 
basal ganglia. 
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From Project 4 (Epilepsia Partialis Continua after an anterior circulation ischaemic 
stroke): 
 
Appendix I. Video 1 (digital only): 
Link to video 1 -  https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.13310 (ene13310-
sup-0002-VideoS1.mov) 
Video 1 description - Irregular, small amplitude, non-synchronized, subtle, mainly jerky 
movements of several fingers of patient 1, accentuated by posture, are observed 
 
From Project 4 (Epilepsia Partialis Continua after an anterior circulation ischaemic 
stroke) 
 
Appendix J. Video 2 (digital only): 
Link to video 2 - https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.13310 (ene13310-
sup-0003-VideoS2.mov) 
Video 2 description - Irregular, small amplitude, non-synchronized, subtle, jerky movements 
of several fingers of patient 2 are observed 
 
From Project 5 (Cortical myoclonus during intravenous thrombolysis for ischaemic 
stroke): 
 
Appendix K. Video 3 (digital only):  
Link to video 3 - http://dx.doi.org/10.1016/j.ebcr.2014.09.004 
Video 3 description - After rtPA bolus, involuntary movements of the upper paretic limb 
were noticed. The movements involved either the distal or the proximal muscles, 
independently, and could be jerk-like, irregular, myoclonic-like, or slow and brief.  
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From Project 7 (Early EEG predicts post-stroke epilepsy): 
 
Appendix N. Clinical, imaging characteristics and 1st EEG abnormalities in patients with 
(vs. without) EEG seizures during hospital stay (bivariate analysis) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend to appendix N: aSD - standard deviation; bNIHSS - National Institutes of Health 
Stroke Scale score; cIQR - interquartile range; d1st CT - 1st CT scan obtain at the emergency 
department; eASPECTS - Alberta Stroke Program Early CT Score ; fCortical ASPECTS - 
value in ASPECTS considering only the 7 cortical territories of this scale; gBA - background 
activity; hFSWA - focal slow wave activity; iRSWA - rhythmic slow wave activity; jPD - 
periodic discharges, kIEA - interictal epileptiform activity  
Patients with (n=7) vs. without EEG seizures  p 
Mean Age (SDa) 0.528 
Median admission NIHSSb (IQRc) 0.476 
1st CTd median ASPECTSe (IQR) 0.028 
1st CT median  CORTICALf ASPECTS (IQR) 0.027 
Islands of preserved cortex within the infarct 0.030 
BAg slowing  1.000 
BA asymmetry  0.135 
Suppression  0.447 
FSWAh 1.000 
RSWAi 0.346 
PDj 0.609 
IEAk 0.161 
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From Project 9 (Quantitative EEG and outcome of ischaemic stroke patients): 
 
Appendix P. qEEG index calculations 
Glossary:  
# RP – Relative Power;  
# AP – Absolute Power;  
# Affected – band power from electrodes in the affected ischaemic stroke hemisphere  
# Unaffected - band power electrodes in the unaffected hemisphere 
# D1 - EEG performed in the first 72 hours after stroke  
# D7 - EEG performed at day 7 after stroke or at discharge  
 
Note: when not mentioned, power from all electrodes (affected, unaffected hemisphere and 
midline) was used. 
 
QEEG indices: 
I. GLOBAL RELATIVE BAND POWER INDICES 
# Delta RP = delta AP / (delta AP + theta AP + alpha AP + beta AP) 
# Theta RP = theta AP / (delta AP + theta AP + alpha AP + beta AP) 
# Alpha RP = alpha AP / (delta AP + theta AP + alpha AP + beta AP) 
# Beta RP = beta AP / (delta AP + theta AP + alpha AP + beta AP) 
# DTABR (Delta-theta / alpha-beta Ratio) = (delta AP + theta AP) / (alfa AP + beta AP) 
# DAR (delta AP / alpha AP ratio) = total delta AP / total alpha AP 
 
II. SYMMETRY INDICES 
# BSI (brain symmetry index) = 
1
𝑁𝑁
∑ ��
𝑅𝑅𝑅𝑅−𝐿𝐿𝑅𝑅
𝑅𝑅𝑅𝑅+𝐿𝐿𝑅𝑅
��𝑁𝑁𝑅𝑅=1  ; where: N = number of 
electrode pairs; R and L = AP in right and left hemisphere electrodes 
# Affected / Unaffected = affected hemisphere AP / unaffected hemisphere AP 
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III. AFFECTED and UNAFFECTED HEMISPHERE INDICES 
# Affected slow RP = (affected delta AP + affected theta AP) / (delta AP + theta AP) 
# Affected fast RP = (affected alpha AP + affected beta AP) / (alpha AP + beta AP) 
# Affected DTABR = (affected delta AP + affected theta AP) / (affected alpha AP + affected 
beta AP) 
# Unaffected DTABR = (unaffected delta AP + unaffected theta AP) / (unaffected alpha AP 
+ unaffected beta AP) 
# Affected DAR = affected delta AP / affected alpha AP 
# Unaffected DAR = unaffected delta AP / unaffected alpha AP 
 
IV. TIME CHANGES INDICES 
# Acute Symmetry Change Index = [(Affected AP in D1 – Unaffected AP in D1) – (Affected 
AP in D1 – Unaffected AP in D7] / [(Affected AP in D1 – Unaffected AP in D1) x (time 
between exams in days)] 
# Acute Delta Change Index = (delta AP in D1 – delta AP in D7) / [(delta AP in D1) x (time 
between exams in days)] 
# Acute Theta Change Index = (theta AP in D1 – theta AP in D7) / [(theta AP in D1) x (time 
between exams in days)] 
# Acute Alpha Change Index = (alpha AP in D1 – alpha AP in D7) / [(alpha AP in D1) x 
(time between exams in days)] 
# Acute Beta Change Index = (beta AP in D1 – beta AP in D7) / [(beta AP in D1) x (time 
between exams in days)] 
# Acute DTABR Change Index = (DTABR in D1 – DTABR in D7) / [(DTABR in D1) x 
(time between exams in days)] 
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From Project 9: 
 
Appendix Q.  
Appendix Q.1. – Symmetry and affected/unaffected qEEG indices and outcome at 
discharge. 
qEEG Index mRS<3 mRS≥3 Bivariate 
analysis 
(p) 
Multivariate 
analysis  
OR (95%CI) 
Cross-
validated  
AUC  
(95% CI) 
1st EEG (0-72h)      
BSI 
0.13 ± 0.06 
(0.13) 
0.16 ±0.07 
(0.15) 
0.010 ns NA 
Affected AP / 
unaffected AP 
1.22 ± 0.35 
(0.12) 
1.37 ± 0.46 
(1.25) 
ns NA 
NA 
Affected slow RP 
0.49 ± 0.08 
(0.48) 
0.52 ± 0.09 
(0.52) 
ns NA 
NA 
Affected fast RP 
0.44 ± 0.05 
(0.44) 
0.41 ± 0.06 
(0.41) 
0.003 ns 
NA 
Affected DTABR 
1.89 ± 1.64 
(1.38) 
5.07 ± 4.17 
(3.97) 
<0.001 
2.74 (1.62-4.64); 
p<0.001 
0.815  
(0.744 - 0.885) 
Affected DAR 
3.00 ± 3.23 
(2.08) 
8.90 ± 9.27 
(6.09) 
<0.001 
2.44 (1.57-3.79); 
p<0.001 
0.821  
(0.751 -  0.891) 
Unaffected DTABR 
1.58 ± 1.15 
(1.34) 
3.63 ± 3.01 
(2.80) 
<0.001 
3.03 (1.66-5.51); 
p<0.001 
0.814  
(0.743 - 0.885) 
Unaffected DAR 
2.34 ± 2.45 
(1.66) 
4.99 ± 4.73 
(3.44) 
<0.001 
2.30 (3.70); 
p<0.001 
0.794  
(0.719 - 0.870) 
Legend to appendix Q1: Results in the 2nd and 3rd column are shown as mean ± standard 
deviation (median) of the natural logarithm of the EEG index. Multivariate analyses 
included the variables age, NIHSS score at admission and ASPECTS; OR - odds ratio; CI 
95% - 95% confidence interval; RP -  relative power; affected - affected ischaemic stroke 
hemisphere; unaffected - unaffected hemisphere; slow - delta + theta; fast - alpha + beta; 
DTABR - delta-theta to alpha-beta ratio; DAR - delta to alpha ratio; ns - non-significant; 
NA - not applicable. All bivariate analysis were performed with Mann-Whitney U test. 
 
 
Appendix Q.2. Symmetry, affected and unaffected and time changes qEEG indices and 
outcome at 12 months.  
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qEEG Index mRS<3 mRS≥3 Bivariate 
analysis 
(p) 
Multivariate 
analysis 
OR (95%CI) 
Cross-
validated 
AUC  
(95% CI) 
1st EEG  
(0 – 72 hours) 
     
BSI 0.14 ± 0.06 (0.13) 
0.17 ± 0.08 
(0.15) 
0.008 ns - 
Affected 
AP/unaffected AP 
1.27 ± 0.34 
(1.18) 
1.37 ± 0.50 
(1.25) 
ns - - 
Affected fast RP  
0.43 ± 0.05 
(0.44) 
0.41 ± 0.07 
(0.41) 
0.002* ns - 
Affected slow RP 2.37 ± 2.12 (1.69) 
5.56 ± 4.39 
(4.48) 
ns* - - 
Affected DTABR 2.36 ± 2.12 (1.69) 
5.56 ± 4.39 
(4.48) <0.001 
2.67  
(1.56-4.55) 
p<0.001 
0.831  
(0.766 - 0.896) 
Affected DAR 
3.58 ± 3.40 
(2.48) 
10.09 ± 
10.07 (7.74) 
<0.001 2.55  
(1.59-4.08) 
p<0.001 
0.849  
(0.788 - 0.911) 
Unaffected  
DTABR 
1.74 ± 1.14 
(1.48) 
4.08 ± 3.24 
(3.16) 
<0.001 3.62  
(1.88-7.02) 
p<0.001 
0.852  
(0.791 - 0.913) 
Unaffected  DAR 
2.38 ± 2.00 
(2.22) 
5.74 ± 5.15 
(4.20) 
<0.001 2.62  
(1.56-4.41) 
p<0.001 
0.850  
(0.787 - 0.912) 
2nd EEG  
(day 7 / discharge) 
     
 BSI 0.13 ± 0.06 
(0.11) 
0.16 ± 0.07 
(0.14) 
0.002 nsb - 
Affected/unaffected  0.49 ± 0.07 (0.48) 
0.48 ± 0.08 
(0.47) 
ns - - 
Affected fast RP 
0.42 ± 0.04 
(0.43) 
0.39 ± 0.07 
(0.39) 
<0.001* 0.02 ( 
0.001-0.45) 
p=0.014 
0.789  
(0.715 - 0.864) 
Affected slow RP 
0.49 ± 0.07 
(0.48) 
0.48 ± 0.08 
(0.47) 
<0.001* 0.39  
(0.01-5.25) 
p<0.001 
0.776  
(0.699 - 0.852) 
Affected DTABR 
2.39 ± 2.84 
(1.46) 
13.31 ± 
48.01 (5.83) 
<0.001 2.76  
(1.7-4.47) 
p<0.001 
0.838  
(0.771 - 0.904) 
Affected DAR 
3.15 ± 3.83 
(1.74) 
21.11 ± 
78.78 (8.39) 
<0.001 2.32  
(1.54-3.48); 
p<0.001 
0.833  
(0.766 - 0.899) 
Unaffected  
DTABR 
1.49 ± 1.31 
(1.06) 
8.67 ± 26.26 
(3.05) 
<0.001 3.45  
(1.9-6.15); 
p<0.001 
0.836  
(0.771 - 0.901) 
Unaffected  DAR 
2.04 ± 1.97 
(1.28) 
13.40 ± 
42.80 (4.11) 
<0.001 2.58  
(1.61-4.15); 
p<0.001 
0.832  
(0.766 - 0.898) 
qEEG Index mRS<3 mRS≥3 Bivariate 
analysis 
(p) 
Multivariate 
analysis 
OR (95%CI) 
Cross-
validated 
AUC  
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Legend to appendix Q2: Results in the 2nd and 3rd column are shown as mean ± standard 
deviation (median) of the natural logarithm of the EEG index. Multivariate analyses included 
the variables age, NIHSS at admission and ASPECTS scores; slow - delta + theta; fast - 
alpha + beta; DTABR - delta-theta to alpha-beta ratio; DAR - delta to alpha ratio; OR - odds 
ratio; RP – relative power; ns - non-significant; NA - not applicable. *t-test (otherwise Mann-
Whitney U test)
(95% CI) 
Time Changes 
índices  
     
Acute Symmetry 
Change Index 
-0.22 ± 1.07 
(0.04) 
-0.22 ±1.03 
(0.08) 
ns NA NA 
Acute Delta 
Change Index 
-0.16 ± 1.04 
(0.05) 
-0.48 ± 2.05 
(0.05) 
ns NA NA 
Acute Alpha 
Change Index 
-0.71 ± 3.47 
(-0.01) 
-0.34 ± 1.25 
(0.02) 
ns NA NA 
Acute Beta Change 
Index 
-0.97 ± 3.68 
(0.01) 
-0.64 ± 3.38 
(0.05) 
ns NA NA 
Acute DTABR 
Change Index  
0.03 ± 0.11 
(0.05) 
-0.29 ±1.42 
(0.002 
0.008 ns NA 
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XVII. FACSIMILE  
 
 
 
“I love science… 
Show me the research, show me the results, show me the conclusions –  
and then show me some qualified peer reviews of all that” 
Claire Scovell LaZebnik
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What you are in love with, what seizes your imagination, will affect everything.  
It will decide what gets you out of bed in the mornings, what you do with your evenings, 
how you spend your weekends, what you read, who you know, what breaks your heart, and 
what amazes you with joy and gratitude.  
Fall in love, stay in love, and it will decide everything 
 
Pedro Arrupe, S.J. 
 
 
